GoHealthcare Clinical & Utilization Excellence Framework™

GoHealthcare Clinical & Utilization Excellence Framework™

Developed by GoHealthcare Practice Solutions

Part of the GoHealthcare Knowledge Center

GoHealthcare Practice Solutions

GoHealthcare Clinical & Utilization Excellence Framework™

A comprehensive operating model for connecting clinical judgment, medical necessity, evidence-based care, utilization management, documentation, procedure readiness, quality, care coordination, technology, and measurable performance across musculoskeletal specialty care.

Explore the 40-Section Framework

Foundation and Governance

1. The Strategic Purpose of Clinical and Utilization Excellence
2. Establishing a Clinical and Utilization Governance Model
3. Aligning Clinical Decisions, Patient Access, and Operational Performance
4. Defining Appropriate and Evidence-Based MSK Specialty Care
5. Building Accountability Across the Clinical Care Continuum

Medical Necessity and Clinical Validation

6. Establishing the Medical Necessity Operating Model
7. Clinical Indication Validation
8. Diagnostic and Conservative Care Requirements
9. Payer Coverage Criteria Alignment
10. Level of Service Appropriateness, Exception Review, and Escalation

Evidence, Pathways, and Patient-Centered Care

11. Clinical Pathways and Protocols
12. Specialty Guidelines and Standards
13. Shared Decision-Making and Patient-Centered Care
14. Treatment Variation Review and Management
15. Evidence Review and Pathway Updates

Utilization Management

16. Establishing the Utilization Management Operating Model
17. Prospective Utilization Review
18. Concurrent Utilization Review
19. Retrospective Utilization Review
20. Prior Authorization, Peer-to-Peer Review, and Appeals Integration

Clinical Documentation Excellence

21. Establishing the Clinical Documentation Excellence Operating Model
22. Documentation Completeness and Medical Necessity Support
23. Procedure-Specific Documentation Standards
24. Clinical Documentation Integrity, Templates, and Copy Forward Controls
25. Provider Education, Clinical Queries, Audits, and Feedback

Procedure Readiness

26. Establishing the Procedure Readiness Operating Model
27. Pre-Procedure Clinical Validation and Readiness Checklists
28. Medical Clearance, Diagnostic Testing, and Clinical Risk Stratification
29. Medication, Anticoagulation, Infection, and Periprocedural Safety Management
30. Facility, Equipment, Implant, Anesthesia, and Patient Logistics Readiness

Quality, Care Coordination, and Performance

31. Establishing the Quality and Care Coordination Operating Model
32. Patient Safety and Clinical Risk Management
33. Multidisciplinary Care Coordination and Closed-Loop Communication
34. Care Transitions, Discharge Planning, and Follow-Up Reliability
35. Outcomes Measurement and Patient-Reported Outcome Integration
36. Adverse Events, Complications, Near Misses, and Organizational Learning
37. Clinical Quality Metrics, Utilization Analytics, and Performance Intelligence

Technology, Improvement, and Implementation

38. Technology, Data, Automation, and Artificial Intelligence in Clinical Operations
39. Continuous Improvement, Workforce Competency, and Change Management
40. Framework Implementation, Maturity, and Enterprise Accountability

01

The Strategic Purpose of Clinical and Utilization Excellence

Clinical and utilization excellence is the disciplined coordination of clinical judgment, medical necessity, evidence-based care, payer requirements, documentation, procedure readiness, quality, and patient outcomes.

In musculoskeletal specialty care, a physician’s treatment recommendation does not move directly from the examination room to the procedure suite or operating room. It must pass through a complex sequence of clinical and operational requirements. The diagnosis must be supported. The indication must be clear. Conservative treatment may need to be demonstrated. Imaging and examination findings must correlate with the treatment plan. Documentation must satisfy clinical, payer, coding, compliance, and facility requirements. Authorization must be obtained when required. The patient, facility, equipment, medications, and clinical team must all be prepared.

A failure at any point in this sequence can delay or prevent appropriate care.

The GoHealthcare Clinical & Utilization Excellence Framework™ creates an integrated operating model for managing this entire continuum. It is designed specifically for interventional pain management, physical medicine and rehabilitation, orthopedic surgery, orthopedic spine surgery, neurosurgery, neuromodulation, and ambulatory surgery centers.

These specialties require a highly coordinated approach because they frequently involve:

• Complex diagnostic pathways
• Step-therapy and conservative-treatment requirements
• Procedure-specific medical-necessity criteria
• Extensive prior authorization requirements
• Payer-directed site-of-care restrictions
• Implants, devices, medications, imaging, and specialized supplies
• Preoperative testing and medical clearance
• Medication and anticoagulation management
• Multiple clinical and administrative handoffs
• High financial exposure when procedures are denied, delayed, or cancelled

The framework addresses these challenges by connecting six essential domains:

• Medical Necessity
• Evidence-Based Care
• Utilization Management
• Clinical Documentation
• Procedure Readiness
• Quality and Care Coordination

These domains are supported by clinical technology, data, automation, analytics, dashboards, utilization platforms, clinical decision support, authorization tools, and performance intelligence.

Moving Beyond Fragmented Clinical Operations

Many specialty organizations manage clinical care through disconnected departments.

The physician determines the treatment plan. Clinical staff document the visit. The prior authorization team reviews payer requirements. Scheduling reserves a procedure date. A facility coordinates supplies. A nurse provides patient instructions. The revenue cycle team later submits the claim.

Each department may complete its assigned task, yet the overall case can still fail because the work was not coordinated as one integrated process.

Examples include:

• A procedure is scheduled before medical-necessity requirements are confirmed.
• An authorization request is submitted without the required conservative-treatment history.
• A payer approval is obtained, but the authorized site of service does not match the scheduled facility.
• A surgical case is approved, but medical clearance is incomplete.
• An implant is ordered, but the payer has not separately authorized the device.
• A patient is instructed to hold medication without clear clinical confirmation.
• A procedure is completed, but the response is not documented sufficiently to support subsequent treatment.

The GoHealthcare framework replaces fragmented task completion with coordinated episode management. Each patient’s pathway is managed from clinical decision through treatment readiness, delivery, follow-up, and outcome evaluation.

The Right Care Operating Principle

The central operating principle of the framework is to help ensure that the right patient receives the right care at the right time, in the right setting, with the right documentation and preparation.

The right patient means that the diagnosis, symptoms, functional limitations, examination findings, treatment history, imaging, risks, and patient goals support the proposed intervention.

The right care means that the service is clinically appropriate, evidence-informed, individualized, and reasonably expected to benefit the patient.

The right time means that the patient has progressed appropriately through the treatment pathway and that unnecessary administrative delays have been prevented.

The right setting means that the care is delivered in an environment appropriate for the patient’s clinical risk, procedure complexity, anesthesia needs, equipment requirements, payer rules, and cost considerations.

The right documentation means that the clinical record clearly communicates the patient’s condition, the physician’s reasoning, the treatment performed, and the patient’s response.

The right preparation means that all clinical, operational, medication, testing, clearance, equipment, supply, scheduling, and patient-readiness requirements are satisfied before the procedure.

This principle is simple to state but difficult to operationalize. The framework provides the structure required to make it repeatable.

Clinical Judgment and Coverage Requirements

Clinical appropriateness and payer coverage are related but are not identical.

A physician may determine that an intervention is appropriate based on the patient’s condition, professional judgment, available evidence, previous treatment response, and expected benefit. A payer may apply additional coverage requirements, such as documented physical therapy, duration of symptoms, imaging findings, diagnostic-block thresholds, frequency limitations, or site-of-care restrictions.

The framework does not allow payer policy to replace physician judgment. It ensures that the organization understands the difference between clinical decision-making and coverage determination.

Clinical teams must determine and document why the care is appropriate.

Utilization teams must determine whether the clinical record satisfies applicable coverage criteria.

When a payer requirement conflicts with the physician’s clinical determination, the organization must have a structured process for clarification, peer-to-peer review, exception handling, or appeal.

The objective is not to practice medicine according to an authorization checklist. The objective is to present the physician’s clinical reasoning in a complete, accurate, and defensible manner.

Protecting Patient Access

Utilization management is often perceived as a mechanism for controlling healthcare expenditures. Within this framework, it is also a critical patient-access function.

A medically appropriate procedure that cannot move forward because of incomplete documentation, missed authorization deadlines, poor communication, or failed readiness processes represents an access failure.

Patients affected by chronic pain, progressive neurologic symptoms, impaired mobility, musculoskeletal injury, spinal disease, or failed conservative treatment may experience significant consequences when care is delayed. These may include:

• Continued pain and functional limitation
• Reduced ability to work or perform daily activities
• Prolonged medication use
• Worsening neurologic or musculoskeletal symptoms
• Repeated office visits
• Increased emergency or urgent-care utilization
• Loss of confidence in the treatment team
• Abandonment of the recommended treatment plan

Clinical and utilization excellence protects access by identifying barriers early, assigning ownership, accelerating escalation, and creating visibility into every unresolved case.

Reducing Preventable Denials and Delays

Many authorization denials are not caused by a fundamentally inappropriate treatment recommendation. They result from preventable operational deficiencies.

Common examples include:

• Incomplete documentation of conservative treatment
• Missing pain or functional-assessment information
• Insufficient explanation of previous treatment response
• Failure to connect imaging findings to symptoms and examination findings
• Incorrect procedure sequencing
• Payer-specific requirements not addressed before submission
• Missing procedural history
• Inconsistent dates or diagnoses
• Failure to document why a standard requirement does not apply
• Missed peer-to-peer or appeal deadlines

These deficiencies create rework, consume physician time, delay care, and increase administrative cost.

The framework shifts the organization from retrospective correction to prospective validation. Medical necessity, evidence, documentation, coverage criteria, and readiness are assessed before the case reaches the point of denial or cancellation.

Strengthening Operational and Financial Performance

Clinical and utilization failures also create significant business consequences.

A denied or cancelled procedure can result in:

• Unused procedure-room or operating-room capacity
• Lost professional and facility revenue
• Delayed implant or device utilization
• Repeated staff intervention
• Additional patient-service calls
• Physician frustration
• Disrupted scheduling
• Reduced patient retention
• Appeal and peer-to-peer costs
• Downstream claim denials
• Increased compliance and audit risk

The framework improves operational performance by reducing rework, clarifying handoffs, improving documentation, accelerating case progression, and preventing avoidable cancellations.

Financial performance is treated as an outcome of operational discipline and appropriate care, not as a substitute for clinical judgment.

Creating Measurable Clinical Operations

Clinical excellence cannot be managed through anecdotal information alone.

Leadership must be able to determine:

• Which cases are delayed
• Why authorizations are denied
• Which payers create the greatest administrative burden
• Which documentation elements are repeatedly missing
• Which procedures have the highest cancellation rates
• Where provider variation exists
• How long patients wait between clinical decision and treatment
• Whether approved interventions produce meaningful benefit
• Which operational failures are recurring

The framework requires data that connects clinical activity with access, authorization, readiness, quality, and outcome performance.

This allows leaders to move from individual-case troubleshooting to system-level improvement.

GoHealthcare Insights

Authorization success is not created by the prior authorization department alone.

It begins with patient selection, diagnostic accuracy, clinical reasoning, evidence-based treatment planning, complete documentation, and clear communication. The authorization team can only submit and defend the information available in the clinical record.

When organizations attempt to solve utilization problems only by adding authorization staff, they often increase labor without correcting the underlying workflow.

The stronger strategy is to redesign the entire clinical and utilization continuum so that the correct information is captured at the correct time, reviewed by the correct person, and escalated before the patient’s care is disrupted.

Leadership Perspective

Clinical and utilization excellence must be treated as an enterprise capability.

Physicians, advanced practice providers, nurses, medical assistants, authorization specialists, scheduling teams, surgical coordinators, facility personnel, coding professionals, revenue cycle leaders, quality teams, and executives all influence whether care moves forward successfully.

Leadership must eliminate the belief that a patient becomes someone else’s responsibility after a departmental handoff.

The patient’s clinical episode remains an organizational responsibility until the treatment decision has been completed, deferred, modified, or appropriately closed.

Key Takeaways

• Clinical and utilization excellence integrates medical necessity, evidence, utilization review, documentation, readiness, quality, and care coordination.
• The framework protects appropriate patient access while reducing preventable denials, delays, cancellations, variation, and administrative burden.
• Clinical judgment remains the responsibility of qualified clinicians. Payer criteria are operationalized as coverage requirements rather than treated as substitutes for medical judgment.
• Authorization performance reflects the effectiveness of the entire clinical operating model.
• The ultimate objective is appropriate, evidence-informed, coordinated care that produces measurable value for patients and sustainable performance for the organization.

Back to top ↑

02

Establishing a Clinical and Utilization Governance Model

Clinical and utilization excellence cannot depend on informal practices, individual employee experience, or isolated departmental decision-making. It requires formal governance.

Governance defines how the organization establishes standards, assigns authority, manages variation, reviews performance, resolves disagreements, approves exceptions, and holds leaders accountable.

Without governance, recurring problems are frequently addressed one case at a time. A denial is appealed, a cancellation is rescheduled, a documentation gap is corrected, or a payer is contacted. The immediate case may be resolved, but the underlying system remains unchanged.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes governance as the mechanism for converting individual operational problems into enterprise improvement.

The Purpose of Governance

Clinical and utilization governance should answer several essential questions:

• Who owns the framework?
• Who approves clinical pathways and documentation standards?
• Who interprets payer requirements?
• Who determines whether treatment variation is clinically appropriate?
• Who reviews repeated authorization denials?
• Who is responsible for procedure-readiness failures?
• Who approves exceptions to standard pathways?
• Who monitors patient outcomes and adverse events?
• Who determines whether technology and automation are performing safely?
• Who holds departments accountable for shared results?

When these responsibilities are unclear, work is delayed and accountability becomes fragmented.

Governance creates a formal structure for making decisions and ensuring that those decisions are implemented.

Recommended Governance Body

Organizations should establish a Clinical and Utilization Excellence Committee or an equivalent governance body.

Representation should be appropriate to the size and complexity of the organization and may include:

• Physician leadership
• Advanced practice provider leadership
• Nursing or clinical operations
• Utilization management
• Prior authorization
• Patient access
• Procedure and surgical scheduling
• Clinical documentation integrity
• Coding and revenue cycle management
• Quality and patient safety
• Compliance and risk management
• Ambulatory surgery center or facility operations
• Information technology
• Data analytics
• Executive leadership

Smaller practices may assign several functions to one person. The requirement is not a large committee. The requirement is complete representation of the functions that influence patient progression through the care continuum.

Physician Leadership

Physician participation is essential.

Clinical pathways, medical-necessity expectations, documentation standards, utilization review, peer-to-peer processes, and treatment-variation analysis require clinical oversight.

Physician leaders should help:

• Approve clinical pathways
• Interpret specialty guidelines and evidence
• Evaluate complex medical-necessity questions
• Review treatment variation
• Support provider education
• Determine when exceptions are clinically justified
• Lead or delegate peer-to-peer reviews
• Evaluate adverse outcomes
• Resolve conflicts between clinical judgment and administrative requirements

Physician governance does not mean that physicians must review every case. Routine cases should move through standardized processes. Physician attention should be reserved for clinical decisions, exceptions, disputes, complex cases, and significant patterns.

Executive Leadership

Executive leadership establishes the authority of the governance model.

Executives are responsible for:

• Defining organizational priorities
• Allocating resources
• Holding departments accountable
• Supporting physician engagement
• Removing operational barriers
• Reviewing enterprise performance
• Ensuring that clinical, quality, access, compliance, and financial goals remain aligned
• A governance body without executive support may identify problems but lack the authority to correct them.

Leadership must make clear that authorization, documentation, procedure readiness, quality, and patient outcomes are shared organizational responsibilities.

Utilization Management Leadership

Utilization management leadership should oversee the operational translation of clinical decisions into structured review processes.

This includes:

• Medical-necessity validation
• Coverage-criteria review
• Prior authorization coordination
• Prospective, concurrent, and retrospective review
• Peer-to-peer preparation
• Appeal development
• Site-of-care review
• Clinical exception management
• Denial analysis
• Utilization trend analysis
• Escalation management
• The utilization leader must identify patterns, not merely manage transactions.

When the same documentation problem repeatedly causes denials, the issue should be escalated to governance for template redesign, provider education, workflow correction, and performance monitoring.

Decision Rights

Each major component of the care continuum must have a clearly assigned owner.

The treating physician owns the clinical diagnosis, treatment recommendation, and clinical rationale.

Clinical staff own the accurate capture of patient information and completion of assigned clinical tasks.

Documentation integrity personnel own the identification of documentation deficiencies, standard development, and education support.

Utilization management owns payer-requirement review, authorization submission, tracking, and escalation coordination.

Scheduling owns the accurate coordination of appointments and procedures after required conditions are met.

Facility operations own readiness related to staffing, equipment, supplies, implants, anesthesia, and site-specific requirements.

Quality leadership owns safety monitoring, outcome evaluation, and corrective-action oversight.

Executive leadership owns enterprise accountability.

Clear ownership reduces ambiguity, but every owner must remain connected to the broader episode of care.

Governance Charter

The governance body should operate under a written charter that defines:

• Purpose
• Scope
• Authority
• Membership
• Leadership roles
• Meeting cadence
• Decision-making process
• Escalation authority
• Reporting responsibilities
• Performance measures
• Policy-review requirements
• Documentation expectations
• The charter should establish that decisions are binding within the approved scope of the committee.

A governance meeting that cannot assign action, establish deadlines, or require corrective plans is primarily informational.

Governance Operating Rhythm

An effective governance model typically includes several operating levels.

Operational huddles address urgent cases, pending authorizations, clinical questions, readiness barriers, upcoming procedures, and time-sensitive escalations.

Monthly performance reviews evaluate denials, turnaround times, documentation deficiencies, cancellations, provider variation, payer trends, and access barriers.

Quarterly governance reviews evaluate pathways, policy performance, outcomes, technology, compliance risks, strategic priorities, and major improvement initiatives.

Annual reviews assess the overall effectiveness of the framework, resource needs, emerging evidence, payer changes, regulatory developments, and organizational strategy.

The frequency should be adjusted based on volume and complexity, but the governance process must remain consistent.

Issue Escalation

Governance should establish clear escalation thresholds.

Examples include:

• Cases approaching authorization deadlines
• High-risk clinical concerns
• Repeated denials for the same reason
• Unresolved payer disputes
• Significant deviation from approved pathways
• Potential patient-safety events
• Repeated procedure cancellations
• Provider-specific variation requiring review
• Equipment or implant failures
• Technology-generated errors
• Adverse events
• Compliance concerns

Escalation criteria should identify who is notified, the required response time, the decision-maker, and the documentation required.

Exception Management

Standardization must not eliminate individualized patient care.

The governance model should include a formal exception process for cases in which the standard pathway does not adequately address the patient’s circumstances.

An exception should document:

• The applicable standard or pathway
• The reason for deviation
• Patient-specific clinical factors
• Alternative options considered
• Risks of delaying or denying treatment
• Supporting evidence
• Physician rationale
• Final decision

Exceptions should be reviewed for patterns. Repeated similar exceptions may indicate that the standard itself requires revision.

Policy and Pathway Management

Every pathway and policy should have an identified owner, approval date, effective date, review date, version history, and source references.

The governance body should maintain a controlled process for:

• Developing pathways
• Reviewing evidence
• Approving operational requirements
• Updating payer information
• Communicating changes
• Educating staff
• Monitoring adoption
• Retiring obsolete versions

Uncontrolled documents create substantial risk. Staff may use different versions of payer criteria, clinical pathways, medication instructions, or readiness checklists.

A centralized source of truth is essential.

Performance Oversight

The governance body should receive a focused dashboard that connects clinical, utilization, access, readiness, quality, and outcome performance.

Relevant measures may include:

• Initial authorization approval rate
• Overall approval rate
• Authorization turnaround time
• Peer-to-peer frequency
• Appeal frequency
• Appeal overturn rate
• Documentation deficiency rate
• Procedure cancellation rate
• Time from decision to treatment
• Site-of-care changes
• Provider variation
• Payer denial trends
• Procedure-specific denial trends
• Outcome-measure completion
• Treatment-response rates
• Adverse-event trends
• Patient complaints related to access

Metrics should be stratified by payer, provider, procedure, specialty, location, facility, and denial reason when appropriate.

Technology Governance

Technology must operate within the clinical governance model.

Clinical decision support, automation, artificial intelligence, documentation tools, utilization platforms, and dashboards should be evaluated for:

• Accuracy
• Reliability
• Appropriate clinical use
• Human oversight
• Data integrity
• Privacy
• Security
• Bias
• Workflow impact
• Error escalation
• Auditability

Technology should assist qualified professionals. It should not make unreviewed clinical decisions or obscure accountability.

GoHealthcare Insights

Many organizations have committees but do not have effective governance.

Reviewing data is not governance unless the organization converts the information into decisions, assigned responsibilities, deadlines, corrective action, and measurable follow-through.

A denial report reviewed every month without process change is reporting.

A clinical pathway stored in a shared folder but not integrated into documentation, authorization, scheduling, and quality workflows is a reference document.

Governance turns standards into operating behavior.

Leadership Perspective

Effective governance should simplify clinical operations.

It should not create unnecessary approval layers or administrative burden. Its purpose is to clarify ownership, standardize repeatable work, resolve uncertainty, and focus leadership attention on the issues that truly require judgment.

Leaders should evaluate the governance model by its results:

Are patients moving through care more reliably?

Are physicians spending less time correcting avoidable problems?

Are denials and cancellations decreasing?

Is documentation improving?

Is unwarranted variation becoming visible?

Are outcomes being measured?

Are corrective actions sustained?

Key Takeaways

• Governance provides the authority and accountability required to implement the framework.
• Physician leadership must remain central to clinical pathways, utilization decisions, and exception management.
• Every critical workflow requires a defined owner and escalation process.
• Governance must convert data into decisions and decisions into measurable improvement.
• Clinical technology and artificial intelligence must operate under formal oversight.
• The effectiveness of governance is demonstrated through better access, stronger documentation, reduced variation, fewer avoidable failures, and improved patient outcomes.

Back to top ↑

03

Aligning Clinical Decisions, Patient Access, and Operational Performance

Clinical decision-making, patient access, and operational performance are often managed as separate organizational priorities. In reality, they are inseparable.

A clinical decision creates an operational obligation. Once a physician recommends a procedure, diagnostic study, therapy, implant, or surgical intervention, the organization must determine how that decision will be documented, authorized, scheduled, prepared, delivered, and evaluated.

When these functions are disconnected, clinically appropriate care becomes vulnerable to administrative failure.

The GoHealthcare Clinical & Utilization Excellence Framework™ aligns these activities so that clinical decisions can be executed reliably.

The Clinical Decision as the Start of an Operational Pathway

The treatment decision should activate a defined pathway.

That pathway should identify:

• The proposed service
• The clinical indication
• Required supporting documentation
• Applicable evidence and guidelines
• Payer requirements
• Authorization status
• Site-of-care requirements
• Pre-procedure testing
• Medical-clearance needs
• Medication instructions
• Equipment or implant requirements
• Patient education
• Scheduling dependencies
• Follow-up requirements
• Outcome measures

The pathway should begin while the clinical decision is being documented, not after the patient has already left the office.

This reduces the delay created when authorization or scheduling personnel later attempt to reconstruct the physician’s reasoning from an incomplete record.

Patient Access Begins Inside the Clinical Workflow

Patient access is frequently associated with registration, insurance verification, scheduling, and authorization. In specialty care, access begins with the clinical encounter.

The physician and clinical team must capture the information required for the next phase of care.

For example, a recommendation for a spinal procedure may require clear documentation of:

• Symptoms and duration
• Functional impairment
• Physical examination findings
• Imaging correlation
• Previous treatment
• Medication history
• Previous injections or surgery
• Response to prior interventions
• Neurologic findings
• Contraindications
• Clinical rationale

When these elements are not documented during the encounter, the access pathway slows down.

The patient may be asked to return, provide outside records, repeat therapy, obtain additional imaging, or wait while staff seek clarification.

Strong clinical documentation is therefore an access intervention.

Eliminating Premature Scheduling

One of the most common operational failures is scheduling a procedure before the case is clinically and administratively ready.

Premature scheduling creates artificial urgency and often leads to:

• Patient anxiety
• Repeated calls
• Staff escalation
• Last-minute authorization activity
• Incomplete medical clearance
• Medication-management errors
• Facility disruption
• Procedure cancellation
• Unused capacity

Organizations should distinguish between:

• Clinical decision date
• Authorization initiation date
• Authorization approval date
• Readiness completion date
• Procedure scheduling date
• Procedure completion date

A procedure date should not be treated as confirmed until critical readiness conditions are satisfied or managed within an established risk-controlled process.

Creating a Single Case Status

Different departments often maintain different interpretations of the same case.

The physician believes the procedure is planned.

The authorization team considers the case incomplete.

Scheduling believes the patient is awaiting approval.

The facility believes the case is confirmed.

The patient believes the procedure is scheduled.

This creates confusion and risk.

The framework requires one authoritative case status that is visible to all appropriate teams.

Examples of standardized statuses include:

• Clinical decision pending completion
• Documentation incomplete
• Authorization not required
• Authorization pending submission
• Authorization submitted
• Additional information required
• Peer-to-peer required
• Appeal in process
• Authorization approved
• Clinical readiness incomplete
• Facility readiness incomplete
• Patient readiness incomplete
• Ready to schedule
• Scheduled
• Completed
• Cancelled
• Deferred
• Closed

Each status should have a defined meaning, owner, and expected next action.

Coordinating Clinical and Administrative Handoffs

Handoffs must be designed rather than assumed.

A complete handoff should communicate:

• What has been decided
• Why it has been decided
• What requirements remain
• Who owns the next step
• What deadline applies
• What risks require attention
• What information is missing
• When escalation is required
• Handoffs should not rely solely on unstructured messages, memory, or informal conversations.

Technology can support work queues and notifications, but the underlying process must be clear before it is automated.

Managing Time as a Clinical and Operational Variable

Delay is not merely an administrative inconvenience.

For some patients, delay may mean continued pain, functional deterioration, neurologic risk, inability to work, prolonged medication use, or worsening quality of life.

The organization should track time across the care continuum, including:

• Time from treatment decision to order completion
• Time from order to authorization submission
• Time from submission to payer determination
• Time from approval to readiness completion
• Time from readiness to scheduling
• Time from scheduling to procedure
• Time from procedure to follow-up
• Time from follow-up to next clinical decision

These intervals reveal where patients are becoming trapped in the system.

Aligning Performance Measures

Departments should not be measured in isolation.

An authorization team may achieve rapid submission times while sending incomplete requests that generate denials.

A scheduling team may maximize calendar utilization while creating avoidable cancellations.

A clinical team may complete documentation quickly while failing to include the information required for medical necessity.

A facility may reduce supply cost while creating readiness problems.

Performance measures should reward the success of the complete episode rather than the speed of one departmental task.

Shared measures may include:

• Time from decision to treatment
• Initial authorization approval rate
• Avoidable denial rate
• Procedure cancellation rate
• Readiness completion rate
• Patient communication timeliness
• Clinical documentation completeness
• Treatment-response documentation
• Patient complaints related to access

Managing Payer Requirements Without Allowing Payers to Direct Care

Payer criteria can significantly influence access.

The organization must understand:

• Coverage policies
• Prior authorization requirements
• Utilization vendors
• Site-of-care rules
• Frequency limits
• Documentation requirements
• Step-therapy requirements
• Appeal processes
• Peer-to-peer deadlines

However, payer requirements must be managed within a clinically led model.

When a payer denial conflicts with the physician’s clinical judgment, the organization should determine whether:

• The documentation was insufficient
• The payer applied the policy incorrectly
• Additional clinical information is available
• A peer-to-peer review is appropriate
• A formal appeal is required
• An exception can be supported
• An alternative clinically acceptable pathway exists
• The patient should be informed of coverage limitations and options

This preserves clinical integrity while managing the operational realities of coverage.

Closing the Loop With Patients

Patients should not be expected to navigate unresolved clinical and authorization issues alone.

The organization should establish communication standards for:

• Explaining the next steps
• Clarifying that a recommendation is not the same as authorization approval
• Requesting missing records
• Communicating payer delays
• Explaining peer-to-peer or appeal activity
• Providing realistic timelines
• Confirming readiness requirements
• Communicating approval, denial, deferral, or treatment alternatives
• Preparing the patient for follow-up

Patient communication should be accurate and coordinated. Conflicting information from the clinical office, authorization team, and facility can undermine trust.

GoHealthcare Insights

Many access failures begin before the authorization team receives the case.

An incomplete clinical note, unclear treatment order, missing diagnosis, absent imaging report, or prematurely selected procedure date creates downstream pressure that may later appear to be an authorization problem.

The most effective access strategy is to move validation upstream.

The earlier the organization confirms medical necessity, documentation completeness, payer requirements, and readiness dependencies, the fewer urgent problems will emerge later.

Leadership Perspective

Leaders should stop treating clinical care, patient access, and operational performance as separate workstreams.

The patient experiences one journey.

The organization should therefore manage one integrated pathway from clinical decision through outcome evaluation.

Every operational metric should be evaluated according to its effect on patient progression, clinical appropriateness, safety, and overall performance.

Key Takeaways

• Every clinical decision should activate a defined operational pathway.
• Patient access begins with complete clinical assessment and documentation.
• Premature scheduling creates avoidable risk and should be replaced with readiness-based scheduling.
• The organization needs one authoritative case status visible across teams.
• Departmental metrics should be aligned with the success of the entire clinical episode.
• Timely and coordinated patient communication is a core component of utilization excellence.

Back to top ↑

04

Defining Appropriate and Evidence-Based MSK Specialty Care

Appropriate care is care that is clinically justified, evidence-informed, individualized, timely, safe, and reasonably expected to improve the patient’s condition, function, or quality of life.

Evidence-based care is not the mechanical application of a guideline. It combines the best available evidence with clinician expertise, patient-specific circumstances, and informed patient preferences.

Within musculoskeletal specialty care, these principles must be applied carefully. Patients frequently present with complex anatomy, chronic symptoms, previous treatment failures, multiple comorbidities, variable imaging findings, and individual functional goals.

The GoHealthcare Clinical & Utilization Excellence Framework™ supports standardization where consistency improves quality while preserving clinical judgment where individualized decision-making is required.

Components of Appropriate Care

An appropriate clinical decision should consider:

• The accuracy and specificity of the diagnosis
• Severity and duration of symptoms
• Functional impairment
• Physical examination findings
• Imaging or diagnostic findings
• Previous treatment
• Response to conservative management
• Response to previous procedures
• Risks and contraindications
• Alternative treatments
• Expected benefit
• Patient goals and preferences
• Site-of-care considerations
• Resource utilization

The decision should be supported by a clinical narrative that explains why the proposed intervention is appropriate for this patient at this point in the care pathway.

Evidence Hierarchy

The organization should evaluate evidence using a structured approach.

Relevant sources may include:

• Clinical practice guidelines
• Systematic reviews
• Randomized controlled trials
• Observational studies
• Specialty-society recommendations
• Consensus statements
• Coverage policies
• Technology assessments
• Clinical registries
• Real-world outcomes
• Expert clinical judgment
• Not all evidence carries equal weight, and not every procedure has a mature evidence base.

The absence of high-level evidence does not automatically mean that a treatment is inappropriate. It may indicate that the organization must apply greater clinical scrutiny, document the rationale more clearly, and monitor outcomes more closely.

Clinical Guidelines and Payer Policies

Clinical guidelines and payer policies serve different purposes.

Clinical guidelines are generally intended to support diagnosis and treatment decisions.

Payer policies define the circumstances under which a service will be covered.

A payer policy may reference clinical evidence, but it may also include utilization controls, benefit limitations, frequency restrictions, or administrative requirements.

The framework requires teams to distinguish among:

• What is clinically recommended
• What is supported by available evidence
• What is covered by the payer
• What documentation is required for authorization
• What the patient’s benefit plan allows

Confusing these categories can result in either inappropriate restriction of care or unnecessary authorization failure.

Clinical Pathways

Clinical pathways translate evidence and organizational standards into repeatable processes.

A pathway should identify:

• The patient population
• Diagnostic considerations
• Initial treatment options
• Conservative-care expectations
• Escalation criteria
• Procedure indications
• Contraindications
• Required documentation
• Relevant outcome measures
• Follow-up expectations
• Permitted exceptions
• A pathway should guide care without becoming an inflexible rule.

Patients may have contraindications to therapy, intolerances to medication, progressive neurologic findings, previous treatment failure, or other circumstances that justify deviation.

The physician’s rationale for deviation should be documented.

Conservative Treatment

Conservative treatment requirements are common in MSK specialty care and frequently influence authorization.

The organization should avoid treating conservative care as a simple checklist.

Clinical documentation should explain:

• What treatment was attempted
• When it was attempted
• How long it was attempted
• Whether the patient participated
• Whether the treatment was completed
• Why it failed
• Whether symptoms worsened
• Whether treatment was contraindicated
• Whether the patient could not tolerate it
• Whether the patient achieved partial but insufficient benefit

Examples may include medications, physical therapy, home exercise, activity modification, bracing, chiropractic treatment, behavioral interventions, or previous injections.

The relevant treatment depends on the diagnosis, procedure, patient condition, and applicable coverage policy.

Shared Decision-Making

Evidence-based care includes the patient’s informed preferences.

Patients should understand:

• The diagnosis
• The proposed treatment
• Expected benefits
• Material risks
• Reasonable alternatives
• The option of no treatment
• Potential limitations of the intervention
• Recovery expectations
• Possible need for additional treatment
• Financial or coverage considerations when relevant

Shared decision-making is particularly important when treatments involve implants, surgery, repeated procedures, variable outcomes, or significant patient commitment.

Documentation should demonstrate that the patient participated in the decision.

Reducing Unwarranted Variation

Variation is expected in individualized care. The concern is variation that cannot be explained by patient need, evidence, or sound clinical judgment.

Potential indicators include:

• Wide differences in procedure frequency
• Repeated treatment without documented benefit
• Inconsistent conservative-care expectations
• Different diagnostic thresholds for similar patients
• Variable use of outcome measures
• Inconsistent follow-up
• Different medication-management practices
• Significant differences in denial or cancellation rates

Variation should be reviewed as an opportunity for clinical learning and process improvement, not automatically treated as misconduct.

Treatment-Response Evaluation

Appropriate utilization requires evaluation after treatment.

The organization should document:

• Pain response
• Functional change
• Duration of benefit
• Medication change
• Activity improvement
• Complications
• Patient satisfaction
• Achievement of treatment goals
• Need for additional intervention

For diagnostic procedures, the clinical record should capture the specific information required to determine the next treatment step.

For therapeutic procedures, the organization should determine whether the intervention produced sufficient benefit to justify continuation, repetition, or escalation.

Emerging Procedures and Technologies

New MSK procedures, implants, devices, and technologies may enter practice before the evidence base is fully mature.

The organization should establish an evaluation process that considers:

• Regulatory status
• Clinical evidence
• Professional guidance
• Patient-selection criteria
• Training requirements
• Facility capabilities
• Safety data
• Payer coverage
• Financial exposure
• Conflict-of-interest considerations
• Outcome-monitoring requirements

Adoption should be clinically governed rather than driven solely by market demand, vendor promotion, or anticipated reimbursement.

GoHealthcare Insights

Evidence-based care is frequently weakened by one of two extremes.

The first is rigid protocolization, in which guidelines or payer policies are applied without regard to the individual patient.

The second is unstructured discretion, in which treatment decisions are not connected to evidence, pathways, documentation standards, or outcome review.

The GoHealthcare model creates disciplined flexibility. Standard processes support consistency, while documented clinical judgment supports appropriate variation.

Leadership Perspective

Clinical leaders must create an environment in which evidence informs practice without becoming a substitute for judgment.

The goal is not identical care for every patient. The goal is consistent clinical reasoning, reliable documentation, transparent exceptions, and measurable outcomes.

Leaders should ask whether the organization can explain why a treatment was selected, why it was appropriate, how it was performed, and whether it helped the patient.

Key Takeaways

• Appropriate care integrates diagnosis, evidence, clinician expertise, patient circumstances, and patient preferences.
• Clinical guidelines and payer coverage policies must not be treated as interchangeable.
• Clinical pathways should guide care while allowing documented exceptions.
• Conservative treatment should be evaluated clinically, not documented as a superficial checklist.
• Treatment response must be measured to support appropriate continued utilization.
• Emerging technologies require structured clinical, operational, and governance review.

Back to top ↑

05

Building Accountability Across the Clinical Care Continuum

Clinical and utilization excellence depends on accountability across the entire patient journey.

Accountability means that every critical action has an identified owner, an expected completion time, a defined standard, and an escalation pathway.

It does not mean that one department is responsible for everything. It means that responsibility transfers clearly and remains visible throughout the episode of care.

In MSK specialty care, the continuum may include:

• Patient evaluation
• Diagnostic testing
• Conservative treatment
• Clinical decision-making
• Documentation completion
• Medical-necessity validation
• Prior authorization
• Peer-to-peer review
• Appeal
• Medical clearance
• Medication management
• Procedure scheduling
• Facility coordination
• Implant or equipment preparation
• Patient instructions
• Procedure completion
• Post-procedure follow-up
• Outcome assessment
• Next-step treatment planning

A breakdown at any point can affect access, safety, quality, patient experience, and financial performance.

Defining the Episode Owner

Organizations should determine who is responsible for monitoring the progression of the complete episode.

The episode owner may be a clinical coordinator, utilization specialist, surgical coordinator, patient navigator, or another designated role.

The episode owner does not personally perform every task. The role is responsible for ensuring that:

• The pathway is visible
• Outstanding requirements are identified
• Owners are assigned
• Deadlines are tracked
• Barriers are escalated
• The patient receives coordinated communication
• The case reaches an appropriate conclusion

Without episode ownership, cases can remain unresolved between departments.

Responsibility Matrix

A responsibility matrix should be developed for major workflows.

For every step, the organization should define:

• Who performs the work
• Who is accountable for completion
• Who must be consulted
• Who must be informed

For example, a physician may be accountable for the clinical decision, while clinical staff support documentation, utilization staff review payer criteria, and scheduling is informed when the case is ready.

This prevents duplication and eliminates assumptions.

Accountability at the Point of Care

Clinical accountability begins during the patient encounter.

Physicians and clinical teams should ensure that the record includes the information required to support the treatment plan.

This may include:

• Clear diagnosis
• Clinical indication
• Functional impact
• Relevant examination findings
• Diagnostic results
• Treatment history
• Response to previous care
• Contraindications
• Patient goals
• Risk discussion
• Medical-necessity rationale

The clinical team should not assume that downstream staff can infer or recreate information that was not documented.

Accountability in Utilization Management

The utilization team should be accountable for:

• Confirming authorization requirements
• Identifying the appropriate utilization vendor
• Reviewing coverage criteria
• Validating submission completeness
• Submitting the request
• Tracking payer response
• Managing requests for additional information
• Escalating deadlines
• Coordinating peer-to-peer review
• Preparing appeals
• Recording outcomes
• Updating case status

Utilization accountability includes communication. The treating team and patient should know when a material barrier affects the treatment plan.

Physician Accountability During Escalation

Peer-to-peer reviews and clinical appeals often require physician participation.

The organization should establish expectations regarding:

• Availability
• Response time
• Required preparation
• Documentation review
• Participation in payer discussions
• Final clinical decision after denial

Physicians should receive a concise case summary, payer rationale, applicable policy, missing information, and recommended strategy before the discussion.

This reduces unnecessary physician burden and improves the quality of the review.

Scheduling Accountability

Scheduling should not function as an isolated calendar-management process.

Schedulers should confirm that the case has reached the required readiness status.

Depending on the procedure, this may include:

• Valid authorization
• Correct provider
• Correct procedure
• Correct site of service
• Appropriate diagnosis
• Medical clearance
• Required testing
• Medication instructions
• Implant or equipment availability
• Facility acceptance
• Patient confirmation
• Financial counseling when appropriate

The scheduling team must have authority to escalate incomplete cases rather than place them on the calendar without adequate preparation.

Facility and Procedure-Readiness Accountability

For procedures involving an ASC, hospital, office procedure suite, implant, anesthesia, or specialized equipment, facility accountability is critical.

The facility or procedure operations team should confirm:

• Room availability
• Staffing
• Anesthesia requirements
• Equipment
• Implants
• Supplies
• Medication availability
• Sterility or infection-control requirements
• Medical-clearance status
• Laboratory or diagnostic testing
• Patient transportation requirements
• Post-procedure needs
• A case should not be considered ready merely because authorization has been approved.

Patient Accountability and Support

Patients have responsibilities within the care pathway, but the organization must communicate them clearly.

Patients may need to:

• Complete testing
• Attend therapy
• Provide outside records
• Follow medication instructions
• Arrange transportation
• Complete preoperative clearance
• Respond to scheduling calls
• Follow fasting instructions
• Attend follow-up appointments

The organization should avoid framing patient noncompletion as simple noncompliance without evaluating whether instructions were understandable, timely, culturally appropriate, and realistically achievable.

Patient accountability is most effective when supported by clear communication and navigation.

Accountability After the Procedure

The episode does not end when the procedure is completed.

Post-procedure accountability includes:

• Follow-up scheduling
• Assessment of treatment response
• Complication monitoring
• Medication review
• Functional reassessment
• Outcome-measure completion
• Documentation of next steps
• Communication with referring providers when appropriate
• Review of unexpected events

Failure to document outcomes weakens continuity of care and makes future utilization decisions less reliable.

Escalation Standards

Every unresolved case should have a defined escalation pathway.

Escalation should be based on risk, urgency, and elapsed time.

Examples include:

• Missing physician documentation
• Payer requests approaching deadlines
• Authorization denial
• Medical-clearance delay
• Unresolved medication issue
• Implant availability concern
• Patient unable to complete requirements
• Facility readiness failure
• Potential safety issue
• Repeated scheduling cancellation
• The escalation pathway should identify the next responsible leader and the expected response time.

Closed-Loop Communication

Communication is complete only when the receiving party acknowledges and acts on the information.

Sending a message is not the same as completing a handoff.

Closed-loop communication requires confirmation that:

• The information was received
• The recipient understood the required action
• The action was completed
• The case status was updated
• Any unresolved barrier was escalated

This is particularly important for medication instructions, critical test results, medical clearance, authorization deadlines, and procedure cancellations.

Measuring Accountability

Accountability should be measured through process and outcome indicators.

Relevant measures include:

• Percentage of cases with a documented owner
• Percentage of cases with a current status
• Time in each workflow stage
• Overdue tasks
• Unresolved documentation requests
• Missed payer deadlines
• Peer-to-peer completion rate
• Procedure-readiness completion rate
• Last-minute cancellation rate
• Patient notification timeliness
• Follow-up completion rate
• Outcome-documentation completion rate
• Repeated failures should be addressed through root-cause analysis rather than isolated reminders.

GoHealthcare Insights

Many operational failures are described as communication problems when the actual issue is unclear accountability.

More messages will not solve a process in which no one knows who owns the next step.

The organization must define ownership before attempting to improve communication.

A strong workflow makes it clear what must happen, who must do it, when it must be completed, and what happens if it is not completed.

Leadership Perspective

Accountability should not be punitive.

Its purpose is to create reliability, protect patients, reduce burden, and ensure that important work does not disappear between departments.

Leaders must distinguish between individual performance problems and system-design failures.

When several competent employees repeatedly struggle with the same process, the process itself should be examined.

Key Takeaways

• Every clinical episode requires visible ownership.
• Responsibility must be clearly assigned across clinical, utilization, scheduling, facility, quality, and follow-up functions.
• Scheduling should occur only after required readiness conditions have been evaluated.
• Closed-loop communication is essential for safe and reliable handoffs.
• Patient responsibilities must be supported through clear instructions and navigation.
• Accountability should extend through post-treatment follow-up and outcome evaluation.
• The strongest accountability systems correct workflow design rather than relying on individual memory or heroics.

Back to top ↑

06

Establishing the Medical Necessity Operating Model

Medical necessity is the foundation of appropriate utilization. It connects the patient’s diagnosis, symptoms, functional limitations, examination findings, diagnostic evidence, treatment history, risk profile, and expected benefit to the service being recommended.

Medical necessity is not established merely because a physician orders a procedure. It must be demonstrated through a coherent clinical record showing why the service is reasonable, necessary, appropriate, and aligned with the patient’s current condition.

Within musculoskeletal specialty care, medical necessity is especially complex because many procedures depend on specific diagnostic sequences, conservative treatment requirements, imaging findings, symptom patterns, prior treatment responses, frequency limitations, and procedure specific documentation.

A medically appropriate service may still be denied when the record does not clearly demonstrate these elements. Conversely, complete documentation cannot make a clinically inappropriate service medically necessary.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes a prospective medical necessity operating model. Clinical appropriateness and documentation sufficiency are evaluated before authorization submission, scheduling, or treatment whenever possible.

Medical Necessity as a Clinical and Operational Standard

Medical necessity should be understood through several related but distinct perspectives.

The physician determines whether the proposed service is clinically appropriate for the patient.

The payer determines whether the service satisfies the applicable coverage policy and benefit requirements.

The authorization team determines whether the submitted record demonstrates the required criteria.

The coding and revenue cycle teams determine whether the diagnoses, procedure codes, documentation, and billing information accurately represent the service.

The facility determines whether the patient and procedure are appropriate for the selected setting.

The compliance function evaluates whether the record supports the service under applicable legal, regulatory, contractual, and audit standards.

These perspectives must be coordinated. A case may appear complete from one department’s perspective while remaining deficient from another.

The framework creates one medical necessity standard that supports clinical care, authorization, scheduling, coding, payment, quality review, and audit defense.

Core Medical Necessity Elements

A complete medical necessity assessment should generally address:

• The patient’s primary diagnosis
• Relevant secondary diagnoses and comorbidities
• Symptoms and their duration
• Severity and pattern of symptoms
• Functional limitations
• Physical examination findings
• Imaging, electrodiagnostic, laboratory, or other diagnostic findings
• Correlation among symptoms, examination findings, and diagnostics
• Previous conservative treatment
• Response to previous interventions
• Medication history
• Contraindications or treatment limitations
• Clinical rationale for the proposed service
• Expected therapeutic or diagnostic benefit
• Alternative treatments considered
• Risks of delaying or not providing treatment
• Patient preferences and treatment goals
• The specific elements required will vary by specialty, payer, procedure, and site of service.

A medial branch block, spinal cord stimulator trial, lumbar fusion, total joint replacement, peripheral nerve stimulation procedure, and office based injection each require different medical necessity narratives.

The operating model must therefore combine universal standards with procedure specific requirements.

Prospective Medical Necessity Validation

Medical necessity should be reviewed before the organization commits substantial time, resources, or capacity to the case.

Prospective validation may occur:

• During the clinical encounter
• Immediately after the treatment order is entered
• Before authorization submission
• Before the procedure is placed on the final schedule
• Before an implant or device is ordered
• Before the facility accepts the case

The review should determine whether the clinical record is complete enough to support the recommendation and whether material requirements remain unresolved.

Prospective validation reduces:

• Incomplete authorization submissions
• Avoidable requests for additional information
• Peer to peer reviews
• Appeals
• Last minute documentation addenda
• Procedure cancellations
• Claim denials
• Physician rework
• Patient frustration

The objective is not to create another administrative barrier. The objective is to identify deficiencies early enough to correct them without disrupting care.

Clinical Versus Administrative Completeness

A record can be clinically meaningful while remaining administratively insufficient.

For example, a physician may understand from the patient’s history that physical therapy was unsuccessful. The note may state only that the patient completed conservative care.

A payer may require the type of therapy, duration, dates, number of visits, response, and reason the treatment did not produce sufficient improvement.

The physician’s clinical conclusion may be valid, but the documentation does not fully communicate the basis for that conclusion.

The operating model should distinguish between:

• Information that is clinically known
• Information that is documented
• Information required by the payer
• Information necessary to support coding and payment
• Information necessary for continuity of care

Medical necessity depends on bringing these elements into alignment.

Medical Necessity Screening Tools

Organizations should develop structured screening tools for high volume, high denial, high cost, or high complexity procedures.

A screening tool may include:

• Required diagnosis
• Clinical indications
• Required symptoms
• Required duration
• Required examination findings
• Imaging requirements
• Conservative treatment expectations
• Previous procedure history
• Required treatment response
• Frequency or repeat procedure limits
• Contraindications
• Site of service requirements
• Required supporting records
• Payer specific differences

The tool should assist staff in identifying gaps. It should not independently determine whether the patient should receive treatment.

Clinical judgment remains with the treating physician.

Procedure Specific Medical Necessity Standards

Each major service line should maintain procedure specific standards.

For interventional pain management, standards may address:

• Facet interventions
• Radiofrequency ablation
• Epidural injections
• Sacroiliac joint procedures
• Trigger point injections
• Peripheral nerve blocks
• Spinal cord stimulation
• Peripheral nerve stimulation
• Vertebral augmentation
• Minimally invasive lumbar procedures

For orthopedic and spine surgery, standards may address:

• Joint replacement
• Arthroscopy
• Spinal decompression
• Spinal fusion
• Disc replacement
• Fracture management
• Revision surgery
• Implant removal

For neuromodulation, standards may address:

• Diagnostic confirmation
• Psychological evaluation when required
• Treatment failure
• Trial criteria
• Trial response
• Permanent implantation criteria
• Device selection
• Post implant follow up

Each standard should be reviewed by appropriate clinical leadership and updated when evidence, payer policies, technology, or organizational practices change.

Internal Consistency of the Medical Record

Medical necessity can be weakened when the record contains contradictions.

Examples include:

• Different symptom durations across notes
• Conflicting pain locations
• Imaging findings that do not correspond with the proposed procedure
• A diagnosis code that does not match the clinical narrative
• A treatment listed as failed in one note and effective in another
• Inconsistent laterality
• Different levels or anatomical sites
• Contradictory medication instructions
• A procedure order that differs from the physician’s plan

The organization should validate internal consistency before submission and scheduling.

Corrections must reflect the actual clinical record. Documentation should never be altered solely to manufacture coverage.

Repeat Procedures

Repeat interventions require additional medical necessity analysis.

The record should address:

• The response to the previous procedure
• The degree of improvement
• The duration of improvement
• Functional benefit
• Medication change
• Adverse effects
• Reason for repetition
• Whether the frequency is clinically appropriate
• Whether payer frequency limits apply
• Whether an alternative treatment should be considered

Repeating a procedure without documenting the previous response creates clinical, authorization, payment, and audit risk.

Outcome capture is therefore part of medical necessity, not merely a quality reporting function.

Medical Necessity and Site of Service

Medical necessity also applies to where the service is performed.

The selected setting should reflect:

• Patient risk
• Procedure complexity
• Anesthesia requirements
• Clinical monitoring needs
• Equipment availability
• Emergency capabilities
• Payer restrictions
• Benefit design
• Cost considerations

Some patients may be appropriate for an office or ambulatory surgery center. Others may require a hospital outpatient department or inpatient setting.

The least costly setting is not always the clinically appropriate setting. The most intensive setting is not always necessary.

The site decision should be based on patient specific clinical factors and documented when the choice may be questioned.

Medical Necessity Escalation

Cases requiring escalation may include:

• A conflict between physician judgment and payer criteria
• Incomplete or inconsistent clinical information
• A procedure outside the standard pathway
• A patient unable to complete required conservative treatment
• Urgent clinical progression
• A denied service with substantial clinical justification
• An emerging procedure with limited coverage
• A repeat procedure with an atypical response pattern
• A site of service dispute

The escalation process should identify the clinical decision maker, required information, response time, and next operational action.

Medical Necessity Audit Readiness

Every case should be supportable after the service is performed.

Authorization approval does not guarantee payment, nor does it establish that the documentation will withstand an audit.

The organization should be able to demonstrate:

• Why the service was recommended
• What clinical evidence supported it
• What alternatives were considered
• How the patient met coverage requirements
• Why the selected setting was appropriate
• What service was actually performed
• What outcome occurred

Medical necessity documentation should be accurate at the time of care rather than reconstructed after a denial or audit.

GoHealthcare Insights

Medical necessity failures frequently originate upstream from the authorization team.

The authorization specialist may identify the deficiency, but the underlying cause may be an incomplete clinical workflow, an inadequate template, unclear procedure requirements, inconsistent outcome documentation, or insufficient provider education.

The solution should address the source of the deficiency.

Repeated requests for addenda are a sign that the organization’s standard documentation process does not reliably capture what is needed.

The strongest organizations design medical necessity into the clinical workflow rather than trying to repair the record after the treatment decision.

Leadership Perspective

Leaders should treat medical necessity as a shared clinical operating standard.

It is not solely a payer requirement, an authorization function, or a billing concern. It is the organization’s ability to explain why a service is appropriate for a specific patient.

Leadership should monitor whether the medical necessity process improves access and reliability without interfering unnecessarily with physician practice.

The goal is not more review. The goal is better information, earlier validation, fewer failures, and stronger clinical decisions.

Key Takeaways

• Medical necessity connects the patient’s condition to the proposed service through a clear clinical rationale.
• Clinical appropriateness, payer coverage, documentation sufficiency, coding support, and site of service are related but distinct considerations.
• Medical necessity should be validated prospectively whenever possible.
• Procedure specific standards are necessary because MSK services have different clinical and coverage requirements.
• Repeat procedures require documented treatment response and continued justification.
• Authorization approval does not eliminate the need for complete, accurate, and audit ready medical necessity documentation.

Back to top ↑

07

Clinical Indication Validation

Clinical indication validation confirms that the proposed service is appropriate for the patient’s documented diagnosis, symptoms, examination findings, diagnostic results, treatment history, and stage of care.

The purpose is not simply to verify that an indication appears on a checklist. It is to determine whether the patient’s clinical presentation supports the proposed intervention and whether the record clearly communicates that relationship.

In musculoskeletal specialty care, similar symptoms may arise from different anatomical structures or disease processes. Pain location alone may not identify the pain generator. Imaging abnormalities may be present without corresponding symptoms. Chronic pain may involve structural, neurologic, functional, behavioral, and psychosocial factors.

Clinical indication validation must therefore evaluate the entire clinical picture.

Diagnostic Specificity

A general diagnosis may be insufficient to support a procedure requiring a more specific clinical indication.

For example, broad diagnoses such as back pain, joint pain, or chronic pain may describe the patient’s complaint but may not establish the specific condition being treated.

The record should identify, when clinically appropriate:

• The anatomical region
• The specific structure or suspected pain generator
• Laterality
• Spinal level
• Acute, chronic, traumatic, degenerative, inflammatory, or postoperative status
• Presence or absence of neurologic involvement
• Relevant complications

The diagnosis should be supported by the clinical narrative rather than selected only because it appears on a payer’s accepted list.

Symptom Validation

The record should describe the patient’s symptoms in sufficient detail to support the indication.

Relevant information may include:

• Location
• Distribution
• Quality
• Severity
• Frequency
• Duration
• Aggravating factors
• Relieving factors
• Associated weakness, numbness, tingling, instability, swelling, or stiffness
• Sleep disruption
• Effect on work
• Effect on activities of daily living
• Effect on mobility
• Progression over time
• Symptoms should be connected to the proposed treatment.

A procedure should not appear as an isolated order without a documented explanation of the clinical problem it is intended to diagnose or treat.

Functional Impact

Functional impairment is a critical component of clinical indication validation.

Pain scores alone may not adequately describe the patient’s condition. Two patients with the same pain rating may have significantly different levels of disability.

The record should explain how the condition affects:

• Walking
• Standing
• Sitting
• Lifting
• Bending
• Sleeping
• Driving
• Working
• Self care
• Household activities
• Exercise
• Recreation
• Caregiving
• Participation in therapy

Functional information strengthens the clinical rationale and provides a baseline for evaluating treatment response.

Physical Examination Correlation

The physical examination should support the diagnosis and proposed intervention.

Relevant findings may include:

• Range of motion
• Tenderness
• Strength
• Sensation
• Reflexes
• Gait
• Provocative maneuvers
• Joint stability
• Swelling
• Deformity
• Motor deficits
• Signs of nerve tension
• Functional testing
• The required examination depends on the condition and procedure.

Documentation should avoid generic examination language that does not meaningfully relate to the patient’s complaint or treatment plan.

Diagnostic Correlation

Imaging and other diagnostic studies should be interpreted within the clinical context.

An abnormality on imaging does not automatically establish the source of symptoms.

The record should explain whether the diagnostic findings correlate with:

• The patient’s symptom distribution
• Examination findings
• Functional impairment
• Clinical diagnosis
• Proposed treatment target

Relevant studies may include:

• Radiographs
• Magnetic resonance imaging
• Computed tomography
• Ultrasound
• Electrodiagnostic testing
• Bone scans
• Laboratory studies
• Diagnostic injections

The framework does not require unnecessary testing. It requires that available diagnostic information be meaningfully connected to the treatment decision.

Diagnostic Procedures

Some procedures are performed to confirm a suspected pain generator or determine whether a patient is appropriate for a subsequent treatment.

Clinical indication validation for diagnostic procedures should identify:

• The suspected diagnosis
• The clinical basis for that suspicion
• The purpose of the procedure
• The expected information to be obtained
• How the result will affect the treatment plan
• The method for measuring the response
• The timeframe for documenting the response

Examples may include diagnostic medial branch blocks, selective nerve root blocks, joint injections, or other targeted diagnostic interventions.

A diagnostic procedure has limited value when the organization does not define how the response will be assessed or used.

Therapeutic Procedures

For therapeutic procedures, validation should establish:

• The condition being treated
• The severity and persistence of symptoms
• Functional impact
• Failure or insufficiency of prior treatment
• Expected benefit
• Why the selected intervention is appropriate now
• Why reasonable alternatives are less appropriate, unsuccessful, contraindicated, or deferred

The record should distinguish a therapeutic objective from a diagnostic objective when this distinction affects coverage or clinical decision making.

Surgical Indications

Surgical indication validation generally requires a broader assessment.

The record may need to address:

• Specific pathology
• Symptoms and functional impairment
• Objective clinical findings
• Imaging correlation
• Progression of disease
• Response to conservative treatment
• Urgency
• Comorbidities
• Surgical risk
• Alternative treatments
• Expected benefit
• Patient goals

The indication should be clear enough that another qualified reviewer can understand why surgery is being considered.

Implant and Neuromodulation Indications

Implant based treatment requires additional validation because it may involve higher cost, long term management, specialized follow up, and device related risks.

The record may need to address:

• The qualifying diagnosis
• Duration and severity of symptoms
• Failure of prior treatment
• Psychological or behavioral evaluation when required
• Patient understanding
• Ability to participate in long term management
• Trial criteria
• Trial response
• Contraindications
• Device specific considerations

Clinical indication validation should continue after implantation through outcome monitoring and device management.

Red Flags and Alternative Diagnoses

Validation should include consideration of clinical findings that may require a different pathway.

Examples may include:

• Progressive neurologic deficit
• Suspected infection
• Fracture
• Malignancy
• Cauda equina symptoms
• Severe vascular compromise
• Unexplained systemic symptoms
• Acute trauma
• Unstable medical condition

The presence of a red flag does not necessarily prohibit the proposed service, but it may require further evaluation, urgent escalation, or a different care setting.

Indication Validation Before Authorization

The authorization team should receive a clinically complete case.

A structured review may confirm:

• The diagnosis matches the procedure
• The symptoms support the indication
• The examination supports the diagnosis
• Diagnostics correlate with the clinical findings
• Conservative treatment has been addressed
• Previous procedure response is documented
• The requested service matches the physician’s plan
• Laterality and level are consistent
• The correct site of service is identified
• Material contraindications have been considered

Deficiencies should be routed back through a defined clarification process rather than managed through informal repeated messages.

Avoiding Administrative Diagnosis Selection

Organizations must not select diagnoses solely to obtain authorization or payment.

Diagnosis coding must accurately represent the condition evaluated and treated.

When the documented diagnosis is not sufficient to support the planned procedure, the correct action is to clarify the clinical record, reconsider the treatment plan, or pursue an appropriate exception or appeal.

Changing the diagnosis without clinical support creates compliance risk and undermines the integrity of the record.

GoHealthcare Insights

Many authorization denials described as payer problems are actually indication communication problems.

The treatment may be clinically appropriate, but the record does not connect the diagnosis, symptoms, functional impairment, examination findings, diagnostic evidence, and treatment recommendation.

A strong clinical note does not merely list information. It explains the relationship among the findings.

Clinical indication validation should answer one central question: Does the record clearly demonstrate why this procedure is appropriate for this patient now?

Leadership Perspective

Clinical leaders should establish indication standards that improve reasoning and documentation without converting clinical encounters into administrative scripts.

Providers need concise, specialty specific guidance regarding the elements that materially affect treatment decisions, patient safety, authorization, and outcomes.

Leadership should use denial data, documentation reviews, and provider feedback to refine these standards continuously.

Key Takeaways

• Clinical indication validation confirms that the patient’s documented condition supports the proposed service.
• Diagnosis, symptoms, functional impairment, examination findings, diagnostics, and treatment history should form a coherent clinical narrative.
• Imaging abnormalities must be interpreted in relation to the patient’s presentation.
• Diagnostic procedures require a clear purpose and a defined method for measuring response.
• Surgical and implant based treatments require broader validation because of their complexity, risk, cost, and long term implications.
• Diagnosis selection must reflect the actual clinical condition and should never be manipulated for authorization or payment.

Back to top ↑

08

Diagnostic and Conservative Care Requirements

Diagnostic evaluation and conservative treatment requirements are central to many MSK care pathways. They help establish the diagnosis, determine the probable source of symptoms, assess severity, evaluate treatment response, and identify whether escalation to an intervention is appropriate.

However, these requirements are frequently reduced to administrative checkboxes.

The GoHealthcare Clinical & Utilization Excellence Framework™ treats diagnostic and conservative care as meaningful components of clinical decision making rather than documentation exercises performed solely to satisfy payer criteria.

Purpose of Diagnostic Requirements

Diagnostic requirements should help answer clinically relevant questions.

These may include:

• What condition is causing the patient’s symptoms?
• Which anatomical structure is involved?
• Do imaging findings correlate with the clinical presentation?
• Is there evidence of neurologic compromise?
• Is the condition stable, progressive, traumatic, inflammatory, or degenerative?
• Is an intervention directed at the correct target?
• Are there contraindications or alternative diagnoses?

The organization should distinguish between testing that is clinically necessary and testing requested only because of an administrative misunderstanding.

Unnecessary testing increases cost, delays treatment, and may expose patients to avoidable risk.

Diagnostic Sequencing

Some clinical pathways require a specific sequence of evaluation.

A typical sequence may include:

• Clinical history
• Physical examination
• Conservative treatment
• Basic imaging
• Advanced imaging
• Electrodiagnostic testing when indicated
• Diagnostic procedure
• Therapeutic intervention

The correct sequence depends on the condition, clinical urgency, procedure, evidence, and coverage criteria.

Pathways should allow appropriate deviation when the patient’s condition requires more urgent evaluation or when a standard step is contraindicated.

Imaging Requirements

Imaging may support diagnosis, treatment planning, procedural targeting, surgical planning, or exclusion of alternative pathology.

The record should identify:

• The type of imaging
• Date of the study
• Relevant findings
• How the findings correlate with symptoms and examination
• Whether the findings affect the proposed treatment

The organization should not assume that attaching an imaging report automatically establishes medical necessity.

The clinical note should explain the significance of the findings.

Outside Diagnostic Records

Many MSK patients receive imaging, therapy, injections, or evaluations from outside organizations.

The practice should establish a process for:

• Requesting outside records
• Tracking receipt
• Confirming that records are readable and complete
• Associating records with the correct patient and episode
• Ensuring that the treating clinician reviews relevant findings
• Making the records available for authorization
• Avoiding unnecessary duplication

A statement that the patient completed therapy or had imaging elsewhere may be insufficient when the supporting documentation is unavailable.

Conservative Treatment as a Clinical Trial

Conservative care should be approached as an active treatment trial.

The record should describe:

• The intervention attempted
• The reason it was selected
• The duration
• Frequency
• Patient participation
• Clinical response
• Functional response
• Adverse effects
• Reason for discontinuation
• Why the result was insufficient

Examples may include:

• Physical therapy
• Home exercise
• Activity modification
• Medication management
• Bracing
• Weight management
• Behavioral interventions
• Chiropractic treatment
• Acupuncture
• Assistive devices
• The appropriate conservative treatment depends on the diagnosis and patient.

Defining Failure of Conservative Care

Failure does not necessarily mean that the patient received no benefit.

Conservative care may be considered insufficient when:

• Symptoms remain clinically significant
• Functional limitations persist
• Improvement is temporary
• The patient cannot progress toward treatment goals
• The intervention is not tolerated
• The treatment is contraindicated
• Symptoms worsen
• Neurologic findings progress
• The patient reaches a plateau
• The documentation should explain the result rather than simply state that treatment failed.

Contraindications to Conservative Care

A patient should not be required to complete a treatment that is clinically inappropriate or unsafe.

Potential contraindications may include:

• Progressive neurologic deficit
• Severe instability
• Acute fracture
• Infection
• Malignancy
• Medical intolerance
• Significant fall risk
• Condition specific restrictions
• Previous documented worsening

When a standard conservative requirement does not apply, the physician should document the clinical reason.

The utilization team should determine whether an exception, peer to peer review, or appeal is necessary.

Patient Noncompletion

Patients may not complete recommended conservative treatment for many reasons.

These may include:

• Cost
• Transportation
• Work obligations
• Caregiving responsibilities
• Limited appointment availability
• Language barriers
• Insurance limitations
• Medical intolerance
• Worsening symptoms
• Lack of understanding

The organization should distinguish between refusal, inability, clinical contraindication, and incomplete access.

The record should accurately describe the circumstances.

Patient barriers may not automatically satisfy payer requirements, but they should be identified so that the care team can consider alternatives or pursue an exception when appropriate.

Home Exercise Programs

Home exercise is frequently documented without sufficient detail.

The record should identify, when relevant:

• The type of exercise program
• Who instructed the patient
• Approximate start date
• Frequency
• Duration
• Adherence
• Response
• Limitations

A generic statement that the patient performs home exercise may provide little clinical or authorization value.

Medication Management

Medication history should address more than the name of the drug.

Relevant information may include:

• Medication class
• Dose
• Duration
• Effectiveness
• Adverse effects
• Contraindications
• Reason for discontinuation
• Patient preference

Medication management should be appropriate to the patient’s diagnosis, comorbidities, risk profile, and overall treatment plan.

The framework does not require that every patient try every medication class. It requires documentation of the clinically relevant medication history and rationale.

Prior Procedures

Previous interventions are part of the diagnostic and therapeutic history.

The record should identify:

• Procedure type
• Date
• Anatomical site
• Laterality
• Provider or facility when relevant
• Response
• Duration of benefit
• Functional improvement
• Complications
• Reason for considering another procedure

This information is particularly important when requesting repeat treatment, moving to the next step in a pathway, or considering surgery or neuromodulation.

Standardized Conservative Care Documentation

Organizations should develop concise documentation prompts that capture:

• What was tried
• When it was tried
• How long it was tried
• Whether the patient participated
• What response occurred
• Why the treatment was insufficient
• Whether the treatment was contraindicated
• Prompts should improve completeness without producing cloned language or inaccurate documentation.

Verification Versus Assumption

The organization should not assume that conservative care occurred simply because the patient reports it.

Patient reported history may be clinically relevant, but payer requirements may demand additional verification.

The practice should determine which services require:

• Patient reported history
• Provider documentation
• Therapy notes
• Medication records
• Imaging reports
• Procedure reports
• Outcome documentation
• The level of verification should reflect the clinical and coverage requirements of the service.

GoHealthcare Insights

Diagnostic and conservative care requirements frequently cause delays because the information is collected too late.

When outside records, therapy documentation, imaging reports, or previous procedure responses are first requested after the authorization team reviews the case, days or weeks may be lost.

The stronger model identifies these requirements during or immediately after the clinical encounter.

The patient should leave with a clear understanding of what records, treatments, tests, or follow up steps are needed before the proposed intervention can proceed.

Leadership Perspective

Leaders should ensure that conservative care remains clinically meaningful.

The organization should not subject patients to repetitive, ineffective, or unsafe treatment merely to complete an administrative requirement.

At the same time, clinicians must document why conservative care was unsuccessful, inappropriate, or contraindicated.

The goal is a defensible pathway that respects clinical judgment, evidence, patient circumstances, and coverage realities.

Key Takeaways

• Diagnostic and conservative care requirements should support clinical decision making rather than function as superficial checkboxes.
• Imaging findings must be connected to symptoms, examination findings, and the treatment plan.
• Conservative treatment documentation should explain what was attempted, for how long, with what response, and why it was insufficient.
• Contraindications and patient barriers should be documented accurately.
• Prior procedure response is essential when advancing to subsequent treatment or repeating an intervention.
• Diagnostic and conservative care requirements should be identified early to prevent authorization and scheduling delays.

Back to top ↑

09

Payer Coverage Criteria Alignment

Payer coverage criteria significantly influence whether a recommended service can proceed through insurance benefits.

These criteria may be established through:

• Medicare national coverage determinations
• Medicare local coverage determinations
• Commercial payer medical policies
• Utilization management vendor guidelines
• Benefit plan documents
• Employer specific plan rules
• Medicaid policies
• Workers compensation requirements
• Clinical review protocols
• Site of care programs

The GoHealthcare Clinical & Utilization Excellence Framework™ requires organizations to understand and operationalize these requirements while preserving the distinction between clinical judgment and coverage determination.

Clinical Appropriateness Versus Coverage

A service may be clinically appropriate but not covered under a particular policy.

A service may satisfy a general medical policy but be excluded under the patient’s benefit plan.

A service may be covered only when performed at a designated site.

A service may require prior authorization even when the policy appears to support it.

A service may be authorized but later denied because the performed service, diagnosis, provider, facility, or date differs from the authorization.

Coverage alignment therefore requires more than reviewing a medical policy.

The organization must evaluate:

• Benefit eligibility
• Plan exclusions
• Medical policy
• Authorization requirements
• Utilization vendor rules
• Network status
• Site of service
• Provider eligibility
• Coding requirements
• Frequency limitations
• Date and duration of authorization

Establishing a Payer Intelligence Function

Organizations should maintain a controlled process for payer intelligence.

This function may include:

• Identification of payer requirements
• Monitoring of policy updates
• Maintenance of payer portals
• Utilization vendor mapping
• Documentation of submission methods
• Tracking of peer to peer processes
• Appeal requirements
• Reference numbers
• Turnaround standards
• Contact information
• Site of care rules
• Provider and facility requirements
• The information should be centralized and accessible to authorized staff.
• Reliance on individual memory creates inconsistency and operational risk.

Payer Policy Hierarchy

When reviewing coverage, the team should identify the most specific applicable source.

This may include:

• Patient specific benefit information
• Applicable governmental coverage determination
• Payer medical policy
• Utilization vendor guideline
• Provider contract terms
• Authorization decision

The presence of a general medical policy does not eliminate the need to verify the patient’s specific benefits or authorization requirements.

Policies may also differ by state, plan type, product, employer group, or administrative service arrangement.

Version Control

Payer criteria change.

Organizations should record:

• Policy name
• Payer
• Plan or product
• Effective date
• Revision date
• Source
• Procedure or service affected
• Summary of material changes
• Date reviewed internally
• Responsible owner

Outdated policies can lead to incorrect submissions, unnecessary treatment delays, and preventable denials.

Screenshots, saved documents, and internal summaries should be dated and linked to the authoritative source when possible.

Procedure Specific Criteria Matrices

For high volume or high risk services, the organization should develop payer comparison matrices.

A matrix may compare:

• Required diagnosis
• Symptom duration
• Conservative treatment
• Imaging
• Diagnostic block requirements
• Relief thresholds
• Functional improvement
• Frequency limits
• Repeat procedure criteria
• Site of service
• Psychological evaluation
• Trial requirements
• Device criteria
• Required forms
• Peer to peer process
• A matrix helps staff identify meaningful differences across payers.
• It should not replace review of the current policy for complex or disputed cases.

Authorization Submission Alignment

The submitted request should match:

• The treating provider
• The rendering provider
• The procedure
• The procedure code
• The diagnosis
• The anatomical site
• Laterality
• Spinal level
• Facility
• Site of service
• Requested date range
• Units
• Device or implant when applicable

Inconsistency among the order, clinical note, authorization request, schedule, and claim creates significant risk.

The organization should validate alignment before submission and again before treatment.

Payer Requests for Additional Information

Requests for additional information should be treated as time sensitive clinical events.

The workflow should identify:

• What information is requested
• Whether the information already exists
• Who must provide or clarify it
• Submission deadline
• Method of submission
• Confirmation of receipt
• Current case status
• Potential effect on the procedure date

The organization should track recurring requests. Repeated requests for the same information indicate that the initial submission process requires improvement.

Peer to Peer Review

Peer to peer review should be prepared systematically.

The physician should receive:

• Patient summary
• Requested service
• Payer denial rationale
• Applicable policy criteria
• Documentation submitted
• Missing or disputed elements
• Relevant evidence
• Recommended discussion points
• Deadline
• Contact instructions
• The outcome should be documented, including the payer’s reasoning and any conditions placed on approval.
• Peer to peer data should be analyzed by payer, procedure, reason, and outcome.

Appeals

An appeal should directly address the reason for denial.

A strong appeal may include:

• Clinical summary
• Medical necessity rationale
• Applicable policy criteria
• Explanation of how the patient meets the criteria
• Correction of factual errors
• Relevant clinical records
• Published evidence
• Specialty guidance
• Patient specific circumstances
• Reason a standard requirement does not apply
• Risks of delay
• Appeals should be clinically accurate and tailored to the case.
• Generic appeal templates may provide structure but should not replace individualized reasoning.

Site of Care Programs

Payers increasingly direct services to preferred or lower cost settings.

The organization should evaluate:

• The payer’s required site
• The patient’s clinical risk
• Facility capabilities
• Anesthesia needs
• Equipment and implant availability
• Network status
• Patient travel burden
• Continuity of care
• Potential safety concerns

When the payer directed setting is not clinically appropriate, the physician should document the patient specific reason and pursue an exception when available.

Frequency and Repeat Service Limits

Coverage policies often contain frequency limits.

The organization should track:

• Previous service dates
• Anatomical site
• Laterality
• Procedure type
• Response
• Duration of benefit
• Authorization periods
• Payer frequency limits
• Frequency tracking should occur before submission and scheduling.

A new authorization does not necessarily eliminate the risk of a later frequency denial if historical information is inaccurate or incomplete.

Benefit Exclusions and Noncovered Services

When a service is excluded or considered noncovered, the organization should communicate clearly with the patient.

The process should address:

• Whether an appeal is available
• Whether an exception can be requested
• Whether an alternative covered service is clinically appropriate
• Potential patient financial responsibility
• Required notices or consent
• Scheduling requirements
• The patient should not discover an exclusion after the service has been performed.

Payer Criteria and Clinical Integrity

Coverage alignment must never result in inaccurate documentation.

The organization should not:

• Add diagnoses that are not clinically supported
• Change symptom duration to meet a threshold
• Misrepresent conservative care
• Inflate treatment response
• Alter laterality or anatomical level
• Select a different site solely to bypass requirements

The correct response to a coverage conflict is clarification, additional documentation, reconsideration, peer to peer review, appeal, exception management, or informed patient discussion.

GoHealthcare Insights

Payer policy management is a knowledge management discipline.

The greatest risk is not merely that a policy exists. The risk is that different employees use different versions, interpret the same criteria differently, or fail to connect policy requirements to clinical documentation.

A high performing organization creates one controlled payer intelligence process and embeds relevant criteria into the workflow.

This reduces dependence on individual experience and protects the organization when knowledgeable staff members are unavailable.

Leadership Perspective

Leaders should avoid two extremes.

One extreme is ignoring payer criteria until a denial occurs.

The other is allowing payer criteria to dictate clinical care without appropriate physician challenge.

The organization must be clinically led and operationally informed.

Coverage requirements should be anticipated, documented, and managed. Disputed or inappropriate restrictions should be escalated through established clinical and appeal processes.

Key Takeaways

• Payer coverage alignment requires review of benefits, medical policy, authorization rules, site of service, provider requirements, and patient specific plan terms.
• Clinical appropriateness and coverage are related but not identical.
• Payer information should be centralized, current, controlled, and accessible.
• Authorization details must align with the clinical order, schedule, facility, and claim.
• Peer to peer reviews and appeals require structured preparation and outcome tracking.
• Payer criteria must never justify inaccurate or misleading documentation.

Back to top ↑

10

Level of Service Appropriateness, Exception Review, and Escalation

Appropriate utilization includes determining not only whether a service is needed, but also whether the selected intensity, frequency, setting, technology, and sequence of care are appropriate for the patient.

Level of service appropriateness asks whether the proposed care matches the patient’s clinical needs without being insufficient, excessive, premature, unnecessarily complex, or delivered in an inappropriate setting.

This analysis is particularly important in MSK specialty care because treatment options may range from office based conservative management to advanced imaging, interventional procedures, implant based therapies, ambulatory surgery, hospital outpatient surgery, and inpatient care.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes structured review and escalation processes for cases that do not fit standard pathways.

Dimensions of Level of Service

Level of service appropriateness may involve:

• Intensity of treatment
• Frequency of treatment
• Duration of treatment
• Diagnostic sequence
• Therapeutic sequence
• Site of care
• Use of anesthesia
• Need for inpatient versus outpatient care
• Use of an implant or device
• Use of advanced technology
• Need for repeat intervention
• Required monitoring

The correct level should reflect the patient’s diagnosis, severity, risk, comorbidities, previous response, functional needs, and expected benefit.

Avoiding Undertreatment

Utilization excellence does not mean minimizing care.

Undertreatment may occur when:

• Clinically necessary escalation is delayed
• Progressive neurologic findings are not addressed
• A patient remains in ineffective conservative care
• A payer restriction is accepted without appropriate challenge
• A patient cannot access the required specialist
• A lower intensity setting cannot safely meet the patient’s needs

The framework must protect patients from both overuse and underuse.

Appropriate utilization means delivering sufficient care to address the patient’s clinical condition.

Avoiding Premature Escalation

Treatment should not advance to a more invasive or resource intensive level without an appropriate clinical basis.

Premature escalation may occur when:

• The diagnosis remains unclear
• Required evaluation is incomplete
• Conservative treatment has not been meaningfully attempted
• Previous treatment response has not been assessed
• The patient has not received appropriate counseling
• A less invasive effective option remains available
• The proposed service does not match the documented condition

The purpose is not to impose rigid sequencing. It is to ensure that escalation is intentional, evidence informed, and patient specific.

Frequency Appropriateness

Repeated services should be evaluated according to:

• Previous response
• Duration of benefit
• Functional improvement
• Progression of disease
• New clinical findings
• Payer limits
• Cumulative risk
• Alternative options

The fact that a procedure was previously performed does not establish that it should automatically be repeated.

The patient’s response should determine whether repetition is clinically justified.

Site of Service Appropriateness

The care setting should be appropriate for the patient and procedure.

Considerations may include:

• Age
• Comorbidities
• Airway risk
• Anticoagulation
• Cardiopulmonary status
• Need for anesthesia
• Procedure complexity
• Post procedure monitoring
• Emergency support
• Equipment
• Implant requirements
• Infection control
• Transportation
• Payer policy

The least expensive setting may not be safe for every patient. The highest intensity setting may not be necessary for every procedure.

The physician’s rationale should be documented when the setting requires exception review.

Anesthesia and Sedation Appropriateness

Anesthesia and sedation should be evaluated based on:

• Procedure requirements
• Patient anxiety or movement
• Pain tolerance
• Comorbidities
• Airway risk
• Need for patient feedback during the procedure
• Facility capabilities
• Coverage requirements
• The use or absence of sedation should reflect clinical judgment, safety, and applicable standards.

Implant and Technology Appropriateness

Implants, devices, biologics, navigation technologies, robotics, and other advanced treatments may provide significant benefit but require additional review.

The organization should consider:

• Clinical indication
• Evidence
• Alternative treatments
• Patient selection
• Training
• Vendor support
• Long term management
• Replacement or revision needs
• Coverage
• Financial exposure
• Outcome measurement
• Conflict of interest

Technology adoption should be clinically governed rather than driven primarily by marketing, novelty, or reimbursement potential.

Exception Review

A patient may appropriately fall outside a standard clinical pathway or payer criterion.

Exception review should be available when:

• A standard prerequisite is contraindicated
• The patient has urgent progression
• Previous treatment produced an atypical but clinically meaningful result
• The patient has unusual anatomy
• The required site is unsafe or inappropriate
• The payer policy does not account for the patient’s circumstances
• A new procedure has limited but relevant evidence
• A comorbidity changes the standard treatment sequence

The exception request should include:

• The standard requirement
• The reason it does not apply
• Patient specific clinical facts
• Alternative options considered
• Supporting evidence
• Risk of delay
• Physician rationale
• Requested decision

Clinical Escalation Levels

Organizations should establish escalation levels based on urgency and complexity.

Routine clarification may be managed between the clinical and utilization teams.

Complex medical necessity questions may require physician review.

Coverage disputes may require peer to peer review.

Formal denials may require appeal.

Potential safety issues may require immediate clinical leadership intervention.

Compliance concerns may require risk and compliance review.

Urgent neurologic or medical findings may require emergency escalation.

Each escalation level should have a defined owner and response expectation.

Escalation Timeliness

Escalation is only effective when it occurs early enough to change the outcome.

The organization should define triggers such as:

• Authorization deadline approaching
• Procedure date at risk
• Required documentation overdue
• Payer request unresolved
• Medical clearance incomplete
• Site of service disputed
• Implant approval uncertain
• Patient condition worsening
• Repeated cancellation
• Potential adverse event
• Escalation should not wait until the day before the procedure.

Decision Documentation

Exception and escalation decisions should be documented.

The record should identify:

• The issue
• Clinical facts
• Applicable standard
• Participants
• Decision
• Rationale
• Required actions
• Responsible owner
• Deadline
• Final outcome

This supports continuity, accountability, learning, and audit readiness.

Review of Exception Patterns

Exceptions should be analyzed collectively.

Repeated exceptions may indicate:

• The pathway is outdated
• The payer policy is being interpreted incorrectly
• Provider documentation is insufficient
• The patient population differs from the original pathway assumptions
• Technology or evidence has evolved
• The standard is too restrictive
• Operational barriers are being mislabeled as clinical exceptions
• The governance body should determine whether the underlying standard requires revision.

Ethical and Financial Considerations

Level of service decisions may have financial implications for the physician, facility, patient, payer, or vendor.

The organization should ensure that financial incentives do not override clinical appropriateness.

Review processes should consider:

• Clinical benefit
• Patient safety
• Alternatives
• Financial burden
• Conflict of interest
• Transparency
• Informed consent
• Coverage status
• Clinical rationale should remain the primary basis for the decision.

Patient Communication

Patients should receive clear explanations when care is delayed, modified, denied, or escalated.

Communication should address:

• The treatment recommendation
• The unresolved issue
• What action is being taken
• What the patient must complete
• Expected timeline
• Available alternatives
• Potential financial responsibility
• Warning signs requiring urgent care
• The patient should not be left to interpret payer communications without clinical guidance.

GoHealthcare Insights

Exception management is an essential part of standardization.

A framework without exceptions becomes rigid and may interfere with appropriate care. A framework in which every case becomes an exception has no meaningful standard.

The objective is disciplined flexibility.

Standard pathways should manage routine care efficiently. Exceptions should receive timely clinical review, clear documentation, and appropriate escalation.

Leadership Perspective

Leaders should evaluate utilization performance through the lens of appropriateness rather than volume reduction alone.

The organization should be able to identify:

Where patients may be receiving unnecessary care

Where patients may be denied necessary escalation

Where site of service decisions create safety or access concerns

Where repeated services lack documented benefit

Where payer restrictions conflict with patient specific needs

Balanced oversight protects clinical integrity, patient access, compliance, and sustainability.

Key Takeaways

• Level of service appropriateness evaluates the intensity, frequency, sequence, setting, and technology selected for the patient.
• Utilization excellence protects against both overuse and undertreatment.
• Repeat services require documented response and continued justification.
• Site of service and anesthesia decisions should reflect patient specific clinical needs and safety.
• Exceptions are necessary when standard pathways do not fit the patient’s circumstances.
• Escalation thresholds, owners, response times, and documentation standards must be defined.
• Repeated exceptions should inform pathway, policy, education, and governance improvements.

Back to top ↑

11

Clinical Pathways and Protocols

Clinical pathways translate evidence, professional standards, organizational expectations, and operational requirements into a coordinated model for managing defined patient populations.

In musculoskeletal specialty care, pathways are essential because many patients move through multiple diagnostic and therapeutic stages before reaching a definitive treatment. A patient may begin with evaluation and conservative management, proceed through imaging or diagnostic testing, undergo one or more interventional procedures, and later require surgery, neuromodulation, rehabilitation, or long-term follow-up.

Without an agreed pathway, treatment decisions may vary unnecessarily, required documentation may be missed, authorization activity may begin too late, and patients may move through care inconsistently.

The GoHealthcare Clinical & Utilization Excellence Framework™ uses clinical pathways to create reliable care progression while preserving physician judgment and patient-specific decision-making.

The Purpose of a Clinical Pathway

A clinical pathway should help the organization determine:

• Which patients are appropriate for the pathway
• What clinical information should be collected
• Which diagnostic steps may be appropriate
• What conservative treatment should be considered
• When escalation may be justified
• Which procedures or treatments may be considered
• What contraindications require attention
• Which documentation elements are necessary
• What payer requirements may affect access
• How treatment response will be evaluated
• When the pathway should end, continue, or change

A pathway should connect clinical decisions to operational execution. It should not function only as an educational document.

For the pathway to influence care, it must be reflected in clinical documentation, order entry, authorization workflows, procedure readiness, scheduling, follow-up, and outcomes measurement.

Pathway Versus Protocol

A clinical pathway describes the expected progression of care for a defined condition or patient group.

A protocol provides more specific instructions regarding how a particular clinical or operational activity should be performed.

For example, a lumbar facet care pathway may identify the evaluation, conservative care, diagnostic medial branch block, response assessment, radiofrequency ablation, and follow-up sequence.

A diagnostic block protocol may define the procedure documentation, pain assessment method, expected patient activity, response measurement, timing of follow-up, and criteria used to determine whether the result supports the next stage.

Pathways establish direction. Protocols establish execution.

Both are necessary.

Core Components of a Clinical Pathway

A complete pathway should identify the clinical population to which it applies.

It should also define:

• Clinical entry criteria
• Diagnostic considerations
• Red flags
• Relevant examination findings
• Appropriate testing
• Initial treatment options
• Conservative care expectations
• Escalation criteria
• Procedural indications
• Contraindications
• Documentation requirements
• Patient education requirements
• Expected follow-up
• Outcome measures
• Permitted exceptions
• Responsible clinical and operational roles
• The pathway should clearly distinguish required elements from elements that depend on clinical judgment.

This distinction prevents staff from treating every component as a mandatory payer checklist.

Procedure-Specific Pathways

MSK specialty organizations should develop pathways for high-volume, high-risk, high-cost, and high-denial procedures.

Examples may include:

• Facet joint interventions and medial branch blocks
• Radiofrequency ablation
• Epidural steroid injections
• Sacroiliac joint interventions
• Spinal cord stimulation
• Peripheral nerve stimulation
• Minimally invasive lumbar procedures
• Vertebral augmentation
• Joint replacement
• Spinal decompression
• Spinal fusion
• Disc replacement
• Arthroscopy
• Fracture treatment
• Revision surgery

Each pathway should be specific enough to guide clinical and operational work without attempting to replace the physician’s individualized treatment plan.

Diagnostic Pathways

Diagnostic pathways should identify how the organization evaluates a suspected condition or pain generator.

The pathway may address:

• Clinical history
• Symptom pattern
• Functional limitation
• Physical examination
• Initial imaging
• Advanced imaging
• Electrodiagnostic studies
• Laboratory studies
• Diagnostic injections
• Specialty consultation
• The pathway should specify how the result of each diagnostic step affects the next decision.
• Diagnostic testing should not become an accumulation of studies without a defined clinical purpose.

Therapeutic Pathways

Therapeutic pathways should describe how the organization moves from initial treatment to escalation.

A pathway may include:

• Patient education
• Activity modification
• Medication management
• Physical therapy or home exercise
• Behavioral or functional interventions
• Interventional procedures
• Surgical consultation
• Neuromodulation
• Rehabilitation
• Long-term follow-up

The expected sequence should be based on diagnosis, severity, evidence, clinical urgency, patient preferences, and treatment response.

Not every patient must complete every step.

The physician should document why a step was omitted, accelerated, repeated, or modified when the deviation is clinically material.

Operational Integration

Clinical pathways should activate operational workflows.

When a physician selects a pathway-based treatment, the system should help identify:

• Required documentation
• Necessary records
• Payer criteria
• Authorization requirements
• Medical clearance
• Medication instructions
• Testing
• Implant or equipment needs
• Facility requirements
• Patient education
• Follow-up timing
• Outcome measures

This integration reduces the number of cases that reach authorization or scheduling without the required information.

Order Sets and Documentation Support

Pathways may be supported through structured order sets, clinical prompts, standardized templates, checklists, and decision-support tools.

These tools should help clinicians capture meaningful information without forcing every patient into identical documentation.

Effective pathway tools should be:

• Clinically relevant
• Concise
• Procedure-specific
• Easy to use
• Updated regularly
• Integrated into the existing workflow
• Designed to allow exceptions
• Poorly designed tools increase documentation burden and may encourage copied or inaccurate language.

Pathway Entry and Exit Criteria

Every pathway should define when a patient enters and exits.

Entry criteria may include:

• Specific diagnosis
• Symptom pattern
• Duration
• Functional impairment
• Examination findings
• Diagnostic evidence
• Previous treatment

Exit criteria may include:

• Treatment goal achieved
• Care transitioned to another specialty
• Patient declined treatment
• Patient was lost to follow-up
• Condition changed
• Treatment was contraindicated
• Procedure completed and outcome documented
• Further care was not clinically indicated
• Clear exit criteria prevent patients from remaining indefinitely in unresolved work queues.

Pathway Exceptions

Clinical pathways must include a formal exception process.

An exception may be appropriate when:

• The patient has progressive neurologic findings
• Standard conservative care is contraindicated
• The patient previously completed equivalent treatment
• Comorbidities require a different sequence
• The diagnosis or anatomy is atypical
• Urgent intervention is necessary
• The payer’s standard pathway conflicts with patient-specific need

The exception should document the reason, clinical rationale, alternative options, and required escalation.

Pathway Adoption

A pathway is not implemented merely because it has been approved.

Adoption requires:

• Physician participation
• Staff education
• Workflow integration
• Technology support
• Clear ownership
• Performance monitoring
• Feedback
• Revision

Leaders should evaluate whether the pathway is actually being used and whether it improves patient progression.

Measuring Pathway Performance

Relevant measures may include:

• Time from pathway entry to treatment
• Percentage of patients completing required steps
• Documentation completeness
• Authorization approval rate
• Procedure cancellation rate
• Exception frequency
• Provider variation
• Treatment response
• Patient adherence
• Patient complaints
• Outcome-measure completion

High exception rates or poor completion may indicate that the pathway is impractical, outdated, poorly understood, or not properly integrated into operations.

GoHealthcare Insights

Many organizations create pathways as static documents. The document may be clinically correct but operationally ineffective.

A pathway becomes valuable only when it changes how care is documented, authorized, scheduled, delivered, and measured.

The GoHealthcare model treats pathways as operating infrastructure.

They should connect the physician’s decision to every downstream action required to move the patient safely and efficiently through care.

Leadership Perspective

Clinical leaders should own the clinical content of pathways, while operational leaders should ensure that the pathways can be executed.

A clinically ideal pathway that cannot function within real-world staffing, technology, payer, facility, and patient constraints will not produce reliable results.

Pathway development should therefore be multidisciplinary from the beginning.

Key Takeaways

• Clinical pathways translate evidence and organizational standards into coordinated patient-care progression.
• Protocols provide specific execution requirements within the broader pathway.
• Pathways should be integrated into documentation, authorization, scheduling, readiness, follow-up, and outcomes.
• Standardization must preserve individualized clinical judgment and formal exception management.
• Pathway performance should be measured through access, documentation, utilization, operational, and outcome indicators.
• A pathway becomes meaningful only when it is embedded into daily clinical operations.

Back to top ↑

12

Specialty Guidelines and Standards

Specialty guidelines and professional standards provide an important foundation for clinical decision-making, quality improvement, utilization review, documentation, and policy development.

In MSK specialty care, relevant guidance may come from specialty societies, multidisciplinary organizations, government agencies, clinical consensus groups, accreditation bodies, safety organizations, and peer-reviewed literature.

The GoHealthcare Clinical & Utilization Excellence Framework™ uses specialty guidance as one source of clinical intelligence. It does not treat every recommendation as an inflexible rule or assume that all guidelines are equal in quality, relevance, or applicability.

The Role of Specialty Guidance

Specialty guidelines may support decisions regarding:

• Patient selection
• Diagnostic evaluation
• Conservative treatment
• Procedure indications
• Contraindications
• Treatment sequencing
• Frequency
• Repeat interventions
• Safety practices
• Medication management
• Imaging guidance
• Anesthesia
• Implant selection
• Follow-up
• Outcome assessment
• Guidelines may also identify areas in which evidence is limited, conflicting, or evolving.

The organization should use these resources to strengthen clinical reasoning rather than simply quote them in authorization requests.

Evaluating the Source

Before adopting a guideline, the organization should consider:

• Who developed it
• The professional disciplines represented
• The methodology used
• The evidence-review process
• Conflict-of-interest disclosures
• Publication date
• Update history
• Patient population
• Clinical setting
• Strength of recommendations
• Quality of supporting evidence
• Applicability to the organization’s services
• A recommendation from one specialty organization may differ from that of another.

Differences may reflect evidence interpretation, professional perspective, patient population, methodology, technology adoption, or policy objectives.

The governance process should evaluate these differences transparently.

Guidelines Are Not Coverage Policies

Specialty guidance and payer coverage criteria must remain clearly distinguished.

A specialty guideline may support a treatment that a payer restricts.

A payer may impose a requirement not found in the specialty guidance.

A coverage policy may cite selected evidence while adding frequency, benefit, or administrative limitations.

The organization should identify separately:

• Clinical recommendations
• Evidence strength
• Organizational standards
• Payer coverage requirements
• Patient-specific benefit limitations

This distinction is critical when preparing peer-to-peer reviews and appeals.

Guidelines Are Not Substitutes for Clinical Judgment

Guidelines are generally developed for populations, while physicians treat individuals.

A guideline may not fully account for:

• Unusual anatomy
• Comorbidities
• Previous treatment response
• Patient intolerance
• Progressive symptoms
• Urgent clinical circumstances
• Patient preferences
• Available resources
• Individual risk
• The physician should document why the guideline applies or why an alternative approach is appropriate.

Deviation from a guideline is not automatically inappropriate. Unexplained deviation may require review.

Translating Guidelines Into Organizational Standards

The organization should determine which recommendations will become internal standards.

This requires clinical governance and should consider:

• Evidence quality
• Relevance to the specialty
• Patient population
• Safety
• Operational feasibility
• Payer environment
• Facility capability
• Technology requirements
• Staff competence
• Measurement capability

The final internal standard should be clear enough to guide practice and flexible enough to support patient-specific exceptions.

Procedure Standards

Procedure standards may address:

• Patient identification
• Clinical indication
• Required records
• Consent
• Anticoagulation review
• Medication management
• Imaging guidance
• Laterality and level verification
• Sterile technique
• Equipment
• Sedation
• Implant safety
• Post-procedure monitoring
• Discharge instructions
• Follow-up
• Outcome documentation
• Standards should support safe, consistent execution across locations and providers.

Documentation Standards

Specialty guidance should inform documentation expectations.

For example, a procedure-specific standard may require documentation of:

• Clinical indication
• Diagnosis
• Functional limitation
• Examination findings
• Relevant imaging
• Previous treatment
• Previous procedure response
• Risk assessment
• Shared decision-making
• Expected benefit

The documentation standard should capture the physician’s reasoning without becoming a repetitive checklist that obscures meaningful information.

Safety Standards

Clinical standards should incorporate procedure-specific and setting-specific safety requirements.

These may involve:

• Patient identification
• Procedure verification
• Site and laterality confirmation
• Medication reconciliation
• Anticoagulation assessment
• Allergy review
• Infection screening
• Pregnancy screening when applicable
• Equipment checks
• Emergency preparedness
• Implant verification
• Post-anesthesia monitoring
• Discharge readiness
• Adverse-event reporting

Safety requirements should be standardized across office procedure suites, ASCs, and hospital settings while accounting for differences in procedure complexity and facility capability.

Standardization Across Locations

Multi-location practices often experience variation because each office develops its own habits.

The organization should standardize core expectations for:

• Clinical documentation
• Medication instructions
• Procedure preparation
• Authorization processes
• Consent
• Follow-up
• Outcome measurement
• Escalation
• Quality reporting

Local variation should be allowed only when required by facility capability, patient population, payer contract, state regulation, or clinical need.

Managing Conflicting Guidance

When reputable sources disagree, the governance body should evaluate:

• The evidence reviewed by each source
• The date of publication
• The population studied
• The strength of the recommendations
• Potential conflicts of interest
• The clinical relevance to the organization’s patients
• The risks and benefits of each approach

The organization may adopt one standard, allow multiple acceptable approaches, or require additional review for selected cases.

The decision and rationale should be documented.

Standards for New and Emerging Services

Before introducing a new procedure, technology, implant, or device, the organization should establish standards for:

• Training
• Credentialing
• Patient selection
• Evidence review
• Contraindications
• Facility readiness
• Vendor involvement
• Authorization
• Financial counseling
• Outcome tracking
• Adverse-event monitoring
• Long-term management

New services should not be introduced solely because reimbursement appears favorable or patient demand is increasing.

Clinical, operational, compliance, and financial readiness must be evaluated together.

Credentialing and Competency

Standards must identify who is qualified to perform or support a service.

This may include:

• Education
• Licensure
• Board certification
• Specialty training
• Procedure volume
• Supervision
• Competency validation
• Continuing education
• Emergency-response capability
• Equipment training
• Competency should be reviewed periodically and when new technology or procedures are introduced.

Education and Communication

Standards should be communicated through:

• Provider meetings
• Clinical education
• Staff training
• Written policies
• Procedure-specific tools
• Workflow prompts
• Competency assessments
• Case reviews

Updates should identify what changed, why it changed, when it becomes effective, and which roles are affected.

Monitoring Adherence

Adherence may be evaluated through:

• Documentation audits
• Procedure observations
• Authorization outcomes
• Cancellation analysis
• Safety-event review
• Clinical outcomes
• Provider variation
• Patient feedback
• A standard that is frequently ignored should be examined.

The problem may be lack of awareness, workflow difficulty, disagreement, insufficient resources, poor technology design, or an unrealistic standard.

GoHealthcare Insights

The existence of a guideline does not create a clinical operating standard.

Organizations must interpret the guidance, determine its relevance, translate it into workflow, educate the affected teams, and measure whether it improves care.

The strongest standards are clinically credible, operationally practical, and measurable.

Leadership Perspective

Leaders should resist adopting every external recommendation without critical review.

Too many overlapping standards create confusion and burden.

The organization should establish a controlled source hierarchy, identify the guidance it relies upon, and create a single internal standard when possible.

Clinical leadership must remain accountable for the final interpretation.

Key Takeaways

• Specialty guidelines support clinical reasoning but do not replace individualized physician judgment.
• The quality, methodology, relevance, and currency of each guideline should be evaluated before adoption.
• Clinical guidance, internal organizational standards, and payer coverage criteria are distinct.
• Standards should address clinical appropriateness, documentation, safety, competency, and operational execution.
• Conflicting guidance requires structured governance review.
• New services and technologies require defined standards before implementation.

Back to top ↑

13

Shared Decision-Making and Patient-Centered Care

Shared decision-making is a structured process through which clinicians and patients evaluate treatment options together.

It combines clinical evidence, physician expertise, patient values, functional priorities, treatment goals, risk tolerance, and personal circumstances.

In MSK specialty care, shared decision-making is particularly important because treatment options may involve repeated procedures, surgery, implants, rehabilitation, medication changes, long recovery periods, uncertain outcomes, and significant patient participation.

The GoHealthcare Clinical & Utilization Excellence Framework™ treats shared decision-making as an essential component of appropriate care rather than a consent form completed immediately before treatment.

Shared Decision-Making Versus Informed Consent

Informed consent is a legal and ethical process through which the patient receives information about a proposed intervention and agrees to proceed.

Shared decision-making begins earlier.

It supports the selection of the treatment itself.

Shared decision-making addresses:

• The patient’s understanding of the condition
• Available treatment options
• Expected benefits
• Material risks
• Reasonable alternatives
• The option to defer treatment
• The patient’s goals
• The patient’s preferences
• The patient’s ability to complete the treatment plan
• Financial or coverage limitations when relevant

Consent confirms the decision. Shared decision-making helps create it.

Understanding the Patient’s Goals

Treatment plans should reflect what the patient is trying to achieve.

Goals may include:

• Walking farther
• Returning to work
• Sleeping more comfortably
• Reducing medication use
• Performing household activities
• Returning to exercise
• Caring for family members
• Improving balance
• Avoiding surgery
• Returning to sports
• Maintaining independence
• Reducing pain is important, but pain reduction alone may not fully represent meaningful improvement.
• Functional goals should be documented and later used to evaluate treatment response.

Presenting Treatment Options

Patients should receive a balanced explanation of reasonable options.

The discussion may include:

• Continued conservative care
• Medication management
• Physical therapy
• Home exercise
• Interventional procedures
• Surgery
• Neuromodulation
• Rehabilitation
• Observation
• No immediate treatment

The clinician should explain why one option may be preferred, but the presentation should not minimize reasonable alternatives.

Communicating Expected Benefits

Expected benefits should be discussed realistically.

The patient should understand:

• What the treatment is intended to accomplish
• Whether the objective is diagnostic or therapeutic
• The likelihood and degree of improvement
• Expected duration of benefit
• Whether additional treatment may be needed
• Which symptoms may not improve
• What constitutes a successful result
• Overpromising outcomes undermines trust and creates unrealistic expectations.

Communicating Risks and Burden

Risk discussions should reflect the specific treatment and patient.

Relevant topics may include:

• Procedure complications
• Anesthesia risk
• Infection
• Bleeding
• Neurologic injury
• Device complications
• Need for revision
• Recovery time
• Temporary worsening
• Treatment failure
• Medication effects
• Transportation
• Time away from work
• Rehabilitation requirements
• Long-term follow-up
• The burden of treatment may significantly affect the patient’s decision.

Patient Preferences and Clinical Appropriateness

Patient preference matters, but preference alone does not establish clinical appropriateness.

A patient may request a procedure that is not supported by the clinical findings.

A patient may decline the treatment that the physician considers most appropriate.

The clinician should explain the reasoning, alternatives, risks, and potential consequences.

The final plan should reflect an ethically and clinically appropriate balance between professional judgment and patient autonomy.

Health Literacy and Communication

Patients vary in their ability to understand medical information.

The organization should support communication through:

• Plain-language explanations
• Visual aids
• Interpreters
• Translated materials
• Teach-back methods
• Written instructions
• Family or caregiver involvement with permission
• Digital education

Staff should avoid assuming understanding because the patient signed a form or nodded during the discussion.

Cultural and Personal Considerations

Patient decisions may be influenced by:

• Cultural beliefs
• Religious considerations
• Family responsibilities
• Work demands
• Financial limitations
• Transportation
• Caregiver support
• Previous healthcare experiences
• Fear of surgery
• Fear of implants
• Medication concerns

These considerations should be approached respectfully.

They may affect the timing, setting, or feasibility of treatment even when the clinical indication is clear.

Financial and Coverage Transparency

When relevant, patients should be informed that:

• A recommendation does not guarantee insurance approval
• Authorization may be required
• The payer may require additional treatment or review
• The requested setting may not be covered
• An implant or device may require separate approval
• Financial responsibility may remain
• An appeal may be available

Financial discussion should not be allowed to substitute for clinical counseling, but patients need sufficient information to make informed decisions.

Shared Decision-Making for Surgery

Surgical discussions should address:

• The condition being treated
• The objective of surgery
• Expected improvement
• Potential limitations
• Risks
• Recovery
• Rehabilitation
• Time away from work
• Likelihood of additional surgery
• Nonoperative alternatives
• Consequences of delaying or declining surgery
• The patient should understand what surgery may and may not accomplish.

Shared Decision-Making for Neuromodulation and Implants

Implant-based care requires detailed patient participation.

The discussion may include:

• Purpose of the trial
• Meaning of a successful trial
• Permanent implantation criteria
• Device maintenance
• Programming
• Charging requirements
• Activity restrictions
• Follow-up
• Potential revision or replacement
• Device limitations
• Imaging compatibility
• Travel considerations
• Long-term commitment
• Patients should demonstrate that they understand the responsibilities associated with the device.

Decision Support Tools

Organizations may use:

• Procedure education sheets
• Decision aids
• Videos
• Risk calculators
• Functional-goal worksheets
• Frequently asked questions
• Preoperative classes
• Device education

These tools should support, not replace, direct clinician communication.

Documentation of Shared Decision-Making

The record should demonstrate:

• The patient’s condition and goals
• Options discussed
• Expected benefits
• Material risks
• Alternatives
• Patient questions
• Patient preference
• Reason for the selected plan
• Important limitations or concerns
• Documentation should reflect the actual conversation rather than generic consent language.

Revisiting the Decision

Shared decision-making is not always completed in one encounter.

The decision may need to be revisited when:

• The diagnosis changes
• The patient’s condition progresses
• Authorization is denied
• New evidence becomes available
• The patient’s goals change
• The patient cannot complete the required preparation
• Treatment response differs from expectations
• The patient develops new comorbidities
• The care plan should remain responsive to the patient’s evolving circumstances.

GoHealthcare Insights

Patient-centered care is not achieved by adding a standard phrase to the clinical note.

The patient must understand the treatment pathway, the responsibilities involved, the realistic expected benefit, and the alternatives.

When shared decision-making is weak, patients are more likely to cancel, fail to complete readiness requirements, misunderstand authorization delays, or become dissatisfied with outcomes that were never clearly explained.

Leadership Perspective

Leaders should view shared decision-making as both a clinical and operational competency.

Patients who understand the plan are more likely to complete required testing, follow medication instructions, attend procedures, participate in rehabilitation, and return for follow-up.

Clear communication improves safety, adherence, experience, and operational reliability.

Key Takeaways

• Shared decision-making helps determine the treatment plan, while informed consent confirms the selected intervention.
• Patient goals should be specific, functional, and measurable.
• Benefits, risks, alternatives, burdens, and realistic expectations must be discussed.
• Patient preference is important but does not replace clinical appropriateness.
• Health literacy, culture, family circumstances, access barriers, and financial considerations may affect the decision.
• Shared decision-making should be documented as a meaningful clinical process.

Back to top ↑

14

Treatment Variation Review and Management

Treatment variation refers to differences in how clinicians evaluate, document, and treat patients with similar conditions.

Some variation is appropriate and necessary. Patients differ in diagnosis, anatomy, severity, comorbidities, treatment response, goals, preferences, and risk.

The concern is unwarranted variation: differences that cannot be adequately explained by patient need, evidence, clinical judgment, or local circumstances.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes a structured method for identifying, reviewing, and managing variation without undermining physician autonomy or creating punitive comparison.

Sources of Variation

Variation may arise from:

• Different clinical training
• Provider experience
• Specialty perspective
• Preference patterns
• Incomplete clinical pathways
• Evidence uncertainty
• Payer requirements
• Technology availability
• Facility capabilities
• Patient population
• Documentation habits
• Scheduling constraints
• Financial incentives
• Local custom
• Variation should not be interpreted without understanding its source.

Appropriate Variation

Appropriate variation may reflect:

• Different patient risk
• Contraindications
• Previous treatment failure
• Anatomical differences
• Urgent clinical progression
• Patient preference
• Comorbidities
• Prior surgery
• Availability of treatment
• Clinically justified exceptions
• The purpose of review is not to eliminate these differences.
• The physician should be able to explain why the selected approach was appropriate for the patient.

Unwarranted Variation

Potential unwarranted variation may include:

• Large differences in procedure frequency
• Repeated intervention without documented benefit
• Inconsistent diagnostic thresholds
• Different conservative-care requirements for similar patients
• Variable use of imaging
• Inconsistent site-of-service selection
• Routine use of anesthesia without patient-specific rationale
• Uneven use of outcome measures
• Different documentation expectations
• Wide variation in denial or cancellation rates

A pattern does not prove inappropriate care. It identifies an area requiring evaluation.

Data Required for Variation Review

Variation analysis should use meaningful clinical and operational data.

Possible dimensions include:

• Provider
• Procedure
• Diagnosis
• Patient age
• Comorbidities
• Payer
• Facility
• Site of service
• Frequency
• Treatment response
• Complications
• Functional improvement
• Authorization outcome
• Appeal activity
• Cancellation rate
• Cost
• Data should be risk-adjusted when possible.
• Simple comparisons may be misleading when providers treat different patient populations.

Provider-Level Review

Provider variation should be reviewed confidentially and constructively.

The process may include:

• Data validation
• Case selection
• Clinical context
• Peer discussion
• Evidence review
• Documentation review
• Identification of barriers
• Education
• Corrective planning
• Follow-up measurement
• The goal is to understand the reason for variation and determine whether improvement is needed.

Procedure Utilization Review

Organizations should examine patterns involving:

• High-volume procedures
• Rapid growth
• Repeated procedures
• Emerging technologies
• Implants
• High-cost services
• Procedures with poor outcome documentation
• Services with significant denial rates
• Utilization review should consider whether the treatment is producing meaningful clinical value.

Documentation Variation

Providers may make clinically similar decisions but document them differently.

This can create significant differences in authorization and payment outcomes.

The organization should evaluate whether some providers consistently omit:

• Functional limitations
• Conservative treatment
• Examination findings
• Imaging correlation
• Previous procedure response
• Shared decision-making
• Medical necessity rationale

The objective is not identical notes. The objective is reliable capture of clinically material information.

Variation in Treatment Response

Variation review should include outcomes.

A provider may perform more procedures but also treat more complex patients or produce strong functional outcomes.

Another provider may perform fewer procedures but repeat interventions without measuring response.

Volume alone does not establish quality.

Treatment response, complications, functional benefit, and patient progression should be included.

Payer-Driven Variation

Different payer rules may create variation that appears clinical but is actually administrative.

Examples include:

• Different conservative treatment requirements
• Different diagnostic-block thresholds
• Different frequency limits
• Different site-of-care rules
• Different implant criteria

The organization should distinguish payer-driven variation from provider-driven clinical variation.

Facility-Driven Variation

Differences in facility capability may influence:

• Anesthesia
• Equipment
• Implant selection
• Patient risk acceptance
• Scheduling
• Post-procedure monitoring

Clinical leaders should determine whether these differences are appropriate or whether inconsistent facility resources are creating access or quality problems.

Financial Influence

Variation review should consider whether financial arrangements may influence utilization.

Potential areas include:

• Ownership interests
• Implant arrangements
• Vendor relationships
• Site-of-service incentives
• Compensation models
• New technology adoption

The organization should maintain appropriate conflict-of-interest and compliance safeguards.

Clinical appropriateness must remain the primary basis for treatment.

Corrective Strategies

When unwarranted variation is identified, the organization may use:

• Pathway development
• Documentation improvement
• Provider education
• Peer review
• Clinical decision support
• Second opinion requirements for selected cases
• Outcome monitoring
• Credentialing review
• Workflow redesign
• Payer education
• Facility standardization
• The response should be proportional to the risk and supported by evidence.

Avoiding Punitive Use of Data

Variation data can damage trust when used without clinical context.

Leaders should avoid:

• Public ranking without validation
• Assuming that lower utilization is always better
• Treating every deviation as noncompliance
• Ignoring patient complexity
• Using denial rates as the sole measure of appropriateness
• Variation review should support learning, patient safety, and responsible utilization.

GoHealthcare Insights

Organizations often focus on the variation they can easily measure, such as procedure volume.

The more important question is whether differences in care are clinically justified and whether they produce meaningful outcomes.

The GoHealthcare model connects utilization data with patient selection, documentation, authorization, readiness, safety, and treatment response.

Leadership Perspective

Clinical leaders should establish a culture in which variation review is a normal part of professional practice.

Providers should be able to examine data, discuss cases, challenge assumptions, and improve standards without feeling that every review is disciplinary.

Trust, transparency, and credible clinical leadership are essential.

Key Takeaways

• Variation is not inherently inappropriate.
• The organization should distinguish patient-driven, evidence-driven, payer-driven, facility-driven, and provider-driven variation.
• Variation review requires valid data and clinical context.
• Volume alone is not a sufficient measure of appropriateness.
• Documentation and outcome variation should be evaluated alongside procedural utilization.
• Corrective action should focus on education, workflow, standards, and measurable improvement.

Back to top ↑

15

Evidence Review and Pathway Updates

Clinical pathways and operational standards must evolve as evidence, professional guidance, payer policies, technology, regulations, and patient populations change.

A pathway that was appropriate several years ago may become outdated because a new procedure emerged, safety guidance changed, payer criteria were revised, or new evidence challenged previous assumptions.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes a controlled process for reviewing evidence and updating clinical pathways.

The Need for Continuous Review

MSK specialty care changes rapidly.

Organizations may encounter:

• New procedures
• New implants
• New devices
• New clinical trials
• Updated specialty guidelines
• Revised Medicare coverage
• Commercial payer policy changes
• New safety advisories
• Coding changes
• Regulatory changes
• New outcome data
• Technology-enabled treatment

Without a structured review process, different providers may adopt changes at different times and based on different information.

This creates inconsistency and risk.

Evidence Review Governance

The Clinical and Utilization Excellence Committee should oversee evidence review.

The process should include:

• Topic identification
• Assignment of a clinical owner
• Literature search
• Guideline review
• Evidence appraisal
• Operational assessment
• Payer review
• Financial and compliance assessment
• Draft recommendation
• Stakeholder input
• Approval
• Implementation
• Monitoring
• Evidence review should be proportionate to the significance of the change.

A minor documentation update may require limited review. Adoption of a new implant or procedure requires a more comprehensive process.

Triggers for Pathway Review

Pathway review may be triggered by:

• Scheduled review date
• New guideline
• New evidence
• Safety alert
• Regulatory change
• Payer policy revision
• Coding update
• Unexpected adverse event
• High denial rate
• Repeated exceptions
• Poor outcomes
• Provider feedback
• Patient complaints
• New technology
• Changes in facility capability

The organization should maintain both scheduled and event-driven review processes.

Evidence Appraisal

Evidence should be evaluated for:

• Study design
• Population
• Sample size
• Clinical relevance
• Comparator
• Outcome measures
• Follow-up duration
• Bias
• Consistency
• Safety
• Generalizability
• Funding source
• Conflict of interest
• Statistical significance does not automatically mean clinical significance.

The organization should assess whether the evidence demonstrates meaningful patient benefit.

Assessing New Technologies

New procedures and technologies require broader review.

The organization should consider:

• Regulatory clearance or approval
• Clinical evidence
• Professional guidance
• Patient selection
• Training requirements
• Credentialing
• Equipment
• Facility readiness
• Safety
• Vendor support
• Coverage
• Patient financial exposure
• Long-term follow-up
• Outcome measurement
• Device replacement or revision
• Cybersecurity when relevant
• The implementation decision should not be based solely on market demand or vendor materials.

Payer Policy Changes

Payer updates should be evaluated for both clinical and operational impact.

A policy change may affect:

• Patient eligibility
• Required documentation
• Conservative treatment
• Procedure frequency
• Diagnostic thresholds
• Site of care
• Authorization submission
• Peer-to-peer review
• Appeal strategy
• Scheduling
• Existing approved cases

The organization should identify affected workflows and communicate changes before they generate denials.

Pathway Revision Process

A pathway revision should document:

• The section changed
• Reason for change
• Evidence or policy source
• Clinical implications
• Operational implications
• Affected specialties
• Effective date
• Required education
• Technology changes
• Performance measures
• Version history
• Old versions should be retired from active use.

Multidisciplinary Review

Pathway updates should involve the roles affected by implementation.

Depending on the change, this may include:

• Physicians
• Advanced practice providers
• Nurses
• Utilization specialists
• Authorization teams
• Scheduling
• Facility leadership
• Coding
• Compliance
• Quality
• Technology
• Finance
• Vendor management

Multidisciplinary review helps identify operational consequences that may not be apparent from the clinical evidence alone.

Implementation Planning

A pathway update should not become effective until the organization is prepared to execute it.

Implementation may require:

• Template changes
• Order-set changes
• Training
• Payer-policy updates
• Authorization checklist changes
• Scheduling rules
• Facility preparation
• Equipment
• Patient education
• Dashboard updates
• Outcome-measure changes
• The implementation date should allow sufficient time for these changes.

Education and Communication

Communication should explain:

• What changed
• Why it changed
• Who is affected
• When it becomes effective
• What staff must do differently
• Where the updated pathway is located
• Who can answer questions
• Training should be role-specific.

Physicians may need the clinical rationale, while authorization staff may need specific documentation and submission changes.

Monitoring After Revision

The organization should evaluate whether the change produced the expected result.

Measures may include:

• Pathway adoption
• Documentation completeness
• Authorization outcome
• Exception frequency
• Procedure volume
• Cancellation rate
• Safety events
• Patient outcomes
• Provider feedback
• Patient experience
• Unexpected consequences
• A change that does not improve performance may require further revision.

Emergency Updates

Urgent changes may be required because of:

• Safety alerts
• Medication recalls
• Device recalls
• Infection concerns
• Regulatory directives
• Critical payer changes
• Technology failures

The organization should have an expedited approval and communication process for urgent updates.

Temporary instructions should later be incorporated into the controlled pathway system.

Evidence Gaps

Some procedures have limited or conflicting evidence.

The organization may respond by:

• Restricting use to defined patients
• Requiring additional clinical review
• Using informed consent specific to uncertainty
• Tracking outcomes prospectively
• Limiting use to trained providers
• Reviewing cases individually
• Requiring governance approval
• Deferring adoption

The absence of definitive evidence should prompt disciplined oversight rather than automatic adoption or rejection.

Real-World Evidence

Internal outcomes can supplement external evidence.

Organizations may evaluate:

• Patient-reported outcomes
• Functional improvement
• Complications
• Repeat treatment
• Device performance
• Medication reduction
• Return to work
• Patient satisfaction
• Long-term durability

Internal evidence should be interpreted carefully because it may lack control groups or formal research methodology.

It can still provide valuable performance intelligence.

GoHealthcare Insights

Pathway development is not a one-time initiative.

The more successful the organization becomes, the more important version control, evidence review, and implementation discipline become.

A pathway that is clinically current but operationally outdated can create the same level of risk as a clinically outdated pathway.

Clinical and operational updates must occur together.

Leadership Perspective

Leaders should establish a review process that is rigorous without becoming so slow that the organization cannot respond to change.

Routine updates should move efficiently.

High-risk technologies, implants, procedures, and major pathway changes should receive deeper review.

The level of governance should match the level of clinical, operational, financial, and compliance risk.

Key Takeaways

• Clinical pathways require scheduled and event-driven review.
• Evidence appraisal should consider quality, relevance, safety, clinical significance, and generalizability.
• Payer, regulatory, coding, safety, and technology changes may all require pathway updates.
• New technologies require multidisciplinary clinical and operational review before adoption.
• Pathway revisions must include implementation planning, education, version control, and performance monitoring.
• Internal outcomes can support continuous improvement when interpreted appropriately.

Back to top ↑

16

Establishing the Utilization Management Operating Model

Utilization management is the structured evaluation of whether healthcare services are clinically appropriate, medically necessary, effectively sequenced, delivered at the appropriate level of care, and supported by sufficient documentation.

Within musculoskeletal specialty care, utilization management must extend beyond insurance authorization. It should support the complete clinical pathway from the initial treatment recommendation through diagnostic review, conservative care, procedural intervention, site-of-service selection, follow-up, repeat treatment, and outcome evaluation.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes utilization management as a clinically governed operating function rather than a transactional administrative department.

Its purpose is not simply to reduce utilization or obtain payer approvals. Its purpose is to ensure that patients receive appropriate care while preventing avoidable delays, denials, duplication, overuse, underuse, and operational waste.

The Scope of Utilization Management

A comprehensive utilization management model should include:

• Prospective review before treatment
• Concurrent review while care is being delivered
• Retrospective review after care has occurred
• Prior authorization management
• Medical necessity validation
• Coverage criteria review
• Treatment sequencing
• Site-of-care review
• Frequency and repeat-procedure review
• Peer-to-peer preparation
• Appeal management
• Clinical exception review
• Denial analysis
• Outcome evaluation
• Utilization trend monitoring
• Provider variation review

The model should be integrated with clinical operations, patient access, documentation integrity, scheduling, quality, compliance, and revenue cycle management.

Utilization Management as a Clinical Support Function

Utilization management should support physicians and clinical teams by identifying the information, evidence, payer requirements, and operational conditions needed to move appropriate care forward.

The function should not independently determine clinical treatment unless appropriately licensed and authorized to perform that role.

The treating physician remains responsible for diagnosis, treatment selection, risk assessment, and patient counseling.

Utilization management supports those decisions by:

• Confirming that the record clearly supports the recommendation
• Identifying applicable coverage requirements
• Clarifying missing information
• Coordinating payer review
• Preparing escalation
• Tracking unresolved barriers
• Analyzing patterns that affect access and quality

A high-performing utilization function makes the physician’s clinical reasoning easier to understand, defend, and execute.

The Three Review Phases

The operating model should address three major review phases.

Prospective review occurs before the service is performed. It evaluates clinical appropriateness, medical necessity, payer requirements, documentation sufficiency, site of service, frequency, and readiness.

Concurrent review occurs while the patient is actively receiving care. It evaluates whether continued treatment, hospitalization, rehabilitation, therapy, observation, monitoring, or additional intervention remains appropriate.

Retrospective review occurs after the service. It evaluates whether the treatment was supported, whether documentation was complete, whether outcomes justified continued utilization, and whether recurring operational or clinical problems require correction.

Each review phase serves a different purpose. Together, they create continuous oversight across the care continuum.

Designing the Utilization Workflow

The organization should define a standard utilization workflow for each major service line.

A typical workflow may include:

• Clinical treatment decision
• Order or case creation
• Initial documentation validation
• Benefit and authorization requirement verification
• Payer policy review
• Medical necessity screening
• Identification of missing information
• Provider clarification
• Submission
• Payer follow-up
• Additional information response
• Peer-to-peer review when required
• Appeal when appropriate
• Final determination
• Procedure-readiness confirmation
• Treatment completion
• Outcome capture
• Case closure

Each stage should have a defined owner, status, deadline, escalation threshold, and documentation standard.

Role-Based Responsibilities

The utilization operating model should distinguish among clinical, nursing, administrative, and leadership responsibilities.

The treating physician owns the clinical decision and rationale.

Advanced practice providers and nurses may support assessment, clinical documentation, patient education, and clinical review within their scope.

Utilization specialists may review payer criteria, prepare cases, track submissions, coordinate additional information, and manage workflow.

Prior authorization staff may complete payer-specific submissions, portal activity, status follow-up, and communication.

Clinical documentation specialists may identify missing or unclear clinical elements.

Physician reviewers may support peer-to-peer discussions, complex cases, and exception review.

Utilization leadership should analyze performance, manage escalation, maintain policies, and report to governance.

Clear role definition prevents clinical decisions from being made by individuals without the appropriate authority and prevents physicians from being burdened with administrative work that can be completed by trained staff.

Centralized Versus Decentralized Utilization Management

Organizations may centralize utilization management across providers and locations or distribute it within individual offices or service lines.

A centralized model can provide:

• Standardization
• Specialized payer knowledge
• Improved staffing flexibility
• Consistent metrics
• Better workload distribution
• Stronger policy management
• More efficient escalation

A decentralized model may provide:

• Closer provider relationships
• Greater local knowledge
• Faster communication
• Specialty-specific familiarity
• The most effective structure may be a hybrid model.

Centralized standards, payer intelligence, analytics, training, and governance can be combined with service-line or location-based coordinators who understand local clinical workflows.

Case Prioritization

Not every case requires the same level of review or urgency.

Cases may be prioritized according to:

• Clinical urgency
• Procedure date
• Payer turnaround requirement
• Risk of neurologic or functional deterioration
• High-cost implant or device
• Previous denial
• Missing documentation
• Patient travel or work constraints
• Facility capacity
• Expiring authorization
• Complex payer requirements

Priority should be based on clinical and operational risk rather than solely on which patient or physician calls most frequently.

Workload Management

Utilization teams should not be evaluated only by case volume.

A spinal cord stimulator implantation, joint replacement, spinal fusion, office injection, and diagnostic imaging request may require substantially different levels of review.

Workload models should consider:

• Case complexity
• Number of payer interactions
• Documentation burden
• Peer-to-peer activity
• Appeal requirements
• Clinical review needs
• Number of procedures or codes
• Device coordination
• Site-of-care issues
• A balanced workload model improves accuracy, timeliness, and staff sustainability.

Clinical Escalation

The utilization team should know when a case requires clinical review.

Escalation triggers may include:

• Unclear diagnosis
• Conflicting clinical information
• Potential contraindication
• Proposed treatment outside the standard pathway
• Urgent clinical deterioration
• Repeat treatment without documented benefit
• Disagreement with payer criteria
• High-risk site-of-service concern
• Uncertain procedure selection
• Complex implant decision
• The utilization team should not independently resolve clinical questions beyond its authority.

Payer Escalation

Payer-related escalation may involve:

• Supervisor review
• Utilization vendor escalation
• Peer-to-peer review
• Medical director review
• Formal appeal
• Expedited appeal
• External review
• State complaint process
• Employer or plan sponsor intervention
• Contracting escalation
• The appropriate pathway depends on the payer, plan, urgency, denial type, and available rights.

The organization should maintain payer-specific escalation instructions and deadlines.

Patient Communication Within Utilization Management

Patients should receive clear communication regarding:

• Whether authorization is required
• What information remains outstanding
• What the payer is reviewing
• Whether additional records are needed
• When a determination is expected
• Whether the procedure date is confirmed
• What a denial means
• Whether an appeal is being pursued
• What alternatives are available
• Staff should avoid guaranteeing approval.

The patient should understand that the physician’s treatment recommendation and the payer’s coverage decision are separate processes.

Data and Performance Intelligence

The utilization operating model should produce actionable data.

Core measures may include:

• Case volume
• Initial approval rate
• Overall approval rate
• Average submission time
• Average payer turnaround time
• Requests for additional information
• Peer-to-peer rate
• Appeal rate
• Appeal overturn rate
• Administrative denial rate
• Clinical denial rate
• Authorization-related cancellation rate
• Time from order to treatment
• Cases exceeding established aging thresholds

Metrics should be stratified by payer, provider, procedure, site, specialty, denial reason, and staff workflow when appropriate.

Compliance and Integrity

Utilization management must operate within ethical and compliance standards.

The organization should prohibit:

• Misrepresentation of symptoms
• Inaccurate diagnoses
• Altered treatment history
• Inflated procedure response
• Backdated records
• False conservative-treatment documentation
• Submission of records not reviewed by the treating clinician
• Use of another provider’s credentials
• Misrepresentation of the rendering provider or facility
• Pressure to obtain approval must never compromise documentation integrity.

GoHealthcare Insights

The authorization department is often expected to solve problems created elsewhere in the care pathway.

Incomplete notes, unclear orders, missing records, inconsistent procedure selection, or absent outcome documentation may all reach the authorization team as urgent requests.

A mature utilization model moves review upstream.

The organization should identify clinical and documentation deficiencies before the payer identifies them.

This reduces denials, protects physicians’ time, and allows the utilization team to focus on legitimate payer barriers rather than repeatedly repairing incomplete cases.

Leadership Perspective

Utilization management should be evaluated by how reliably it supports appropriate patient care.

Approval rate is important, but it is not sufficient.

A high approval rate achieved through delayed submissions, excessive physician addenda, repeated staff overtime, or inaccurate documentation does not represent excellence.

Leadership should evaluate the complete system, including clinical appropriateness, staff workload, patient access, physician burden, documentation integrity, payer friction, and treatment outcomes.

Key Takeaways

• Utilization management is a clinically governed operating function, not only an authorization department.
• The model should include prospective, concurrent, and retrospective review.
• Clinical judgment remains with qualified clinicians, while utilization teams support documentation, payer review, coordination, and escalation.
• Every case should move through a defined workflow with visible status, ownership, deadlines, and escalation.
• Performance should be measured across approvals, delays, denials, workload, patient access, documentation integrity, and outcomes.
• Effective utilization management protects patients from overuse, underuse, preventable delay, and administrative failure.

Back to top ↑

17

Prospective Utilization Review

Prospective utilization review occurs before a service is performed.

It evaluates whether the proposed treatment is clinically appropriate, medically necessary, supported by the record, correctly sequenced, consistent with applicable coverage requirements, and planned for an appropriate setting.

In MSK specialty care, prospective review is the most effective point for preventing avoidable denials, cancellations, patient delays, and resource waste.

Once a procedure has been scheduled, an implant ordered, facility time reserved, or patient instructed to stop medications, unresolved requirements become more difficult and costly to correct.

The GoHealthcare Clinical & Utilization Excellence Framework™ therefore places prospective review as early as possible in the clinical and operational pathway.

Objectives of Prospective Review

Prospective review should determine:

• Whether the diagnosis supports the proposed service
• Whether the clinical indication is clear
• Whether required testing has been completed
• Whether conservative treatment has been addressed
• Whether prior treatment response is documented
• Whether the service is correctly sequenced
• Whether the payer requires authorization
• Whether the patient’s benefits cover the service
• Whether the planned provider and facility are eligible
• Whether the selected site is appropriate
• Whether frequency limits apply
• Whether a clinical or payer exception is required
• Whether the case is ready to proceed operationally
• The review should identify barriers while there is still time to resolve them.

Review at the Point of Decision

The most efficient prospective review begins during or immediately after the clinical encounter.

The treatment order should include enough information to initiate the pathway.

This may include:

• Requested service
• Diagnosis
• Anatomical site
• Laterality
• Spinal level when applicable
• Clinical indication
• Priority
• Preferred facility
• Required equipment or implant
• Relevant previous procedures
• Expected follow-up

When the order is incomplete or inconsistent with the note, the case should be clarified before authorization activity begins.

Initial Clinical Screening

The initial screening should evaluate whether the record supports the treatment recommendation.

The reviewer may assess:

• Symptom duration
• Functional impact
• Physical examination
• Imaging correlation
• Conservative treatment
• Previous response
• Contraindications
• Patient selection
• Procedure-specific requirements
• The screening should not convert nonclinical staff into independent clinical decision-makers.
• Questions requiring judgment should be routed to a qualified clinician.

Coverage and Benefit Verification

Prospective review should include verification of:

• Active coverage
• Applicable payer
• Plan type
• Authorization requirement
• Utilization vendor
• Referral requirement
• Network status
• Provider eligibility
• Facility eligibility
• Site-of-care restrictions
• Benefit exclusions
• Deductible or cost-sharing information when relevant to patient communication

Coverage verification should occur early enough to identify whether the planned pathway must be modified or escalated.

Procedure and Code Alignment

The order, clinical note, authorization request, schedule, and eventual claim should align.

Prospective validation should confirm:

• Correct procedure
• Correct code
• Correct diagnosis
• Correct anatomical location
• Correct laterality
• Correct spinal level
• Correct provider
• Correct facility
• Correct site of service
• Correct units
• Correct device or implant information when required
• Code selection should reflect the actual planned service and documented clinical condition.

Procedure Sequencing

Some treatments require a defined sequence.

Examples may include:

• Diagnostic block before radiofrequency ablation
• Trial before permanent neuromodulation implantation
• Conservative treatment before elective surgery
• Imaging before selected interventions
• Psychological evaluation before certain implantable therapies when required
• Medical clearance before surgery
• Prospective review should identify sequence requirements before the case is submitted or scheduled.

When a clinically appropriate exception applies, the physician’s rationale should be documented and escalated through the correct pathway.

Repeat Procedure Review

Repeat treatments require prospective assessment of prior response.

The record should identify:

• Previous procedure date
• Procedure type
• Anatomical site
• Degree of improvement
• Functional change
• Duration of benefit
• Complications
• Reason for repetition

A repeat intervention should not be authorized or scheduled based only on the fact that it was performed previously.

The prior outcome should support the next decision.

Site-of-Care Review

Prospective review should determine whether the proposed site is clinically and administratively appropriate.

Factors may include:

• Patient comorbidities
• Anesthesia needs
• Procedure complexity
• Monitoring requirements
• Emergency capabilities
• Equipment
• Implant availability
• Payer policy
• Network participation
• Patient travel burden
• Facility acceptance

When a payer directs the patient to a different setting, the clinical team should evaluate whether the alternative is safe and appropriate.

Preauthorization Clinical Clarification

When documentation is incomplete, clarification should occur through a standardized process.

The request should identify:

• The specific missing element
• Why the information is required
• Who must respond
• The response deadline
• Effect on the case status

Examples include:

• Missing conservative-treatment duration
• Unclear laterality
• Incomplete procedure response
• Absent imaging correlation
• Inconsistent diagnosis
• Unclear rationale for repeat treatment
• Clinical teams should not receive vague requests such as “note does not meet criteria.”
• Specificity reduces frustration and accelerates correction.

Risk Stratification

Prospective review should be more intensive for high-risk or complex cases.

These may include:

• Implant-based procedures
• Major spine surgery
• Revision surgery
• Patients with significant comorbidities
• Anticoagulated patients
• Procedures requiring complex anesthesia
• Services with high denial rates
• Emerging technologies
• Cases involving multiple payers or coordination of benefits
• High-risk cases may require multidisciplinary review before authorization or scheduling.

Prospective Review Outcomes

The review should produce a clear disposition.

Possible outcomes include:

• Meets clinical and documentation requirements
• Ready for authorization submission
• Authorization not required
• Additional clinical information required
• Additional records required
• Physician review required
• Payer exception required
• Alternative site review required
• Not ready to proceed
• Treatment plan reconsideration required
• The status should be visible across relevant teams.

Preventing Premature Patient Commitments

Patients should not be given a confirmed procedure date when material requirements remain unresolved unless the organization has an established conditional scheduling policy.

Staff should clearly distinguish among:

• Treatment recommendation
• Tentative date
• Authorization pending
• Readiness pending
• Confirmed procedure

This reduces patient confusion and avoidable cancellations.

Prospective Review Metrics

Performance measures may include:

• Percentage of cases reviewed before scheduling
• Documentation completeness at first review
• Time from order to review
• Time from review to submission
• Percentage requiring clinical clarification
• Initial approval rate
• Additional information request rate
• Cases scheduled before approval
• Authorization-related cancellations
• Frequency denials prevented
• Site-of-care issues identified before scheduling

These measures demonstrate whether the review is preventing downstream failure.

GoHealthcare Insights

The most expensive utilization problem is often the one discovered too late.

When a deficiency is identified after the patient has arranged transportation, stopped medication, taken time off work, or arrived at the facility, the consequences extend far beyond the authorization team.

Prospective review should move the discovery of risk to the earliest practical point.

The goal is not to slow care. It is to eliminate avoidable rework so that appropriate care moves faster.

Leadership Perspective

Leaders should evaluate whether prospective review is adding value or merely adding another step.

A well-designed review should reduce repeated messages, physician addenda, payer requests, cancellations, and patient dissatisfaction.

If review creates substantial delay without improving outcomes, the workflow should be redesigned.

The standard should be early, targeted, procedure-specific validation rather than broad administrative review of every possible detail.

Key Takeaways

• Prospective utilization review occurs before treatment and is the strongest point for preventing avoidable failure.
• Review should begin during or immediately after the clinical decision.
• The process should validate indication, documentation, coverage, sequencing, frequency, site, and readiness.
• Repeat procedures require review of documented prior response.
• Clinical clarification requests must be specific, timely, and routed to the appropriate professional.
• Patients should not receive a confirmed procedure commitment before material requirements are resolved.

Back to top ↑

18

Concurrent Utilization Review

Concurrent utilization review occurs while a patient is actively receiving care.

It evaluates whether the current level, duration, intensity, and continuation of treatment remain clinically appropriate.

Concurrent review is commonly associated with hospitalization, but it also applies to rehabilitation, therapy, observation, prolonged treatment plans, postoperative care, device trials, complex recovery, and other episodes in which the patient’s condition changes over time.

Within MSK specialty care, concurrent review helps ensure that the treatment plan remains responsive to the patient’s progress, complications, functional status, and evolving clinical needs.

The Purpose of Concurrent Review

Concurrent review should determine:

• Whether the patient continues to require the current level of care
• Whether the treatment plan is producing expected progress
• Whether complications require additional intervention
• Whether the patient can safely transition to a lower level of care
• Whether continued hospitalization, therapy, rehabilitation, or monitoring is justified
• Whether discharge barriers are clinical or operational
• Whether the original treatment plan should be modified
• The purpose is not simply to reduce length of stay or treatment duration.
• It is to match ongoing care to the patient’s current condition.

Concurrent Review in Surgical Care

After major orthopedic or spine surgery, concurrent review may evaluate:

• Pain control
• Neurologic status
• Mobility
• Wound status
• Medical stability
• Therapy progress
• Complications
• Need for continued inpatient care
• Discharge destination
• Durable medical equipment
• Home support
• Follow-up requirements
• The patient should remain at the current level of care only as long as clinically necessary.

Premature discharge may create safety risk and readmission. Unnecessary continuation may expose the patient to avoidable cost, infection risk, deconditioning, and resource use.

Observation Versus Inpatient Status

Some surgical and acute MSK episodes require review of observation or inpatient status.

The determination may depend on:

• Procedure type
• Expected recovery
• Comorbidities
• Complications
• Pain control
• Functional status
• Medical instability
• Need for monitoring
• Payer criteria

The patient’s status should reflect actual clinical need rather than routine habit or reimbursement preference.

Rehabilitation and Therapy Review

Concurrent review of rehabilitation or therapy should evaluate:

• Baseline function
• Treatment goals
• Attendance
• Participation
• Progress
• Barriers
• Clinical response
• Need for continued skilled intervention
• Potential transition to home exercise
• A fixed number of visits should not replace assessment of patient progress.
• Continued treatment should be supported by measurable need and expected benefit.

Neuromodulation Trial Review

During a neuromodulation trial, concurrent review may evaluate:

• Pain relief
• Functional improvement
• Medication change
• Device use
• Patient understanding
• Adverse events
• Lead or equipment issues
• Ability to manage the system
• Whether the trial result supports permanent implantation
• The trial should have predefined success criteria.
• The result should be documented promptly and accurately before a permanent implant decision is made.

Concurrent Review of Complications

Complications may change the level of care required.

Relevant events may include:

• Neurologic change
• Infection
• Bleeding
• Thromboembolic concern
• Uncontrolled pain
• Medication reaction
• Wound complication
• Fall
• Implant malfunction
• Unexpected functional decline

The review process should support rapid clinical escalation rather than focus narrowly on utilization authorization.

Continued Stay Review

When continued stay authorization is required, the organization should submit current and clinically relevant information.

This may include:

• Updated diagnosis
• Clinical status
• Treatment provided
• Response
• Complications
• Functional status
• Discharge plan
• Reason continued care is required
• Expected next milestone
• Repeated submission of unchanged or outdated notes weakens the request and may delay payer determination.

Discharge Planning

Discharge planning should begin early.

The review should identify:

• Expected discharge destination
• Transportation
• Home support
• Rehabilitation needs
• Durable medical equipment
• Medication access
• Home health services
• Wound care
• Follow-up appointments
• Red-flag instructions
• Potential barriers

Delays caused by unresolved equipment, transportation, insurance, caregiver, or facility issues should be addressed proactively.

Clinical and Administrative Delays

Concurrent review should distinguish between clinical need and administrative delay.

A patient may remain in care because of:

• Awaiting placement
• Insurance approval
• Transportation
• Equipment availability
• Home support
• Delayed consultation
• Facility acceptance

These barriers may not represent continued clinical necessity for the same level of care.

The organization should document the distinction and escalate operational barriers.

Communication Across Settings

Concurrent review often requires communication among:

• Hospital teams
• Surgeons
• Pain physicians
• Therapists
• Case managers
• Utilization nurses
• Payers
• Rehabilitation facilities
• Home health agencies
• Primary care providers
• Families and caregivers
• The review process should maintain one current plan and prevent contradictory communication.

Patient and Family Engagement

Patients and families should understand:

• The current treatment goals
• Expected recovery milestones
• Potential discharge date
• Required participation
• Available post-discharge options
• Equipment needs
• Warning signs
• Follow-up responsibilities
• Unrealistic expectations can delay transition and create dissatisfaction.

Denial Prevention During Active Care

Concurrent review should monitor authorization periods and payer deadlines.

The team should know:

• Approved days or visits
• Next review date
• Required updates
• Payer contacts
• Potential denial risk
• Appeal rights
• Services should not continue under the assumption that coverage will automatically extend.

At the same time, clinically necessary care should not be discontinued solely because a payer response is delayed without appropriate physician review and patient communication.

Concurrent Review Metrics

Relevant measures may include:

• Average length of stay
• Observation conversion
• Continued stay denial rate
• Therapy visit utilization
• Rehabilitation duration
• Time to discharge planning
• Discharge delays
• Readmission rate
• Complication rate
• Transition-of-care completion
• Percentage of neuromodulation trials with documented outcome
• Metrics must be interpreted with clinical context and patient complexity.

GoHealthcare Insights

Concurrent review becomes ineffective when it is treated only as a daily payer reporting task.

Its value lies in connecting the patient’s changing condition to the current treatment plan, level of care, discharge readiness, and next clinical decision.

Strong concurrent review helps patients avoid both premature transition and unnecessary continuation.

Leadership Perspective

Leadership should ensure that utilization staff are empowered to escalate clinical changes and operational barriers.

The review function should not be isolated from the treating team.

Concurrent review works best when clinical, therapy, nursing, case management, utilization, and discharge planning teams operate from the same current information.

Key Takeaways

• Concurrent utilization review evaluates ongoing care while the patient is actively receiving treatment.
• The current level and duration of care should reflect the patient’s evolving clinical condition.
• Surgical recovery, rehabilitation, therapy, hospitalization, observation, and device trials may all require concurrent review.
• Discharge planning should begin early and distinguish clinical barriers from administrative barriers.
• Neuromodulation trials require predefined success criteria and timely outcome documentation.
• Concurrent review should protect patients from both premature transition and unnecessary continuation of care.

Back to top ↑

19

Retrospective Utilization Review

Retrospective utilization review evaluates care after the service or episode has occurred.

It examines whether the treatment was clinically appropriate, medically necessary, properly documented, correctly authorized, accurately coded, performed at the appropriate level of care, and supported by the patient’s outcome.

Retrospective review is often associated with payer claim review or audit activity. Within the GoHealthcare Clinical & Utilization Excellence Framework™, it is also a critical organizational learning function.

It allows leaders to identify patterns that were not visible during the individual case and convert those findings into improved pathways, documentation, training, authorization, scheduling, and quality management.

Objectives of Retrospective Review

Retrospective review may evaluate:

• Whether the clinical indication was supported
• Whether documentation was complete
• Whether the performed service matched the authorized service
• Whether the site of care was appropriate
• Whether frequency limits were followed
• Whether previous treatment response justified repetition
• Whether the treatment produced meaningful benefit
• Whether complications occurred
• Whether billing accurately reflected the service
• Whether the case reveals a recurring operational failure
• The review should support improvement rather than operate only as a search for error.

Case Selection

Organizations may review cases based on:

• Random sampling
• High-cost procedures
• Implants and devices
• Repeat interventions
• High denial rates
• Unexpected outcomes
• Patient complaints
• Adverse events
• Provider variation
• New procedures
• High-frequency services
• Payer audit activity
• Claims denials
• Cases with repeated documentation addenda
• The sampling method should reflect organizational risk and strategic priorities.

Medical Necessity Review

Retrospective medical necessity review should determine whether the record available at the time of care supported the treatment.

The review may assess:

• Diagnosis
• Symptoms
• Functional limitation
• Examination findings
• Diagnostics
• Conservative treatment
• Prior response
• Clinical rationale
• Patient selection
• Contraindications
• Expected benefit
• The review should not assume that authorization approval proves medical necessity.

Payers may authorize a service and later deny payment when the performed service, record, coding, or claim differs from what was approved.

Authorization-to-Service Reconciliation

The organization should compare:

• The physician order
• Authorization approval
• Scheduled service
• Performed service
• Procedure report
• Claim

This reconciliation should confirm:

• Correct provider
• Correct facility
• Correct code
• Correct diagnosis
• Correct anatomical site
• Correct laterality
• Correct spinal level
• Correct units
• Correct date range
• Correct device or implant
• Misalignment can result in payment denial even when the clinical service was appropriate.

Documentation Integrity Review

Retrospective review should identify whether the clinical record is:

• Accurate
• Complete
• Internally consistent
• Timely
• Procedure-specific
• Supported by source information
• Consistent with the service performed

The review should identify patterns such as:

• Cloned language
• Contradictory findings
• Missing procedure response
• Incorrect laterality
• Incomplete operative reports
• Unclear medical necessity
• Late documentation
• Missing patient counseling
• Findings should be used to improve templates, education, and workflow.

Outcome Review

Retrospective utilization review should include treatment response.

Relevant outcomes may include:

• Pain reduction
• Functional improvement
• Duration of benefit
• Medication change
• Return to work
• Patient satisfaction
• Complications
• Need for additional treatment
• Revision or reoperation
• Unplanned healthcare utilization

A procedure that meets authorization criteria but repeatedly produces poor outcomes may require pathway, patient-selection, or provider review.

Repeat Utilization Patterns

The organization should examine whether repeated care is supported by documented benefit.

Patterns may include:

• Frequent injections without sustained improvement
• Repeated imaging without treatment-plan change
• Multiple procedures at short intervals
• Repeated therapy with limited progress
• Device revisions
• Recurring emergency visits
• Repeated surgical consultations without resolution

These patterns should be evaluated clinically and not judged solely by volume.

Denial and Appeal Review

Retrospective analysis should categorize denials according to root cause.

Categories may include:

• Missing authorization
• Authorization mismatch
• Medical necessity
• Benefit exclusion
• Site of service
• Frequency
• Documentation
• Coding
• Provider eligibility
• Timely filing
• Administrative submission error

The organization should distinguish:

• Preventable denials
• Payer interpretation disputes
• Clinically justified but noncovered services
• Documentation failures
• Operational errors
• Corrective action should address the actual root cause.

Provider Feedback

Retrospective findings should be communicated in a constructive and clinically credible manner.

Feedback should include:

• Case facts
• Applicable standard
• Specific deficiency
• Clinical or operational impact
• Recommended correction
• Education or support available
• Follow-up expectation
• Generalized criticism is unlikely to produce improvement.
• Specific, evidence-based feedback is more effective.

Corrective Action

Corrective strategies may include:

• Template revision
• Clinical education
• Authorization checklist changes
• Workflow redesign
• Coding review
• Payer-policy education
• Procedure pathway revision
• Provider coaching
• Facility coordination changes
• Technology prompts
• Additional prospective review
• The corrective action should match the identified cause.

Audit Readiness

Retrospective review strengthens preparedness for:

• Payer audits
• Medicare reviews
• Commercial utilization audits
• Recovery audit activity
• Government investigations
• Contractual reviews
• Internal compliance audits

The organization should be able to demonstrate that identified deficiencies are corrected and monitored.

Learning From Near Misses

Not every important event results in a denial, complication, or financial loss.

A case may be saved through last-minute staff intervention.

Examples include:

• An implant authorization mismatch corrected before surgery
• A medication hold clarified on the procedure day
• An incorrect laterality caught by the facility
• A missing clearance identified before anesthesia

These near misses should be reviewed.

Repeated reliance on individual heroics indicates a fragile system.

Retrospective Review Metrics

Measures may include:

• Documentation deficiency rate
• Authorization mismatch rate
• Medical necessity denial rate
• Repeat procedure outcome completion
• Claim denial rate
• Appeal overturn rate
• Post-service cancellation or rescheduling issues
• Adverse-event rate
• Audit findings
• Corrective-action completion
• Recurrence of previously identified problems
• The effectiveness of retrospective review is measured by whether future performance improves.

GoHealthcare Insights

Retrospective review should not become an exercise in documenting what went wrong after nothing can be changed for the patient.

Its value is realized only when the organization uses the findings to redesign prospective processes.

Every recurring retrospective deficiency should trigger a question: Where could this have been prevented earlier?

Leadership Perspective

Leaders should create a learning environment in which retrospective review is expected and useful.

The objective is not to assign blame for every imperfection.

The objective is to identify where clinical standards, workflows, technology, training, communication, or accountability failed to support reliable care.

Serious misconduct or intentional misrepresentation requires appropriate action, but most recurring problems should first be examined as potential system failures.

Key Takeaways

• Retrospective utilization review evaluates care after the service has occurred.
• The review should examine medical necessity, authorization alignment, documentation, coding, site of care, outcomes, and recurring utilization patterns.
• Authorization approval does not guarantee payment or audit protection.
• The performed service must align with the clinical order, approval, procedure documentation, and claim.
• Outcome data should inform whether repeated or ongoing utilization remains appropriate.
• Retrospective findings must be converted into prospective prevention and measurable corrective action.

Back to top ↑

20

Prior Authorization, Peer-to-Peer Review, and Appeals Integration

Prior authorization is the payer-directed process through which selected healthcare services are reviewed before coverage is approved.

Within MSK specialty care, prior authorization may apply to imaging, injections, surgery, implants, neuromodulation, therapy, medications, durable medical equipment, and site of care.

Prior authorization should not operate as a separate administrative process disconnected from clinical care.

The GoHealthcare Clinical & Utilization Excellence Framework™ integrates prior authorization, peer-to-peer review, and appeals into the broader clinical and utilization pathway.

This approach strengthens approval performance while protecting clinical integrity, patient access, physician time, and organizational accountability.

Prior Authorization Begins With the Clinical Decision

The authorization process begins when the physician selects and documents the treatment plan.

The clinical record should establish:

• The diagnosis
• Clinical indication
• Symptoms
• Functional impairment
• Examination findings
• Diagnostic evidence
• Treatment history
• Previous response
• Medical necessity
• Procedure details
• Site of service
• Patient-specific rationale
• The authorization team should not be expected to create the clinical case after the encounter.

Its role is to organize, validate, submit, track, and escalate the information documented by the clinical team.

Authorization Requirement Verification

The team should confirm:

• Whether authorization is required
• Which entity manages the review
• Submission method
• Required forms
• Applicable policy
• Required records
• Provider and facility eligibility
• Site-of-care rules
• Review timeframe
• Peer-to-peer rights
• Appeal rights
• Reference number

A verbal statement that authorization is not required should be documented with the date, representative, and reference information when available.

Complete Initial Submission

The strongest opportunity for approval is the initial submission.

A complete request may include:

• Physician order
• Relevant office notes
• Imaging reports
• Therapy documentation
• Medication history
• Previous procedure reports
• Outcome documentation
• Procedure-specific forms
• Psychological evaluation when required
• Operative reports
• Clinical rationale
• The submission should be targeted.
• Sending large volumes of unrelated records can obscure the relevant information and slow review.

Case Narrative

Complex cases benefit from a concise clinical narrative.

The narrative may identify:

• The patient’s condition
• Severity and functional impact
• Relevant diagnostics
• Previous treatment
• Why prior treatment was insufficient
• Why the requested service is appropriate
• How the patient meets policy criteria
• Why an exception is required when applicable
• The narrative should not misrepresent the record or substitute for missing clinical documentation.

Tracking and Follow-Up

Every submitted case should have:

• Submission date
• Method
• Confirmation
• Reference number
• Expected determination date
• Current status
• Assigned owner
• Next follow-up date
• Escalation deadline
• Procedure date when applicable
• The team should not rely on payer portals alone to identify all pending actions.
• Portal information may be delayed, incomplete, or inconsistent with verbal communication.

Requests for Additional Information

When the payer requests additional information, the team should determine:

• Exactly what is missing
• Whether it already exists
• Whether the request reflects a policy criterion
• Whether the payer overlooked submitted information
• Who must respond
• Deadline
• Effect on the planned treatment date
• The response should be tracked through confirmation of receipt.
• Repeated payer requests for the same information should trigger review of the initial submission process.

Denial Categorization

A denial should be categorized accurately.

Possible categories include:

• Clinical criteria not met
• Missing documentation
• Conservative care
• Diagnostic requirement
• Frequency
• Site of care
• Benefit exclusion
• Provider or facility eligibility
• Experimental or investigational status
• Incorrect code
• Incorrect diagnosis
• Administrative submission failure
• The category determines the appropriate response.
• Not every denial requires the same escalation.

Peer-to-Peer Review

Peer-to-peer review allows the treating physician or another qualified clinician to discuss the case with the payer’s reviewer.

The organization should determine whether the peer-to-peer is:

• A reconsideration before final denial
• A post-denial discussion
• Mandatory before appeal
• Limited to a specific deadline
• Available only to selected provider types
• The physician should not enter the review without preparation.

Peer-to-Peer Preparation

The physician should receive a concise briefing containing:

• Patient summary
• Requested service
• Clinical indication
• Payer policy
• Submitted documentation
• Denial reason
• Disputed criterion
• Relevant dates
• Previous treatment
• Previous response
• Patient-specific exception
• Key discussion points
• Deadline
• Contact instructions
• Preparation should require minutes, not a full reconstruction of the case.

This protects physician time and improves the quality of the discussion.

Peer-to-Peer Documentation

The outcome should be recorded.

Documentation should include:

• Date and time
• Participants
• Payer reviewer
• Issues discussed
• Clinical information provided
• Decision
• Approval details
• Conditions
• Additional requirements
• Next appeal right
• If the payer maintains the denial, the reviewer’s stated rationale should inform the appeal.

Appeal Strategy

An appeal should address the actual denial reason.

A clinically strong appeal may include:

• Clear case summary
• Medical necessity rationale
• Policy analysis
• Explanation of how criteria are met
• Correction of payer factual errors
• Patient-specific circumstances
• Relevant specialty guidance
• Published evidence
• Risk of delay
• Alternative treatments considered
• Previous treatment response
• The appeal should be individualized and supported by the record.

Levels of Appeal

Appeal rights may include:

• Internal reconsideration
• First-level appeal
• Second-level appeal
• Expedited appeal
• External review
• Independent review organization
• State regulatory review
• Employer or plan sponsor escalation
• Medicare administrative review

The organization should understand the available pathway and deadline for each payer and plan.

Expedited Review

An expedited review may be appropriate when delay could seriously jeopardize:

• Life
• Health
• Recovery
• Neurologic function
• Ability to regain maximum function
• The request for expedited review should include a clear clinical explanation.
• Expedited status should not be requested solely because the procedure was scheduled prematurely.

Patient Involvement

Patients may have independent appeal rights.

The organization should explain:

• What was denied
• Why it was denied
• What the practice is doing
• Whether the patient must authorize the appeal
• Whether the patient may submit additional information
• Potential timelines
• Available clinical alternatives
• Financial implications
• Patients should receive understandable guidance rather than only a copy of the payer notice.

Physician Decision After Final Denial

A payer denial does not complete the clinical decision.

The treating physician should determine:

• Whether to continue the appeal
• Whether another clinically acceptable treatment is available
• Whether the treatment should be deferred
• Whether the patient should be referred
• Whether self-pay is appropriate and legally permissible
• Whether the patient’s condition requires urgent alternative management

The payer determines coverage. The physician remains responsible for the treatment plan.

Denial Prevention Learning

Every denial should contribute to organizational intelligence.

The organization should analyze:

• Payer
• Procedure
• Provider
• Denial reason
• Policy criterion
• Documentation gap
• Peer-to-peer outcome
• Appeal outcome
• Time to resolution
• Effect on patient access
• Preventable versus nonpreventable status

Patterns should drive provider education, payer-policy updates, workflow redesign, and contract discussions.

Physician Burden Reduction

Prior authorization frequently consumes substantial physician time.

The framework reduces this burden by ensuring that:

• Cases are complete before submission
• Staff use procedure-specific criteria
• Physicians receive targeted clarification requests
• Peer-to-peer reviews are prepared
• Appeals are drafted for clinical review
• Recurring denial patterns are corrected upstream
• The physician should perform the clinical work that only a physician can perform.
• Administrative preparation should be managed by trained teams.

GoHealthcare Insights

A peer-to-peer review should not be the organization’s standard method for obtaining approval.

Frequent peer-to-peer activity may indicate poor initial documentation, incomplete submissions, misunderstood payer criteria, or payer behavior requiring contractual or regulatory escalation.

The strongest utilization model measures success at the initial submission.

Appeals and peer-to-peer reviews remain essential, but they should function as structured escalation rather than routine workflow.

Leadership Perspective

Prior authorization performance should be managed as an enterprise indicator.

A denial may reflect clinical documentation, payer policy, staff training, technology, coding, site selection, provider behavior, or benefit design.

Leadership should avoid placing responsibility solely on the authorization team.

The organization must review the entire pathway that produced the result.

Key Takeaways

• Prior authorization should be integrated with clinical decision-making, documentation, utilization review, scheduling, and patient communication.
• The initial submission is the strongest opportunity for approval and should be complete, targeted, and clinically coherent.
• Requests for additional information, peer-to-peer reviews, and appeals require defined ownership and deadline management.
• Physicians should receive concise preparation before payer discussions.
• Appeals must directly address the denial reason and remain supported by the clinical record.
• Final payer denial requires a new physician-directed clinical decision rather than administrative closure alone.
• Denial patterns should drive improvement across clinical workflows, documentation, payer intelligence, staffing, technology, and governance.

Back to top ↑

21

Establishing the Clinical Documentation Excellence Operating Model

Clinical documentation is the operational bridge between the patient’s condition, the clinician’s judgment, the treatment plan, the payer’s coverage review, the procedure performed, the claim submitted, and the outcome achieved.

In musculoskeletal specialty care, documentation must do more than record that a patient was seen. It must explain the clinical reasoning that supports the diagnosis, demonstrates medical necessity, justifies the selected intervention, communicates risk, guides the next team, and creates a defensible record of care.

The GoHealthcare Clinical & Utilization Excellence Framework™ treats clinical documentation as an enterprise capability. Documentation quality is not solely the responsibility of the physician, the medical assistant, the authorization team, the coder, or the revenue cycle department. Each role contributes to the integrity and usefulness of the record.

A clinically appropriate service can be delayed, denied, downcoded, recouped, or questioned when the documentation does not clearly support what was recommended or performed. Conversely, extensive documentation does not establish quality when the record is inaccurate, repetitive, internally inconsistent, or disconnected from the patient’s actual condition.

The objective is not more documentation. The objective is better documentation.

The Strategic Purpose of Clinical Documentation

A high-quality clinical record should support:

• Diagnosis and treatment planning
• Continuity of care
• Medical necessity
• Prior authorization
• Peer to peer review
• Appeals
• Procedure readiness
• Patient safety
• Coding accuracy
• Claim submission
• Payment
• Quality measurement
• Outcome evaluation
• Compliance review
• Audit defense
• Communication across care settings

When documentation is designed only for the immediate office visit, downstream teams are forced to reconstruct the clinical story from fragmented information.

The documentation operating model should therefore consider the complete lifecycle of the record.

The Clinical Story

Every note should communicate a coherent clinical story.

That story should explain:

• What condition the patient has
• How the condition affects the patient
• What evidence supports the diagnosis
• What treatment has already been attempted
• How the patient responded
• Why the proposed treatment is appropriate
• What risks and alternatives were considered
• What the patient understands and prefers
• What the next step will be

The record should allow another qualified professional to understand the physician’s reasoning without relying on assumptions, undocumented conversations, or institutional memory.

Documentation as a Workflow

Clinical documentation begins before the physician enters the examination room.

Information may be collected through:

• Patient intake
• Medical history review
• Medication reconciliation
• Outside records
• Imaging reports
• Therapy documentation
• Previous procedure reports
• Patient reported outcomes
• Functional assessments
• Clinical staff preparation

The physician then validates, interprets, and integrates the relevant information into the clinical assessment and plan.

After the encounter, the documentation may be reviewed for completeness, routed for authorization, used for scheduling, referenced by the facility, and later used by coding, billing, quality, and compliance teams.

The workflow should identify which role is responsible for each component and which information requires physician confirmation.

Role Clarity

The physician is responsible for the clinical assessment, diagnosis, treatment plan, medical necessity rationale, risk assessment, and clinical decision.

Advanced practice providers document services within their scope and are responsible for the accuracy and completeness of their clinical reasoning.

Nurses and medical assistants may collect history, medication, vital sign, screening, and procedural information according to organizational policy.

Documentation integrity specialists may identify missing, unclear, contradictory, or incomplete elements.

Authorization teams may identify payer specific information requirements but should not alter or create clinical facts.

Coding professionals may clarify code selection and documentation requirements but should not direct the clinician to document unsupported diagnoses.

Compliance leadership should establish integrity standards, audit processes, and escalation procedures.

Technology teams should ensure that templates, prompts, interfaces, and automation support accurate documentation rather than creating duplication or error.

Timeliness

Documentation should be completed as close to the encounter or procedure as practical.

Delayed documentation increases the risk of:

• Incomplete recall
• Inaccurate details
• Missing authorization deadlines
• Procedure scheduling delays
• Claim submission delays
• Contradictory information
• Audit vulnerability

Clinical decisions should not routinely advance into authorization or scheduling while the supporting note remains unsigned or materially incomplete.

The organization should establish timeliness expectations by note type, procedure complexity, clinical urgency, and operational need.

Accuracy

Every entry must accurately reflect the patient’s condition and the service provided.

Accuracy requires confirmation of:

• Patient identity
• Date of service
• Provider
• Diagnosis
• Anatomical site
• Laterality
• Spinal level
• Procedure
• Medication
• Dose
• Clinical findings
• Treatment response
• Facility
• Implant or device

The record should be corrected when an error is discovered, but corrections must follow appropriate amendment and audit trail procedures.

Documentation should never be rewritten to create the appearance that information existed at the time of the original decision when it did not.

Relevance

More text does not necessarily produce a stronger record.

Excessive imported histories, copied review of systems, repeated imaging reports, outdated problem lists, and irrelevant normal findings may obscure the information that supports the current decision.

The note should emphasize clinically material information.

Relevant documentation improves:

• Provider efficiency
• Payer review
• Coding accuracy
• Patient safety
• Care coordination
• Audit readability
• The record should be sufficiently detailed without becoming clinically unusable.

Internal Consistency

The note should be consistent within itself and with the broader record.

Common inconsistencies include:

• Different laterality in the history and plan
• A diagnosis that does not match the symptoms
• A procedure order that differs from the assessment
• Conflicting symptom duration
• Different levels documented across records
• An imaging finding unrelated to the proposed target
• A previous procedure described as both successful and unsuccessful
• A medication listed as active and discontinued
• A patient described as having completed therapy when no details are available

The organization should identify material contradictions before authorization, scheduling, coding, or claim submission.

Documentation Standards by Encounter Type

Different encounter types require different documentation.

Initial evaluations may require comprehensive history, examination, diagnostic reasoning, and treatment planning.

Follow-up visits should focus on interval change, treatment response, current function, updated examination, and the next clinical decision.

Procedure planning visits should clearly establish the indication, target, prior treatment, expected benefit, risks, and readiness requirements.

Procedure notes should document what was actually performed, including site, level, laterality, technique, medications, imaging guidance, findings, complications, and disposition.

Post-procedure visits should document response, duration of benefit, function, complications, and next steps.

The organization should not apply one generic template to every encounter type.

Documentation and Authorization Integration

Procedure specific authorization requirements should be considered during the clinical encounter.

The documentation system may prompt for:

• Symptom duration
• Functional limitation
• Conservative treatment
• Relevant imaging
• Previous procedure response
• Diagnostic block result
• Medication history
• Contraindications
• Clinical rationale
• Site of service

The prompts should support clinical completeness without allowing payer criteria to replace physician judgment.

When the patient does not meet a standard payer requirement for a clinically valid reason, the physician should document the exception clearly.

Documentation and Procedure Readiness

Clinical documentation should communicate information required for safe procedure preparation.

This may include:

• Allergies
• Anticoagulants
• Diabetes management
• Infection risk
• Pregnancy status when applicable
• Implanted devices
• Cardiac conditions
• Pulmonary conditions
• Medication holds
• Required clearance
• Anesthesia concerns
• Mobility limitations
• Transportation needs
• Communication barriers
• Readiness teams should not need to search through unrelated notes to identify critical information.

Documentation and Coding

Coding depends on documentation that accurately identifies:

• The condition treated
• The service performed
• The anatomical location
• Laterality
• Number of levels or units
• Imaging guidance
• Distinct procedures
• Implants or devices
• Complications
• Medical necessity

The coder may interpret the record, but the coder should not infer clinical facts that are not documented.

The clinical record must support the code, not the other way around.

Documentation Governance

The organization should establish a Clinical Documentation Governance Committee or assign documentation oversight to the broader Clinical and Utilization Excellence Committee.

Governance responsibilities may include:

• Approving documentation standards
• Reviewing templates
• Monitoring documentation timeliness
• Evaluating deficiency trends
• Reviewing audit findings
• Managing query standards
• Overseeing education
• Evaluating automation and artificial intelligence
• Resolving conflicts among clinical, payer, coding, and compliance requirements

The governance process should prevent each department from independently adding documentation requirements without considering total provider burden.

Documentation Performance Measures

Relevant measures may include:

• Note completion time
• Unsigned note volume
• Documentation deficiency rate
• Authorization requests returned for clarification
• Payer requests for additional information
• Procedure orders lacking required details
• Internal inconsistency rate
• Coding queries
• Claim denials related to documentation
• Audit findings
• Outcome documentation completion
• Provider specific variation
• Metrics should be used to improve systems and education, not simply to create punitive scorecards.

GoHealthcare Insights

Clinical documentation problems are often blamed on individual providers when the true cause is poor workflow design.

A template may fail to capture required information. Outside records may not be available during the encounter. Outcome data may not be routed to the provider. The authorization team may send vague clarification requests. Multiple systems may contain conflicting information.

Documentation excellence requires improvement across people, process, technology, governance, and accountability.

The clinician should remain responsible for the clinical record, but the organization must provide an operating environment that makes accurate documentation practical.

Leadership Perspective

Leaders should protect providers from unnecessary documentation burden while holding the organization to a high standard of clinical integrity.

Every requested field, prompt, template section, and attestation should serve a defined clinical, operational, regulatory, or patient safety purpose.

Documentation systems that require substantial effort but do not improve care, access, safety, payment, or compliance should be redesigned.

Key Takeaways

• Clinical documentation connects clinical judgment with authorization, readiness, coding, payment, quality, compliance, and outcomes.
• The objective is not greater documentation volume. It is accurate, relevant, timely, complete, and internally consistent documentation.
• Every encounter type requires documentation appropriate to its clinical and operational purpose.
• The physician owns the clinical reasoning, while the organization must provide effective workflows, tools, education, and governance.
• Documentation quality should be measured through its ability to support appropriate care and reliable operational execution.

Back to top ↑

22

Documentation Completeness and Medical Necessity Support

Documentation completeness means that the record contains the information necessary to understand and support the patient’s diagnosis, condition, treatment history, clinical decision, and proposed service.

Completeness does not mean that every possible field must be populated. It means that all clinically material and operationally required information is present.

Within MSK specialty care, incomplete documentation is one of the most common causes of authorization delays, requests for additional information, peer to peer reviews, appeals, claim denials, and procedure cancellations.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes prospective documentation validation as a core medical necessity control.

The Medical Necessity Narrative

A strong medical necessity narrative connects several elements:

• The patient’s condition
• The severity and duration of symptoms
• The effect on function
• Relevant examination findings
• Diagnostic evidence
• Previous treatment
• Response to treatment
• Reason for the proposed intervention
• Expected benefit
• Risk of delay or non-treatment when relevant
• The record should not present these as unrelated data points.
• It should demonstrate how the information supports the physician’s conclusion.

Diagnosis Support

The diagnosis should be:

• Clinically accurate
• Sufficiently specific
• Consistent with the history
• Supported by examination or diagnostics when applicable
• Aligned with the proposed service
• The record should identify anatomical site, laterality, level, or other details when clinically relevant.

Broad symptom diagnoses may be appropriate during an initial evaluation, but procedure planning often requires greater diagnostic specificity.

Symptom Documentation

Symptoms should be described according to the needs of the condition and procedure.

Relevant elements may include:

• Location
• Distribution
• Severity
• Duration
• Frequency
• Quality
• Progression
• Aggravating factors
• Relieving factors
• Associated neurologic symptoms
• Sleep disruption
• Effect on work
• Effect on daily activities
• A generic statement that the patient has pain may be insufficient to support a targeted intervention.

Functional Limitation

Functional documentation should explain what the condition prevents or limits the patient from doing.

Examples include:

• Walking
• Standing
• Sitting
• Lifting
• Bending
• Sleeping
• Driving
• Working
• Exercising
• Caring for family
• Performing household activities
• Managing personal care
• Functional information should be patient specific rather than copied identically across visits.
• Baseline function allows the organization to measure whether treatment produced meaningful improvement.

Examination Findings

The examination should be relevant to the condition and treatment decision.

Documentation may include:

• Range of motion
• Tenderness
• Strength
• Sensation
• Reflexes
• Gait
• Provocative testing
• Joint stability
• Swelling
• Deformity
• Neurologic findings
• Functional testing
• The note should distinguish patient reported symptoms from objective findings.

Diagnostic Evidence

The record should identify the diagnostic studies that support or inform the treatment plan.

This may include:

• Radiographs
• Magnetic resonance imaging
• Computed tomography
• Ultrasound
• Electrodiagnostic testing
• Laboratory testing
• Diagnostic injections
• The physician should explain the significance of the findings.

Simply attaching a report may not demonstrate how the result relates to the patient’s symptoms or the proposed intervention.

Conservative Treatment

Documentation should state:

• What treatment was attempted
• Approximate dates
• Duration
• Frequency
• Patient participation
• Clinical response
• Functional response
• Adverse effects
• Reason for discontinuation
• Why treatment was insufficient
• The phrase “failed conservative care” is often inadequate without supporting detail.

When conservative treatment was contraindicated, unavailable, intolerable, or clinically inappropriate, the reason should be documented.

Medication History

Medication documentation should identify clinically relevant treatment, including:

• Medication or class
• Dose when material
• Duration
• Effectiveness
• Adverse effects
• Contraindications
• Reason for discontinuation
• The record should not imply that a medication was attempted when the patient never received it.

Previous Procedures

Previous procedure history should include:

• Procedure
• Date
• Anatomical site
• Laterality
• Level
• Degree of relief
• Duration of relief
• Functional improvement
• Complications
• Reason for considering the next intervention

This information is critical for repeat procedures, diagnostic progression, radiofrequency ablation, neuromodulation, surgery, and other advanced treatments.

Medical Necessity for Repeat Services

Repeat services require evidence that the prior treatment produced clinically meaningful benefit or that circumstances have changed.

The record should address:

• Previous response
• Duration of benefit
• Current symptoms
• Current functional limitation
• Reason repetition is appropriate
• Alternative treatments considered
• Applicable frequency limits
• A repeat procedure should not be supported by copied language from the previous authorization request.

Clinical Rationale

The assessment and plan should explain why the selected treatment is appropriate now.

A strong rationale may address:

• Why the diagnosis is the probable source of symptoms
• Why previous treatment was insufficient
• Why the proposed service is expected to help
• Why another treatment is less appropriate
• Why a standard requirement does not apply
• Why the selected site is necessary
• Why repetition is justified
• The rationale should reflect individualized clinical judgment.

Contraindications and Risk Factors

Documentation should address material contraindications and risk factors.

These may include:

• Infection
• Bleeding risk
• Anticoagulation
• Allergy
• Uncontrolled medical condition
• Pregnancy
• Implanted device
• Psychological or behavioral considerations
• Substance use risk
• Inability to complete postoperative care
• Lack of transportation or support
• The record should identify whether a risk was absent, managed, or accepted after clinical review.

Patient Goals and Preferences

The treatment plan should reflect the patient’s goals and informed participation.

Documentation may include:

• Desired functional improvement
• Treatment preferences
• Concerns
• Alternatives discussed
• Patient understanding
• Agreement with the plan

This supports shared decision-making and provides a standard for evaluating success.

Required Supporting Records

Some services require documentation beyond the physician’s office note.

Examples include:

• Imaging reports
• Physical therapy notes
• Previous procedure reports
• Operative reports
• Psychological evaluation
• Device trial documentation
• Medical clearance
• Laboratory results
• Specialist consultation

The organization should identify required records early and track them through receipt and review.

Documentation Completeness Review

A completeness review should determine whether the case contains the information required to proceed.

Possible findings include:

• Complete and ready for submission
• Missing external records
• Missing procedure response
• Missing examination detail
• Unclear diagnosis
• Inconsistent laterality or level
• Incomplete conservative-care history
• Physician clarification required
• Clinical review required
• The review should be procedure specific and focused on material deficiencies.

Clarification Process

Requests for clarification should be concise and specific.

The request should identify:

• The missing or unclear information
• Why it matters
• Where the inconsistency appears
• What action is required
• Who must respond
• The deadline
• The effect on the case
• The clarification process should not pressure the provider to document a predetermined answer.

Addenda

An addendum may be appropriate when the provider needs to clarify or complete an existing record.

The addendum should:

• Be dated
• Identify the author
• State the additional or corrected information
• Preserve the original record
• Reflect information known or verified by the provider
• Avoid creating a false impression about when the information became available
• Addenda should not become the organization’s routine method for completing every authorization case.
• High addendum volume indicates that standard workflows or templates require improvement.

Documentation Completeness and Audit Risk

A record created only to obtain authorization may remain insufficient for coding, payment, quality, or audit review.

The organization should ensure that documentation supports:

• The clinical decision
• The performed service
• The codes submitted
• The site of care
• The outcome
• The continuity of treatment

Medical necessity must remain supportable after the authorization process is complete.

Completeness Metrics

Relevant measures may include:

• Percentage of cases complete at first review
• Average number of clarification requests
• Addendum rate
• Time from encounter to complete note
• Payer requests for additional information
• Authorization delay caused by missing documentation
• Denials related to documentation
• Procedure cancellations related to incomplete records
• Provider variation

The organization should identify the most frequent missing elements and correct them systematically.

GoHealthcare Insights

Documentation completeness should be achieved during the normal clinical workflow, not through repeated rescue activity.

When utilization teams spend substantial time chasing imaging, therapy notes, procedure responses, or physician addenda, the organization is paying for rework.

The more effective model identifies the required information before or during the encounter and routes it into the clinical record automatically whenever possible.

Leadership Perspective

Leaders should focus on the smallest set of documentation elements that reliably support clinical reasoning, patient safety, authorization, payment, and compliance.

Overly broad documentation requirements can slow providers without improving the record.

The standard should be clinically meaningful completeness rather than indiscriminate data collection.

Key Takeaways

• Documentation completeness requires all clinically material information needed to support the diagnosis and treatment decision.
• The record should connect symptoms, function, examination, diagnostics, previous treatment, and clinical rationale.
• Repeat services require documented response and continued justification.
• Clarification requests should be specific, objective, and nonleading.
• Frequent addenda indicate a workflow or template problem that should be corrected upstream.
• Medical necessity documentation must remain defensible beyond the authorization process.

Back to top ↑

23

Procedure-Specific Documentation Standards

MSK specialty procedures have different indications, risks, sequencing requirements, payer criteria, technical components, and outcome expectations.

A single generic documentation standard cannot adequately support every procedure.

The documentation required for a medial branch block differs from that required for spinal cord stimulation, lumbar fusion, joint replacement, epidural injection, peripheral nerve stimulation, or vertebral augmentation.

The GoHealthcare Clinical & Utilization Excellence Framework™ requires procedure-specific documentation standards for services with significant clinical, authorization, compliance, or financial exposure.

Purpose of Procedure-Specific Standards

Procedure-specific standards help ensure that the record addresses the elements most relevant to:

• Patient selection
• Medical necessity
• Clinical indication
• Safety
• Authorization
• Procedure readiness
• Coding
• Payment
• Quality
• Outcome evaluation
• The standards should guide providers and staff without replacing individualized documentation.

Standard Development

Each procedure-specific standard should be developed with input from:

• Physician leadership
• Advanced practice providers
• Clinical operations
• Utilization management
• Prior authorization
• Coding
• Revenue cycle
• Quality
• Compliance
• Facility leadership

The standard should be reviewed against:

• Current clinical evidence
• Specialty guidance
• Government coverage policies
• Commercial payer criteria
• Procedure risks
• Coding rules
• Facility requirements
• Organizational experience

The final standard should distinguish clinical requirements from payer-specific administrative requirements.

Procedure Planning Documentation

The planning note should generally identify:

• Diagnosis
• Clinical indication
• Symptoms
• Functional impairment
• Relevant examination
• Diagnostics
• Previous treatment
• Previous procedure response
• Contraindications
• Proposed procedure
• Target anatomy
• Laterality
• Level
• Expected benefit
• Alternatives
• Patient decision
• Readiness requirements
• The exact elements should reflect the procedure.

Facet and Medial Branch Procedures

Documentation may need to address:

• Predominantly axial pain
• Duration of symptoms
• Functional limitation
• Relevant examination findings
• Imaging when clinically relevant
• Conservative treatment
• Absence or management of competing pathology
• Purpose of the diagnostic block
• Target levels
• Laterality
• Method for evaluating response
• Previous block results
• Degree and duration of relief
• Functional change

The record should clearly distinguish diagnostic medial branch blocks, facet joint injections, and therapeutic radiofrequency ablation.

Radiofrequency Ablation

Documentation may need to establish:

• Qualifying diagnosis
• Diagnostic block history
• Number of blocks when applicable
• Target nerves or levels
• Laterality
• Percentage of relief
• Duration of relief
• Functional improvement
• Reason for proceeding to ablation
• Previous ablation response when repeated
• Frequency compliance

The result of the diagnostic process should be documented consistently across the office note, procedure report, authorization request, and follow-up assessment.

Epidural Procedures

Documentation may need to address:

• Radicular or referred symptoms
• Anatomical distribution
• Neurologic findings
• Imaging correlation
• Functional impairment
• Conservative treatment
• Target level
• Approach
• Laterality
• Previous injection response
• Reason for repeat treatment
• The clinical record should support the selected region and approach.

Sacroiliac Joint Procedures

Documentation may need to include:

• Pain location
• Functional limitation
• Provocative examination findings
• Imaging or exclusion of alternative pathology when appropriate
• Conservative treatment
• Diagnostic intent
• Response to previous injection
• Laterality
• Rationale for therapeutic or advanced intervention
• The record should distinguish sacroiliac mediated pain from lumbar, hip, or other sources.

Neuromodulation

Spinal cord stimulation and peripheral nerve stimulation documentation may require:

• Qualifying diagnosis
• Duration and severity of symptoms
• Functional limitation
• Previous treatment
• Previous surgery when relevant
• Medication history
• Psychological assessment when required
• Patient education
• Treatment goals
• Trial plan
• Trial results
• Pain reduction
• Functional improvement
• Medication change
• Patient ability to manage the device
• Reason for permanent implantation
• Long-term follow-up plan
• The trial and permanent implant records must form a coherent sequence.

Minimally Invasive Spine Procedures

Documentation for minimally invasive lumbar procedures may require:

• Specific diagnosis
• Symptoms
• Functional impact
• Imaging findings
• Severity of stenosis or other pathology
• Conservative-care history
• Neurologic findings
• Patient selection
• Alternative treatments
• Reason surgery is not preferred or not yet appropriate when relevant
• Expected benefit
• The note should clearly distinguish among procedures with different anatomical targets and mechanisms.

Orthopedic Surgery

Surgical documentation may need to address:

• Specific pathology
• Severity
• Symptoms
• Functional impairment
• Objective examination findings
• Imaging correlation
• Conservative treatment
• Progression
• Risk factors
• Comorbidities
• Alternative treatments
• Patient goals
• Surgical plan
• Expected benefit

The surgical recommendation should be supported by a complete clinical narrative rather than an isolated operative order.

Spine Surgery

Spine surgery documentation may require:

• Specific levels
• Diagnosis
• Neurologic symptoms
• Objective deficits
• Imaging correlation
• Instability or deformity
• Previous surgery
• Conservative-care response
• Urgency
• Surgical approach
• Need for decompression, fusion, or instrumentation
• Alternative options
• Patient counseling
• The indication should be specific enough to support the planned procedure and number of levels.

Joint Replacement

Documentation may need to include:

• Diagnosis and severity
• Pain
• Functional limitation
• Examination findings
• Radiographic evidence
• Conservative treatment
• Medication history
• Injection history
• Weight-bearing limitation
• Mobility impact
• Surgical risk
• Patient goals
• Expected recovery
• The record should explain why continued nonoperative treatment is insufficient.

Procedure Note Standards

The procedure note should document what was actually performed.

Depending on the service, this may include:

• Patient identification
• Consent
• Preprocedure verification
• Diagnosis
• Procedure
• Site
• Laterality
• Level
• Anesthesia or sedation
• Positioning
• Imaging guidance
• Technique
• Medication
• Contrast
• Equipment
• Implant
• Findings
• Specimens
• Complications
• Estimated blood loss
• Disposition
• Postprocedure instructions
• The procedure note must reconcile with the order, authorization, schedule, and claim.

Implant Documentation

Implant-based procedures may require:

• Device manufacturer
• Model
• Serial or lot number
• Lead or component information
• Implant location
• Programming information
• Vendor participation
• Device integrity
• Patient education
• Warranty or registry documentation

Implant data should be accurately captured and available for recalls, revisions, follow-up, and quality reporting.

Procedure Outcome Documentation

Post-procedure documentation should measure the result relevant to the intervention.

This may include:

• Pain relief
• Functional improvement
• Duration of benefit
• Medication change
• Complications
• Patient satisfaction
• Device use
• Return to activity
• Achievement of treatment goals
• The procedure standard should define when and how the outcome will be collected.

Procedure-Specific Checklists

Checklists may support:

• Documentation completeness
• Authorization submission
• Readiness
• Safety
• Coding
• Follow-up
• The checklist should be concise and designed for the procedure.

It should not substitute for clinical reasoning or become a billing-driven form disconnected from patient care.

Version Control

Procedure-specific standards should include:

• Procedure name
• Responsible owner
• Approval date
• Effective date
• Review date
• Version number
• Supporting sources
• Material changes
• Affected roles
• Old versions should be removed from active use.

GoHealthcare Insights

Procedure-specific standards create the greatest value when they connect clinical care with authorization, scheduling, facility readiness, coding, and outcomes.

When each department maintains a different checklist, the organization creates duplication and inconsistency.

The stronger model uses one coordinated standard that supports the full procedure lifecycle.

Leadership Perspective

Clinical leaders should determine which procedures require formal standards based on volume, risk, denial exposure, cost, complexity, and strategic importance.

The organization should begin with the procedures that create the greatest patient access and operational risk rather than attempting to standardize every service at once.

Key Takeaways

• Different MSK procedures require different documentation standards.
• Procedure-specific standards should support patient selection, medical necessity, safety, authorization, readiness, coding, payment, and outcomes.
• The planning note, procedure note, authorization, schedule, and claim must remain aligned.
• Implant procedures require detailed device and follow-up documentation.
• Procedure-specific standards should be clinically governed, multidisciplinary, version controlled, and integrated across the full care pathway.

Back to top ↑

24

Clinical Documentation Integrity, Templates, and Copy Forward Controls

Clinical documentation integrity means that the record accurately, completely, and honestly represents the patient’s condition, the clinician’s reasoning, and the service provided.

Documentation integrity is not achieved merely because all required fields are completed.

A note can appear complete while containing copied, outdated, contradictory, or clinically unsupported information.

Electronic health records have improved access to information, but they have also introduced risks related to templates, autofill, copy forward, macros, voice recognition, imported data, artificial intelligence, and automated coding suggestions.

The GoHealthcare Clinical & Utilization Excellence Framework™ requires formal controls over these tools.

The Purpose of Templates

Templates can support:

• Consistency
• Efficiency
• Procedure-specific documentation
• Medical necessity
• Safety
• Authorization
• Coding
• Quality measurement
• Templates are valuable when they prompt the clinician to consider and document relevant information.

They become harmful when they create:

• Cloned notes
• Irrelevant text
• False findings
• Contradictions
• Assumed treatment history
• Unsupported diagnoses
• Excessive documentation burden
• The template should serve the clinical encounter, not control it.

Template Design Principles

A strong template should be:

• Specific to the encounter type
• Specific to the procedure or condition when appropriate
• Clinically concise
• Easy to navigate
• Flexible
• Able to support exceptions
• Limited to material information
• Reviewed by clinical leadership
• Validated by users

The template should distinguish between required information, optional information, and fields that should appear only when clinically relevant.

Copy Forward

Copy forward can improve efficiency by carrying stable information into the current encounter.

However, copied information must be reviewed and updated.

Risks include:

• Outdated symptoms
• Old examination findings
• Resolved conditions
• Incorrect medications
• Previous treatment response presented as current
• Wrong laterality
• Wrong level
• Duplicate diagnoses
• Statements that the clinician did not verify
• Providers should remain responsible for the accuracy of all information included in the signed note.

Copy and Paste Controls

Organizations should establish policies addressing:

• Which information may be copied
• Which information requires revalidation
• How copied text is identified
• When copying is prohibited
• Provider responsibility
• Audit expectations
• Correction procedures

The policy should not prohibit clinically useful information sharing, but it must prevent copying from becoming a substitute for current assessment.

Autofill and Default Values

Default values create risk when they populate normal findings or negative responses that were not assessed.

Examples include:

• Normal neurologic examination
• No anticoagulant use
• No infection
• No allergy
• No complication
• Successful patient education
• Medication reconciliation completed
• Default statements should be used cautiously.
• Material clinical findings should require active confirmation when feasible.

Imported Data

Information imported from patient questionnaires, outside records, devices, or other systems should be clearly distinguishable from provider-authored interpretation.

The clinician should review and incorporate clinically relevant information.

Imported data should not automatically become part of the final assessment without validation.

Voice Recognition

Voice recognition can introduce errors involving:

• Anatomical terms
• Medication names
• Laterality
• Numbers
• Spinal levels
• Procedure names
• Negation
• Providers should review dictated notes before signature.

Errors involving “no,” “not,” “left,” “right,” medication dose, or procedure level can create significant clinical and authorization consequences.

Artificial Intelligence Assisted Documentation

Artificial intelligence may support:

• Drafting notes
• Summarizing records
• Extracting relevant history
• Suggesting missing elements
• Creating patient instructions
• Identifying contradictions
• Artificial intelligence should not independently create clinical facts or replace clinician review.

Governance should address:

• Approved uses
• Human validation
• Data privacy
• Security
• Accuracy
• Bias
• Source transparency
• Auditability
• Error reporting
• Vendor oversight
• The signing clinician remains responsible for the final record.

Cloned Documentation

Cloned documentation may occur when multiple notes contain substantially identical text despite changes in the patient’s condition.

This creates risks involving:

• Medical necessity
• Continuity of care
• Coding
• Audit credibility
• Treatment-response assessment
• Patient safety

The organization should evaluate repeated identical language, particularly when it concerns symptoms, examination findings, functional status, conservative care, or treatment response.

Standard phrasing is not inherently inappropriate. The concern is whether the record accurately reflects the current encounter.

Unsupported Diagnoses

Diagnoses should not be added solely because they support a procedure or code.

The record should contain clinical support for each material diagnosis.

Problem lists should be reviewed periodically to remove or clarify:

• Resolved conditions
• Duplicated conditions
• Historical diagnoses
• Unconfirmed diagnoses
• Incorrect laterality
• Unsupported severity
• An outdated problem list can create clinical and compliance risk.

Contradiction Detection

The documentation system or review process should identify contradictions such as:

• Left versus right
• Cervical versus lumbar
• Different symptom durations
• Different procedure levels
• Medication active versus discontinued
• Successful versus failed prior treatment
• No neurologic deficit versus documented weakness
• No anticoagulation versus active medication list
• Some contradictions may be identified through automation, but clinical review remains necessary.

Amendments and Corrections

The organization should maintain a policy for:

• Late entries
• Addenda
• Corrections
• Deleted information
• Electronic audit trails
• Provider authentication

The amendment should preserve the integrity of the original record and clearly identify what was changed and why.

Records should not be silently overwritten.

Authentication

Clinical records should identify:

• Author
• Credentials
• Date
• Time
• Signature
• Supervising provider when required

Authentication standards should comply with organizational policy, payer requirements, facility rules, and applicable law.

Shared credentials should never be used.

Template Governance

All templates should have:

• An owner
• Clinical approval
• Effective date
• Review date
• Version control
• Change history
• Testing before release
• User feedback process

The organization should avoid allowing individual departments or vendors to add fields without governance review.

Every new documentation requirement increases cognitive load and should have a defined purpose.

Documentation Integrity Audits

Audits may evaluate:

• Accuracy
• Completeness
• Copy forward
• Template use
• Internal consistency
• Diagnosis support
• Procedure alignment
• Timeliness
• Authentication
• Outcome documentation

The audit should distinguish education needs, workflow problems, technology defects, and intentional misconduct.

GoHealthcare Insights

Documentation integrity risk increases when organizations attempt to solve every denial by adding more template fields.

This produces longer notes without necessarily producing clearer clinical reasoning.

The better approach is to identify which information materially affects patient care, authorization, safety, coding, and compliance, then redesign the workflow around those elements.

Leadership Perspective

Leaders should recognize that documentation technology can amplify both good and poor practice.

A strong template can standardize essential information. A poorly designed template can distribute the same error across thousands of encounters.

Technology changes affecting clinical documentation should receive the same governance attention as changes to clinical pathways.

Key Takeaways

• Documentation integrity requires accuracy, relevance, timeliness, authorship, and clinical support.
• Templates and copy forward can improve efficiency but require formal controls.
• Default values, imported data, voice recognition, and artificial intelligence can create clinically significant errors.
• The signing clinician remains responsible for the final record.
• Amendments must preserve the original record and maintain an auditable history.
• Template governance should balance clinical completeness with provider usability and documentation burden.

Back to top ↑

25

Provider Education, Clinical Queries, Audits, and Feedback

Clinical documentation excellence requires continuous education, structured clarification, credible auditing, and timely feedback.

One-time training is insufficient because procedures, payer policies, coding requirements, evidence, technology, and organizational workflows continue to change.

Providers also differ in specialty focus, clinical style, documentation habits, technology proficiency, and familiarity with payer requirements.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes a learning system that supports providers without allowing administrative demands to interfere with clinical integrity.

The Purpose of Provider Education

Provider education should help clinicians understand:

• Which information is clinically important
• Which documentation supports medical necessity
• Which payer criteria frequently affect access
• Which procedure-specific elements are required
• How outcome documentation affects future treatment
• How documentation supports coding and payment
• How to use templates efficiently
• How to avoid copy forward and autofill risks
• How to respond to clarification requests
• Education should explain why the information matters.

Clinicians are more likely to adopt standards when they understand the patient access, safety, quality, and operational consequences.

Role-Specific Education

Education should be tailored to the role.

Physicians may need focused guidance on:

• Clinical rationale
• Procedure-specific requirements
• Medical necessity
• Peer to peer review
• Appeals
• Risk documentation
• Shared decision-making
• Outcome measurement

Advanced practice providers may require similar clinical guidance along with clarity regarding scope, supervision, and escalation.

Nurses and medical assistants may need education on:

• History collection
• Medication reconciliation
• Functional assessment
• Outside records
• Procedure preparation
• Patient education
• Red flags

Utilization and authorization teams may need education on:

• Payer policies
• Clinical terminology
• Procedure pathways
• Documentation review
• Escalation
• Nonleading queries
• Appeal preparation

Coding teams may need education on clinical services, anatomy, procedure terminology, and documentation standards.

Education Delivery

Education may be delivered through:

• Orientation
• Procedure-specific training
• Case conferences
• Provider meetings
• Short reference guides
• Clinical pathway reviews
• Denial trend briefings
• Audit feedback
• Peer education
• Recorded modules
• Office hours
• Point-of-care prompts
• Education should be concise, practical, and connected to actual cases.
• Long presentations without workflow support rarely create sustained change.

Clinical Query Process

A clinical query is a request for clarification when the record is incomplete, unclear, conflicting, or inconsistent.

The query should be:

• Clear
• Specific
• Objective
• Nonleading
• Supported by the record
• Clinically relevant
• Timely

The purpose is to clarify the physician’s actual clinical judgment, not to obtain a preferred diagnosis or authorization result.

Appropriate Query Topics

Queries may address:

• Unclear diagnosis
• Missing laterality
• Unclear anatomical level
• Conflicting symptom duration
• Incomplete conservative treatment
• Missing procedure response
• Inconsistent imaging correlation
• Unclear clinical rationale
• Unspecified complication
• Ambiguous procedure plan
• Unclear site-of-care rationale
• The query should identify the issue and request clarification without suggesting unsupported information.

Inappropriate Queries

The organization should prohibit queries that:

• Direct the provider to select a specific diagnosis
• Suggest changing dates to meet payer criteria
• Encourage overstating symptom severity
• Inflate treatment response
• Create undocumented conservative care
• Alter laterality or level without clinical support
• Imply that authorization or payment depends on a particular answer
• Queries should protect the integrity of the record.

Query Workflow

The query process should define:

• Who may issue a query
• How the query is submitted
• Expected response time
• Who receives escalation
• How the response is incorporated
• How unresolved queries affect authorization or scheduling
• How query volume is monitored
• Urgent queries affecting patient safety or imminent procedures should follow an expedited pathway.

Provider Response

The provider should:

• Review the underlying record
• Clarify the clinical facts
• Update the note or add an appropriate addendum
• Decline the query when no clarification is clinically supported
• Escalate disagreements when necessary
• The provider should not feel compelled to change the record to satisfy a payer or administrative request.

Documentation Audits

Audits provide a structured method for assessing documentation quality and identifying improvement opportunities.

Audits may be:

• Prospective
• Concurrent
• Retrospective
• Random
• Risk based
• Procedure specific
• Provider specific
• Payer focused

Audit priorities may include high-volume procedures, high-denial services, implants, new technologies, repeat procedures, or areas with significant coding risk.

Audit Criteria

Audit tools should evaluate material elements such as:

• Diagnosis support
• Clinical indication
• Functional impairment
• Examination findings
• Diagnostic correlation
• Conservative treatment
• Previous response
• Medical necessity rationale
• Procedure alignment
• Patient counseling
• Outcome documentation
• Internal consistency
• Timeliness
• Authentication

Audit tools should avoid assigning equal weight to minor formatting issues and major clinical deficiencies.

Auditor Qualifications

Auditors should have appropriate knowledge of:

• Clinical terminology
• MSK specialties
• Procedure pathways
• Payer requirements
• Coding
• Documentation integrity
• Compliance

An auditor who does not understand the clinical service may misinterpret appropriate variation or overlook significant deficiencies.

Clinical questions should be escalated to qualified clinical leadership.

Feedback Standards

Provider feedback should be:

• Specific
• Timely
• Evidence based
• Respectful
• Actionable
• Connected to patient or operational impact

The feedback should identify:

• What was found
• Why it matters
• What standard applies
• How to improve
• Whether education or workflow support is available
• When follow-up will occur
• Generic messages such as “documentation insufficient” provide little value.

Individual and System-Level Feedback

Some findings are provider specific.

Others reflect system problems.

System-level causes may include:

• Poor template design
• Missing outside records
• Inadequate staff intake
• Unclear procedure orders
• Unavailable outcome data
• Incorrect payer criteria
• Technology defects
• Inconsistent facility requirements

Leaders should avoid assigning individual blame for problems created by the operating system.

Denial-Based Education

Denial data should be used to identify education priorities.

The organization may analyze:

• Procedure
• Payer
• Provider
• Denial reason
• Missing documentation
• Peer to peer outcome
• Appeal result
• Preventability
• Recurring documentation-related denials should result in targeted education and workflow redesign.

Measuring Improvement

Education and audit programs should be evaluated through outcomes such as:

• Reduced clarification requests
• Improved initial documentation completeness
• Reduced addenda
• Fewer payer requests for additional information
• Improved initial approval rate
• Reduced documentation denials
• Improved note timeliness
• Reduced internal inconsistencies
• Improved outcome documentation
• Sustained improvement is more important than completion of a training module.

Corrective Action

When deficiencies persist, the organization may use:

• Targeted coaching
• Focused re-audit
• Template modification
• Workflow support
• Peer mentoring
• Additional clinical review
• Credentialing intervention
• Formal corrective action

The response should reflect the seriousness, frequency, patient impact, and whether the issue appears intentional or unintentional.

Recognition of Strong Performance

The organization should also recognize providers and teams demonstrating:

• High documentation completeness
• Strong patient-centered narratives
• Low clarification rates
• Reliable outcome documentation
• Effective peer to peer performance
• Meaningful improvement

Recognition reinforces that documentation excellence is a clinical and organizational value, not merely a compliance obligation.

GoHealthcare Insights

The most effective provider education is generated from real operational data.

Generic documentation training is less valuable than showing clinicians which elements repeatedly delay their patients, generate payer requests, create cancellations, or weaken future treatment decisions.

Education should focus on the small number of changes that produce the greatest improvement.

Leadership Perspective

Leaders should build trust around clinical queries and audits.

Providers must understand that clarification is intended to protect the patient, strengthen the record, and improve operational reliability.

At the same time, leadership must ensure that documentation teams do not pressure clinicians to create unsupported records.

Credibility depends on clinical integrity, mutual respect, and consistent standards.

Key Takeaways

• Documentation education must be continuous, role specific, and connected to actual operational needs.
• Clinical queries should be clear, objective, nonleading, and supported by the record.
• Audits should focus on material clinical and operational requirements rather than minor formatting issues.
• Feedback should be timely, specific, actionable, and linked to patient access, safety, quality, or compliance.
• Leaders must distinguish individual performance issues from system-design failures.
• The effectiveness of education is measured through sustained improvement in documentation, authorization, patient access, outcomes, and operational reliability.

Back to top ↑

26

Establishing the Procedure Readiness Operating Model

Procedure readiness is the coordinated confirmation that the patient, clinical team, facility, authorization, documentation, equipment, medications, testing, and operational resources are prepared for the planned intervention.

Authorization approval alone does not mean that a procedure is ready to occur.

A case may be approved by the payer and still be unsafe, incomplete, incorrectly scheduled, financially unresolved, or operationally unprepared. Medical clearance may be missing. Anticoagulation instructions may be unclear. The authorized site may not match the scheduled location. An implant may not be available. The patient may not understand fasting or transportation requirements. Required laboratory testing may be incomplete. The procedure order may conflict with the clinical note.

These failures are frequently discovered shortly before the procedure, when correction is most difficult and disruptive.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes procedure readiness as a formal operating discipline. The objective is to identify and resolve material barriers before the patient reaches the procedure suite, ambulatory surgery center, or hospital.

Procedure Readiness as a Clinical Control

Procedure readiness is often managed as an administrative checklist. In reality, it is a clinical safety and patient access function.

Readiness confirms that:

• The correct patient is receiving the correct procedure
• The procedure remains clinically appropriate
• The documentation supports the treatment plan
• The authorization matches the planned service
• The selected site can safely perform the procedure
• Required testing and clearance have been completed
• Medication risks have been evaluated
• Equipment, supplies, and implants are available
• The patient understands and can complete preparation requirements
• Post-procedure support and follow-up are arranged

The case should not be considered ready until all critical requirements are satisfied, formally waived by an authorized clinician, or managed through a documented exception process.

Readiness Begins With the Treatment Decision

Procedure readiness should begin when the physician recommends the intervention.

At that point, the organization should identify:

• The procedure
• Diagnosis
• Clinical indication
• Anatomical target
• Laterality
• Spinal level when applicable
• Preferred facility
• Anesthesia or sedation needs
• Implant or equipment requirements
• Authorization requirements
• Medical clearance requirements
• Testing
• Medication considerations
• Patient education needs
• Expected follow-up

Waiting until the procedure has been authorized or scheduled to identify these requirements creates unnecessary delay and risk.

The Readiness Continuum

Procedure readiness should progress through defined stages.

A practical readiness continuum may include:

• Clinical decision complete
• Documentation complete
• Authorization requirements confirmed
• Authorization approved or not required
• Medical clearance requirements identified
• Testing ordered
• Medication plan established
• Facility accepted
• Equipment and implant confirmed
• Patient instructions completed
• Transportation or caregiver requirements confirmed
• Financial responsibilities communicated when appropriate
• Final readiness review completed
• Procedure confirmed

Each stage should have a clear status, owner, due date, and escalation threshold.

Clinical Readiness

Clinical readiness confirms that the patient remains appropriate for the procedure.

The review may include:

• Current symptoms
• Changes in clinical condition
• New neurologic findings
• Recent illness
• Infection
• Recent hospitalization
• Medication changes
• New anticoagulation
• Pregnancy status when applicable
• Changes in medical risk
• Recent procedures
• New diagnostic information

A procedure that was appropriate several weeks earlier may require reassessment if the patient’s condition has changed.

Documentation Readiness

Documentation readiness confirms that the record supports the planned service.

The review should verify:

• Signed clinical note
• Complete procedure order
• Diagnosis alignment
• Correct anatomical site
• Correct laterality
• Correct levels
• Relevant imaging
• Conservative treatment
• Previous procedure response
• Medical necessity rationale
• Patient counseling
• Procedure-specific documentation
• Documentation should be complete before final scheduling whenever possible.
• Last-minute addenda should be the exception rather than the operating model.

Authorization Readiness

Authorization readiness confirms that the approval matches the service that will be performed.

The team should validate:

• Patient
• Payer
• Provider
• Rendering provider
• Facility
• Procedure code
• Diagnosis
• Laterality
• Anatomical level
• Units
• Device or implant
• Authorization number
• Effective dates
• Site of service
• Any payer conditions
• The approval should be reconciled against the current clinical order and schedule.
• A valid authorization for a different provider, facility, code, or date range may not protect the claim.

Facility Readiness

The facility should confirm that it can safely and operationally support the procedure.

This may include:

• Credentialed provider
• Appropriate room
• Staffing
• Anesthesia availability
• Required equipment
• Required supplies
• Implant availability
• Imaging capability
• Emergency preparedness
• Recovery capacity
• Infection-control requirements
• Patient risk acceptance
• The facility should not assume that authorization or physician scheduling confirms readiness.

Patient Readiness

Patient readiness includes the patient’s ability to complete the preparation and recovery plan.

The organization should confirm:

• Understanding of the procedure
• Arrival time
• Fasting requirements
• Medication instructions
• Transportation
• Caregiver support
• Testing
• Medical clearance
• Financial counseling when appropriate
• Post-procedure restrictions
• Follow-up
• The patient should receive instructions in a format that is understandable and accessible.

Readiness Ownership

Every procedure should have an identified readiness owner.

The readiness owner may be:

• A surgical coordinator
• Procedure scheduler
• Clinical coordinator
• Nurse
• Patient navigator
• Utilization specialist
• ASC coordinator

The owner does not personally complete every task. The role ensures that requirements are visible, responsibilities are assigned, deadlines are tracked, and unresolved barriers are escalated.

Without an owner, the case may move between departments without anyone confirming that the complete readiness pathway has been satisfied.

Readiness Tiers

Not every procedure requires the same level of readiness review.

Organizations may establish readiness tiers.

Lower-complexity office procedures may require limited documentation, medication, and patient preparation review.

Moderate-complexity procedures may require authorization, imaging, medication management, and facility confirmation.

High-complexity procedures may require multidisciplinary clearance, anesthesia assessment, implant coordination, extensive testing, financial counseling, and postoperative planning.

Examples of high-complexity services may include:

• Spinal cord stimulator implantation
• Peripheral nerve stimulation implantation
• Major orthopedic surgery
• Spine surgery
• Revision procedures
• Procedures involving significant medical comorbidities
• Tiering helps the organization apply resources according to risk and complexity.

Readiness Deadlines

Each readiness requirement should have a completion deadline relative to the planned procedure.

Examples may include:

• Authorization completed before final confirmation
• Medical clearance completed within the required timeframe
• Laboratory testing completed early enough for review
• Anticoagulation plan confirmed before medication interruption
• Implant availability confirmed before the procedure date
• Patient instructions delivered and acknowledged
• Final readiness review completed before the day of service
• Deadlines should allow sufficient time to resolve abnormal results or missing information.

Readiness Huddles

Organizations with significant procedure volume may use structured readiness huddles.

The huddle may review cases scheduled within the next several days and identify:

• Authorization concerns
• Missing documentation
• Medical-clearance issues
• Medication questions
• Abnormal test results
• Facility concerns
• Implant or equipment risk
• Patient communication problems
• Transportation barriers
• Financial issues
• Cases at risk of cancellation
• The huddle should focus on unresolved exceptions rather than reviewing every completed item.

Stop Rules

The organization should define conditions that prevent a case from proceeding until resolved.

Potential stop conditions include:

• Patient identity discrepancy
• Incorrect procedure or laterality
• Missing required authorization
• Authorization mismatch
• Unresolved infection
• Unsafe anticoagulation status
• Missing critical medical clearance
• Abnormal test result not reviewed
• Implant unavailable
• Facility unable to support the patient’s risk
• Patient unable to provide required transportation
• Unresolved clinical deterioration
• A stop rule should identify who has authority to clear the condition.

Exception Management

Some readiness requirements may be modified or waived based on clinical judgment.

An exception should document:

• The standard requirement
• The reason it does not apply
• Patient-specific circumstances
• Clinical decision-maker
• Risk assessment
• Alternative safeguards
• Final disposition
• Operational staff should not independently waive clinical readiness requirements.

Procedure Cancellation Prevention

A cancellation should be treated as a system event requiring review.

The organization should identify whether the cause involved:

• Authorization
• Documentation
• Medical clearance
• Testing
• Medication management
• Patient communication
• Transportation
• Financial responsibility
• Facility capacity
• Equipment
• Implant
• Clinical change
• Patient decision

Some cancellations are unavoidable. Repeated cancellations for the same reason indicate a correctable operating failure.

Readiness Metrics

Relevant performance measures may include:

• Percentage of cases fully ready before final confirmation
• Cases scheduled before authorization completion
• Medical-clearance completion rate
• Medication-plan completion rate
• Testing completion rate
• Authorization mismatch rate
• Implant readiness rate
• Patient instruction acknowledgment
• Day-of-procedure cancellation rate
• Cancellation reasons
• Time from readiness completion to procedure
• Repeat readiness failures
• Metrics should be stratified by procedure, provider, facility, location, and reason.

GoHealthcare Insights

Many organizations measure procedure volume and cancellation rates but do not measure readiness.

This creates a reactive model in which teams work urgently to save cases that were never fully prepared.

The stronger model measures how early the organization confirms readiness and how many cases require last-minute intervention.

The objective is not to prove that staff can rescue difficult cases. It is to build a system that rarely requires rescue.

Leadership Perspective

Procedure readiness should be treated as a shared clinical and operational responsibility.

Clinical teams, authorization staff, scheduling, facilities, anesthesia, vendors, patients, and leadership all influence readiness.

Leadership must ensure that no department can declare a case ready based only on completion of its own task.

The case is ready only when the entire episode is ready.

Key Takeaways

• Procedure readiness extends beyond authorization and scheduling.
• Clinical, documentation, authorization, facility, equipment, medication, patient, and follow-up requirements must be coordinated.
• Readiness should begin at the treatment decision and progress through defined stages.
• Every procedure needs a visible readiness owner.
• Complex procedures require more intensive review and earlier planning.
• Stop rules and exception authority must be clearly defined.
• The success of procedure readiness is measured through fewer preventable delays, cancellations, safety risks, and last-minute interventions.

Back to top ↑

27

Pre-Procedure Clinical Validation and Readiness Checklists

A pre-procedure checklist is a structured tool used to confirm that essential clinical and operational requirements have been completed before an intervention.

The checklist supports reliability, but it does not replace clinical judgment.

A checked box is meaningful only when the underlying information has been reviewed, is accurate, and remains current.

The GoHealthcare Clinical & Utilization Excellence Framework™ requires procedure-specific readiness checklists that reflect the risk, complexity, setting, and clinical requirements of the planned service.

The Purpose of the Readiness Checklist

A readiness checklist should help confirm:

• Correct patient
• Correct procedure
• Correct anatomical site
• Correct laterality
• Correct level
• Current clinical indication
• Complete documentation
• Valid authorization
• Appropriate facility
• Completed testing
• Completed medical clearance
• Reviewed medications
• Available equipment and implants
• Patient preparation
• Transportation and recovery planning
• Post-procedure follow-up
• The checklist should reduce reliance on memory and informal communication.

Checklist Design

An effective checklist should be:

• Procedure-specific
• Risk-based
• Concise
• Easy to complete
• Integrated into workflow
• Assigned to defined roles
• Time-stamped
• Auditable
• Capable of identifying unresolved exceptions

A checklist that is too long may be completed mechanically. A checklist that is too broad may fail to identify procedure-specific risks.

Universal Readiness Elements

Some readiness elements apply to most procedures.

These may include:

• Patient identity
• Procedure order
• Diagnosis
• Procedure
• Site and laterality
• Consent status
• Allergy review
• Medication reconciliation
• Anticoagulation review
• Infection screening
• Authorization
• Facility confirmation
• Transportation when required
• Follow-up appointment
• Procedure-specific requirements should then be added according to the service.

Procedure-Specific Readiness

Different procedures require different controls.

A medial branch block checklist may include:

• Target levels
• Laterality
• Diagnostic purpose
• Baseline pain assessment
• Planned post-procedure response measurement
• Payer-specific diagnostic requirements

A radiofrequency ablation checklist may include:

• Qualifying diagnostic block results
• Target levels
• Laterality
• Previous ablation history
• Frequency requirements

A spinal cord stimulator trial checklist may include:

• Psychological evaluation when required
• Device selection
• Trial goals
• Medication review
• Patient education
• Vendor coordination
• Trial follow-up

A permanent implantation checklist may include:

• Successful trial documentation
• Permanent authorization
• Device and implant confirmation
• Anesthesia assessment
• Infection-prevention planning
• Postoperative support

An orthopedic or spine surgery checklist may include:

• Imaging
• Medical clearance
• Laboratory testing
• Cardiac evaluation when indicated
• Implant availability
• Surgical side and level
• Preoperative instructions
• Postoperative disposition

Clinical Indication Reconfirmation

The readiness review should reconfirm that the procedure remains appropriate.

Questions may include:

• Has the patient’s condition changed?
• Has the patient developed new symptoms?
• Has the patient improved enough that the procedure should be reconsidered?
• Has the patient developed an infection?
• Has the patient started a new medication?
• Has another procedure been performed?
• Has new imaging changed the plan?
• Has the patient been hospitalized?
• Has the physician changed the target, laterality, level, or procedure?
• Material changes should trigger clinical review.

Identity, Procedure, Site, and Laterality

The organization should reconcile:

• Clinical note
• Procedure order
• Authorization
• Schedule
• Facility record
• Consent
• Procedure documentation
• All sources should agree regarding the patient, procedure, site, laterality, and level.
• Discrepancies must be resolved before the procedure.

This reconciliation is particularly important in bilateral procedures, multilevel spine procedures, staged surgeries, and repeat interventions.

Authorization Reconciliation

The checklist should confirm:

• Approval remains active
• The date falls within the authorization period
• The approved provider matches the rendering provider
• The facility and site of service are correct
• The procedure codes match
• Units are sufficient
• The diagnosis is consistent
• Device authorization is included when necessary
• Conditions of approval have been satisfied
• A portal approval screenshot should not replace reconciliation with the actual planned service.

Medication Review

The checklist should confirm that medication risks have been evaluated.

This may include:

• Anticoagulants
• Antiplatelet agents
• Diabetes medications
• Weight-loss medications affecting gastric emptying
• Immunosuppressive therapy
• Steroids
• Antibiotics
• Sedatives
• Opioids
• Allergy-related medications
• The medication plan should be established by an appropriately qualified clinician.

Administrative staff should communicate approved instructions but should not independently determine medication discontinuation.

Infection Screening

Pre-procedure infection screening may address:

• Fever
• Respiratory symptoms
• Active antibiotic use
• Skin infection
• Open wound
• Dental infection when relevant
• Urinary infection
• Recent systemic illness
• Recent exposure concerns
• Implant-based and surgical procedures may require more extensive infection-prevention controls.
• The presence of infection risk should be escalated for clinical decision.

Pregnancy Screening

For selected procedures involving radiation, medication, anesthesia, or surgical risk, pregnancy status may be relevant.

The organization should define:

• Which patients require screening
• Which procedures require testing
• When testing must occur
• Who reviews the result
• How urgent cases are handled
• The process should be clinically appropriate and respectful.

Allergies and Reactions

The readiness review should confirm allergies and previous reactions involving:

• Contrast
• Latex
• Adhesives
• Antibiotics
• Local anesthetics
• Sedation medications
• Implant materials
• Skin preparation agents
• The record should distinguish allergy, intolerance, side effect, and uncertain history when possible.

Baseline Clinical Measures

Some procedures require baseline data to evaluate response.

Examples include:

• Pain score
• Functional limitation
• Neurologic status
• Range of motion
• Medication use
• Patient-reported outcome measure
• Walking tolerance
• Device-specific goals
• The baseline should be documented before treatment rather than reconstructed afterward.

Consent Readiness

Consent readiness includes more than obtaining a signature.

The checklist should confirm that the patient has received appropriate information regarding:

• Nature of the procedure
• Expected benefit
• Material risks
• Alternatives
• Potential limitations
• Anesthesia or sedation
• Implant responsibilities
• Recovery expectations
• Consent should be completed in accordance with organizational and facility policy.

Patient Understanding

The checklist may verify that the patient understands:

• Arrival time
• Fasting instructions
• Medication plan
• Transportation requirements
• Clothing or personal item instructions
• Expected recovery
• Post-procedure restrictions
• Whom to contact with questions
• Warning signs

The organization should use teach-back or acknowledgment processes when appropriate.

Final Clinical Review

High-risk cases may require final review by:

• Treating physician
• Anesthesia clinician
• Nurse
• Medical director
• Facility clinical leader

The review should address unresolved risks, abnormal testing, comorbidities, medication issues, or changes in the patient’s condition.

Checklist Completion Responsibility

The checklist should identify which role completes each component.

For example:

• Authorization team confirms payer approval.
• Clinical staff confirm current clinical information.
• Nursing confirms medication and testing status.
• Facility operations confirm equipment and room readiness.
• The physician confirms clinical indication and any exceptions.
• Scheduling confirms patient logistics.
• One role should perform final reconciliation and confirm that no critical item remains unresolved.

Checklist Exceptions

A checklist item should not be marked complete when it is merely not applicable or unresolved.

The system should distinguish:

• Complete
• Not applicable
• Pending
• Exception approved
• Failed
• Escalated

This creates transparency and prevents false readiness.

Day-of-Procedure Revalidation

Some elements should be revalidated on the day of service.

These may include:

• Identity
• Procedure
• Site
• Laterality
• Consent
• Allergies
• Medication status
• Fasting
• Transportation
• Recent illness
• New symptoms
• Pregnancy status when applicable
• Final clinical appropriateness

Pre-procedure readiness and day-of-service verification serve different purposes. Both are necessary.

Checklist Audit

The organization should periodically evaluate whether checklists are:

• Completed accurately
• Completed on time
• Preventing cancellations
• Identifying risks
• Creating unnecessary burden
• Being bypassed
• Outdated
• Associated with recurring exceptions
• Checklists should evolve when procedures, policies, technology, or safety standards change.

GoHealthcare Insights

The effectiveness of a checklist depends on what happens when an item is incomplete.

If staff routinely mark unresolved items as complete to keep the case moving, the checklist becomes a liability rather than a safety tool.

The organization must create a culture in which identifying a readiness problem is valued because it prevents harm, denial, or cancellation.

Leadership Perspective

Leaders should avoid turning checklists into documentation theater.

The purpose is not to create evidence that a box was checked. The purpose is to ensure that the clinical and operational condition represented by the box is actually satisfied.

Readiness checklists should be reviewed according to whether they prevent failure and improve patient progression.

Key Takeaways

• Pre-procedure checklists support reliability but do not replace clinical judgment.
• Checklists should be procedure-specific, risk-based, concise, and integrated into workflow.
• The clinical note, order, authorization, schedule, consent, and facility record must agree.
• Medication, infection, allergy, testing, consent, transportation, and follow-up requirements should be validated.
• Incomplete items must remain visible and trigger escalation.
• Day-of-procedure verification is required even when earlier readiness review was completed.

Back to top ↑

28

Medical Clearance, Diagnostic Testing, and Clinical Risk Stratification

Medical clearance and pre-procedure testing help determine whether a patient can safely undergo the planned intervention and whether additional risk management is required.

These processes should be patient-specific and procedure-specific.

Routine testing without a clinical reason may delay care, increase cost, generate incidental findings, and create unnecessary administrative burden. Insufficient evaluation may expose the patient to avoidable risk.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes a risk-based approach to medical clearance and diagnostic testing.

Medical Clearance Versus Risk Assessment

The phrase “medical clearance” may imply that another clinician guarantees that the patient is safe for a procedure.

In practice, no evaluation eliminates all risk.

A pre-procedure medical assessment should:

• Identify active medical conditions
• Assess the patient’s current stability
• Evaluate relevant procedure and anesthesia risks
• Recommend risk-reduction strategies
• Identify additional testing or consultation when indicated
• Communicate whether unresolved conditions require delay or modification

The treating proceduralist and anesthesia team retain responsibility for determining whether to proceed within their respective roles.

Risk-Based Evaluation

The level of assessment should reflect:

• Procedure complexity
• Anesthesia plan
• Expected blood loss
• Physiologic stress
• Patient age
• Cardiovascular risk
• Pulmonary risk
• Renal function
• Diabetes
• Bleeding risk
• Infection risk
• Functional status
• Previous anesthesia complications
• Implanted devices
• Frailty

Office-based injections may require limited assessment. Major spine surgery or joint replacement may require comprehensive multidisciplinary evaluation.

Standardized Risk Stratification

Organizations should establish risk categories or pathways.

A lower-risk patient undergoing a minor procedure may proceed through a streamlined process.

A moderate-risk patient may require targeted testing or primary care assessment.

A higher-risk patient may require specialty consultation, anesthesia review, hospital-based care, or modification of the treatment plan.

The risk model should be clinically governed and periodically reviewed.

Medical History Requirements

The assessment may address:

• Cardiovascular disease
• Pulmonary disease
• Renal disease
• Diabetes
• Liver disease
• Neurologic disease
• Bleeding disorders
• Previous thrombosis
• Infection history
• Obstructive sleep apnea
• Medication use
• Substance use when clinically relevant
• Previous anesthesia reaction
• Implanted cardiac or neurologic devices
• The information should be current enough to support the planned procedure.

Cardiovascular Evaluation

Cardiovascular assessment may consider:

• Known coronary disease
• Heart failure
• Arrhythmia
• Valve disease
• Hypertension
• Functional capacity
• Recent cardiac symptoms
• Recent intervention
• Antiplatelet or anticoagulant use
• Additional testing should be based on clinical indication rather than routine practice alone.
• Abnormal findings should be reviewed by the appropriate clinician before the procedure.

Pulmonary and Airway Risk

Pulmonary assessment may address:

• Chronic obstructive pulmonary disease
• Asthma
• Sleep apnea
• Oxygen use
• Recent respiratory infection
• Smoking history
• Airway concerns
• Previous intubation difficulty
• Obesity-related risk

These factors may affect sedation, anesthesia, monitoring, facility selection, and postoperative planning.

Diabetes Management

Diabetes may affect:

• Medication instructions
• Fasting
• Glucose monitoring
• Infection risk
• Wound healing
• Procedure timing
• Postoperative recovery

The organization should establish clinically approved instructions for diabetes medications and escalation of abnormal glucose results.

Renal and Hepatic Considerations

Renal or hepatic impairment may affect:

• Medication selection
• Contrast use
• Anesthesia
• Fluid management
• Laboratory testing
• Post-procedure monitoring
• The readiness pathway should identify when additional review is required.

Laboratory Testing

Laboratory testing should be ordered based on:

• Patient condition
• Procedure
• Anesthesia
• Medication use
• Bleeding risk
• Facility policy

Potential tests may include:

• Complete blood count
• Basic or comprehensive metabolic testing
• Coagulation studies
• Hemoglobin A1c
• Pregnancy testing
• Infection-related testing
• Urinalysis when clinically indicated
• Testing should be completed early enough for results to be reviewed and acted upon.

Imaging and Diagnostic Studies

Pre-procedure imaging should support:

• Diagnosis
• Target confirmation
• Surgical planning
• Anatomical assessment
• Implant planning
• Exclusion of alternative pathology

The organization should confirm that imaging is:

• Current enough for the procedure
• Available to the treating provider
• Available to the facility when required
• Correctly associated with the patient
• Consistent with the planned site and level
• Repeat imaging should be ordered only when clinically justified.

Specialty Consultation

Specialty evaluation may be appropriate when the patient has:

• Unstable cardiac disease
• Significant pulmonary disease
• Bleeding disorder
• Complex anticoagulation
• Active infection
• Poorly controlled diabetes
• Advanced renal disease
• Previous anesthesia complication
• Complex device management

The consultation request should ask a specific clinical question rather than request a broad statement that the patient is cleared.

Abnormal Results

The organization should define how abnormal results are:

• Received
• Routed
• Reviewed
• Documented
• Escalated
• Communicated to the patient
• Incorporated into the final decision

An abnormal result should not remain in a work queue without evidence that an authorized clinician reviewed it.

The final disposition may include:

• Proceed
• Proceed with precautions
• Repeat testing
• Obtain consultation
• Modify the procedure
• Change the setting
• Delay
• Cancel

Expiration and Validity

Medical evaluations and test results may have limited validity based on:

• Procedure type
• Patient risk
• Facility policy
• Payer requirement
• Change in condition

Organizations should define when repeat assessment is required.

A previously acceptable clearance may no longer be sufficient after hospitalization, new symptoms, medication change, or significant delay.

Avoiding Duplicate Testing

Patients may complete testing through another provider or facility.

The organization should establish a process for retrieving, reviewing, and accepting outside results when clinically appropriate.

Duplicate testing should be avoided when existing information is adequate and current.

Clearance Communication

The medical assessment should clearly identify:

• Relevant conditions
• Current stability
• Recommendations
• Medication instructions
• Testing reviewed
• Unresolved concerns
• Required precautions
• Whether further evaluation is needed

Ambiguous statements such as “cleared pending labs” should remain incomplete until the conditions are resolved.

Facility and Anesthesia Acceptance

The proceduralist, facility, and anesthesia team may apply different risk criteria.

The readiness process should reconcile these expectations before the procedure date.

A physician office may consider the patient clinically acceptable, while an ASC may determine that the patient requires a hospital setting.

These differences should be resolved through defined clinical review rather than on the day of service.

Risk Communication With the Patient

Patients should understand:

• Why additional evaluation is required
• Which testing must be completed
• How medical conditions may affect the procedure
• Whether the site may change
• What could cause postponement
• How to report changes in health
• Clear communication reduces frustration when safety requirements affect scheduling.

Risk and Clearance Metrics

Relevant measures may include:

• Percentage of high-risk cases reviewed before scheduling
• Medical-clearance completion rate
• Abnormal result escalation time
• Procedures delayed for incomplete testing
• Procedures cancelled for medical reasons
• Repeat testing rate
• Day-of-procedure medical cancellations
• Facility rejection rate
• Unplanned transfers
• Post-procedure complications
• Metrics should be interpreted according to patient complexity and procedure type.

GoHealthcare Insights

Medical-clearance failures frequently arise because the process begins too late.

When testing is ordered after the procedure has already been confirmed, abnormal findings create immediate scheduling pressure.

The stronger model identifies risk and initiates testing when the treatment decision is made.

Time should be treated as a clinical resource. Earlier assessment creates more options for safe correction.

Leadership Perspective

Leaders should ensure that clearance requirements are clinically justified and standardized across providers and facilities whenever possible.

Excessive testing can become as problematic as insufficient testing.

The goal is proportional risk management: the right evaluation for the right patient and procedure.

Key Takeaways

• Medical clearance is a risk assessment, not a guarantee of safety.
• The level of evaluation should reflect patient risk, procedure complexity, anesthesia, and care setting.
• Testing should be clinically indicated, current, reviewed, and completed early enough for action.
• Abnormal results require closed-loop clinical review and documented disposition.
• Facility and anesthesia risk requirements should be reconciled before the procedure date.
• Early risk identification reduces cancellations, unnecessary testing, and patient harm.

Back to top ↑

29

Medication, Anticoagulation, Infection, and Periprocedural Safety Management

Medication management is one of the most clinically sensitive components of procedure readiness.

Incorrect instructions may expose patients to bleeding, thrombosis, infection, metabolic instability, withdrawal, aspiration, poor pain control, or treatment failure.

The GoHealthcare Clinical & Utilization Excellence Framework™ requires medication and periprocedural safety decisions to be clinically governed, procedure-specific, patient-specific, clearly communicated, and documented through closed-loop processes.

Medication Reconciliation

The organization should maintain a current medication list that includes:

• Prescription medications
• Over-the-counter medications
• Anticoagulants
• Antiplatelet agents
• Diabetes medications
• Weight-loss medications
• Steroids
• Immunosuppressants
• Antibiotics
• Supplements
• Herbal products
• Opioids
• Sedatives
• The patient should be asked about recent changes and medications prescribed by outside clinicians.
• Medication reconciliation should occur early enough to identify risks before the procedure.

Anticoagulant and Antiplatelet Management

Anticoagulation decisions require balancing:

• Bleeding risk from the procedure
• Thrombotic risk from interrupting therapy
• Medication pharmacology
• Renal function
• Patient history
• Indication for therapy
• Procedure location
• Ability to manage bleeding
• Potential need for bridging
• The proceduralist should not automatically instruct every patient to stop anticoagulation.
• The prescribing or managing clinician may need to participate in the decision.

Clinical Decision Authority

Medication interruption or continuation should be directed by an appropriately qualified clinician.

Administrative staff may:

• Collect medication information
• Route requests
• Communicate approved instructions
• Confirm patient understanding
• Document responses

Administrative staff should not independently determine:

• Whether medication should be stopped
• How long it should be held
• Whether bridging is required
• Whether the patient may proceed after incorrect medication use
• Clinical authority must remain clear.

Anticoagulation Coordination

The process should identify:

• Medication
• Dose
• Indication
• Prescribing clinician
• Procedure bleeding risk
• Recommended plan
• Prescriber response
• Patient instructions
• Date of last dose
• Restart instructions
• Unresolved disagreement
• The plan should be documented in a location visible to the procedural team.

Thrombotic Risk

Interrupting medication may create significant risk for patients with:

• Recent stent
• Recent thrombosis
• Atrial fibrillation
• Mechanical heart valve
• Hypercoagulable disorder
• Recent stroke
• Complex cardiovascular disease

The organization should establish an escalation pathway for high-risk patients.

The planned procedure may need to be delayed, modified, or performed without interruption when clinically appropriate.

Diabetes Medication Management

Periprocedural diabetes management may involve:

• Insulin adjustment
• Oral medication instructions
• Fasting modifications
• Glucose monitoring
• Timing of the procedure
• Hypoglycemia risk
• Hyperglycemia risk

The plan should reflect the procedure, fasting requirements, sedation, and patient-specific diabetes control.

Medications Affecting Gastric Emptying

Selected medications may influence fasting and aspiration risk.

The organization should maintain current clinically approved guidance regarding:

• Which medications are relevant
• Patient risk factors
• Procedure type
• Sedation or anesthesia
• Symptoms of delayed gastric emptying
• When anesthesia review is required
• Policies should be updated when professional guidance changes.

Steroids and Immunosuppressive Therapy

Steroids or immunosuppressive therapy may affect:

• Infection risk
• Wound healing
• Adrenal response
• Glucose
• Timing of elective procedures

The treating and procedural teams should determine whether modification or additional precautions are required.

Antibiotics

The readiness process should identify:

• Active antibiotic treatment
• Reason for treatment
• Presence of infection
• Prophylactic antibiotic requirements
• Allergies
• Timing
• Dose
• Implant-specific requirements
• A patient taking antibiotics for an active infection may require clinical reassessment before proceeding.

Supplements and Herbal Products

Some supplements may influence:

• Bleeding
• Sedation
• Blood pressure
• Glucose
• Medication interactions
• Patients may not consider supplements to be medications.
• The intake process should ask about them explicitly when relevant.

Infection Risk Assessment

Infection screening should be proportionate to the procedure.

Relevant factors may include:

• Fever
• Recent illness
• Active infection
• Skin lesion
• Wound
• Dental infection when relevant
• Urinary infection
• Respiratory symptoms
• Recent antibiotic use
• Immunosuppression
• Poorly controlled diabetes
• Previous implant infection
• The clinical team should determine whether the procedure should proceed, be modified, or be delayed.

Implant Infection Prevention

Implant-based procedures require enhanced controls.

These may include:

• Preoperative infection screening
• Skin preparation
• Antibiotic protocol
• Glucose management
• Smoking considerations
• Wound planning
• Sterile technique
• Implant handling
• Postoperative surveillance
• Patient education

An implant infection can create significant clinical harm, revision surgery, hospitalization, and financial exposure.

Allergy Management

Allergy review should distinguish among:

• True allergy
• Intolerance
• Expected side effect
• Uncertain reaction

Relevant substances may include:

• Antibiotics
• Contrast
• Latex
• Adhesives
• Local anesthetics
• Opioids
• Sedatives
• Skin preparation agents
• Implant materials
• The plan should identify safe alternatives when needed.

Fasting and Sedation Safety

Fasting instructions should reflect:

• Procedure
• Sedation
• Anesthesia
• Patient risk
• Facility policy

Patients should receive clear instructions regarding:

• Solid food
• Clear liquids
• Medication use
• Diabetes management
• Consequences of nonadherence
• Conflicting instructions from the physician office and facility should be eliminated.

Pain Medication Planning

Patients may require guidance regarding:

• Baseline pain medication
• Opioid tolerance
• Postoperative prescriptions
• Prescriber responsibility
• Medication access
• Potential duplication
• Controlled substance agreements

The proceduralist, surgeon, pain physician, and primary prescriber should coordinate when multiple clinicians are involved.

Restart Instructions

Medication management does not end when the procedure begins.

Patients should receive clear instructions regarding:

• When medication may restart
• What conditions may delay restart
• Whom to contact with concerns
• Signs of bleeding or thrombosis
• Changes to diabetes medication
• Temporary postoperative medication
• Restart instructions should be documented and included in discharge planning.

Patient Communication and Teach-Back

Medication instructions should be:

• Written
• Specific
• Dated
• Procedure-specific
• Confirmed by the patient
• Available to the facility

Teach-back may be used to confirm that the patient understands:

• Which medication
• Last dose
• Restart plan
• Fasting
• What to do if an error occurs
• The patient should be instructed to contact the team rather than make independent changes.

Day-of-Procedure Verification

The team should confirm:

• Medication plan was followed
• Last dose
• Fasting status
• New medication
• New antibiotic
• New anticoagulant
• Recent infection
• New allergy information
• Discrepancies should be escalated to an authorized clinician.

Safety Event Review

Medication-related delays, cancellations, near misses, or adverse events should be reviewed.

Examples include:

• Incorrect hold instructions
• Medication stopped unnecessarily
• Procedure performed despite unresolved anticoagulation
• Conflicting instructions
• Unrecognized infection
• Antibiotic allergy
• Fasting failure
• Diabetes-related instability

The review should identify whether the cause involved policy, communication, technology, staffing, or individual performance.

Medication and Safety Metrics

Relevant measures may include:

• Medication-plan completion rate
• Anticoagulation clarification volume
• Medication-related cancellations
• Day-of-procedure discrepancies
• Infection-related postponements
• Fasting-related cancellations
• Unresolved prescriber responses
• Patient instruction acknowledgment
• Medication-related adverse events
• Repeat communication failures

GoHealthcare Insights

Medication instructions often move through several parties: physician, nurse, authorization team, scheduler, facility, patient, and prescribing clinician.

Every additional handoff creates risk.

The strongest model creates one authoritative medication plan, assigns one clinical owner, and ensures that all affected teams can see the same approved instruction.

Leadership Perspective

Leaders should not allow medication management to become an informal scheduling task.

These decisions carry substantial clinical risk and require clear authority, standardized processes, and reliable documentation.

Operational efficiency must never override appropriate clinical review.

Key Takeaways

• Medication management is a clinical safety function.
• Anticoagulation decisions must balance bleeding and thrombotic risk.
• Administrative staff may communicate approved instructions but should not independently create medication plans.
• Infection, diabetes, fasting, allergies, immunosuppression, and implant risk must be addressed according to the procedure and patient.
• One authoritative medication plan should be visible across the care team.
• Day-of-procedure discrepancies require clinical review before proceeding.

Back to top ↑

30

Facility, Equipment, Implant, Anesthesia, and Patient Logistics Readiness

A clinically appropriate and authorized procedure can still fail when the facility, equipment, implant, anesthesia, or patient logistics are not prepared.

These readiness elements are especially important in orthopedic surgery, spine surgery, neuromodulation, ambulatory surgery centers, and advanced interventional pain procedures.

The GoHealthcare Clinical & Utilization Excellence Framework™ requires final operational readiness to be managed as part of the clinical episode rather than as separate facility or scheduling activity.

Facility Acceptance

The facility should confirm that it is able to accept the case based on:

• Provider credentialing
• Procedure privileges
• Patient risk
• Procedure complexity
• Anesthesia needs
• Equipment
• Implant requirements
• Recovery capability
• Emergency preparedness
• Network participation
• Payer authorization
• Facility acceptance should occur before the patient is given a final procedure commitment.

Provider Credentialing and Privileging

The readiness process should confirm that the treating provider is:

• Credentialed
• Privileged for the procedure
• Eligible under the payer contract
• Authorized to use the required equipment or implant
• Compliant with facility requirements

Credentialing problems should be identified before authorization is requested under an ineligible provider or facility.

Room and Capacity Planning

The facility should confirm:

• Appropriate room
• Procedure duration
• Turnover requirements
• Imaging equipment
• Staffing
• Recovery capacity
• Isolation or infection precautions
• Implant support
• High-complexity cases may require additional time, specialized staff, or specific room configuration.
• Scheduling should reflect actual resource requirements rather than only physician availability.

Equipment Readiness

Equipment readiness may include:

• Fluoroscopy
• Ultrasound
• Navigation
• Microscope
• Radiofrequency generator
• Neuromodulation equipment
• Positioning devices
• Monitoring equipment
• Surgical instruments
• Emergency equipment

The facility should verify that equipment is:

• Available
• Functional
• Maintained
• Compatible
• Sterile when required
• Supported by trained personnel
• Equipment failure should be tracked as a readiness and quality event.

Implant Readiness

Implant-based procedures require detailed coordination.

The readiness process should confirm:

• Correct implant
• Manufacturer
• Model
• Size
• Components
• Backup options
• Authorization
• Facility approval
• Vendor availability
• Delivery
• Sterility
• Expiration
• Tracking information
• Patient-specific compatibility
• The clinical plan, authorization, facility schedule, vendor order, and operative record should agree.

Vendor Coordination

Vendors may support implant or device procedures, but the organization must maintain clinical and operational control.

Vendor coordination should define:

• Approved vendor
• Required credentials
• Facility access
• Arrival time
• Equipment responsibility
• Inventory confirmation
• Technical support role
• Privacy and compliance expectations
• Documentation responsibilities
• Vendors should not independently direct clinical decision-making or patient selection.

Implant Financial Exposure

Implants can create significant financial risk when:

• The device is not separately authorized
• The payer considers the implant bundled
• The facility lacks contractual reimbursement
• The wrong device is ordered
• The case is cancelled after the implant is opened
• The payer requires a preferred product
• The patient’s benefits exclude the technology

Financial review should occur early enough to prevent avoidable loss while preserving clinical decision-making.

Anesthesia Readiness

Anesthesia readiness should confirm:

• Anesthesia type
• Patient risk classification
• Airway concerns
• Relevant comorbidities
• Fasting
• Medication plan
• Medical evaluation
• Required testing
• Post-anesthesia support
• Facility capability
• Anesthesia concerns should be resolved before the day of service whenever possible.

Anesthesia and Procedure Coordination

The proceduralist and anesthesia team should agree regarding:

• Procedure duration
• Positioning
• Patient feedback requirements
• Sedation depth
• Neurologic monitoring
• Implant needs
• Potential blood loss
• Postoperative disposition

For selected interventional procedures, excessive sedation may interfere with clinical feedback or payer policy. For surgical procedures, insufficient planning may create safety or cancellation risk.

Staffing Readiness

The facility should confirm the availability of:

• Proceduralist
• Assistant
• Nursing
• Technologist
• Anesthesia
• Recovery staff
• Device or implant support
• Interpreter when needed
• Specialty support
• Staff should have appropriate competency for the procedure and equipment.

Patient Transportation

Transportation requirements should be communicated clearly.

The organization should confirm:

• Whether the patient may drive
• Whether a responsible adult is required
• Whether transportation has been arranged
• Whether the patient has postoperative supervision when necessary
• Whether travel distance creates risk
• Transportation problems should be identified before the procedure day.

Caregiver and Home Support

Some patients require support after:

• Anesthesia
• Major surgery
• Implantation
• Mobility-limiting procedures

The readiness review should identify:

• Caregiver availability
• Home accessibility
• Mobility support
• Medication access
• Wound care support
• Emergency contact
• Ability to attend follow-up
• Postoperative planning should reflect the patient’s actual living circumstances.

Financial Communication

When appropriate, patients should receive information regarding:

• Insurance approval
• Estimated responsibility
• Facility charges
• Professional charges
• Anesthesia charges
• Implant-related responsibility
• Noncovered services
• Payment expectations
• Financial discussions should occur before the day of service whenever possible.

Patients should not be surprised by unresolved financial requirements after completing clinical preparation.

Patient Instructions

Final instructions should include:

• Arrival time
• Location
• Fasting
• Medication plan
• Transportation
• Clothing
• Identification and insurance documents
• Equipment to bring
• Post-procedure restrictions
• Follow-up
• Contact information
• Instructions should be consistent across the physician office, facility, and anesthesia team.

Final Readiness Confirmation

A final readiness confirmation should reconcile:

• Clinical plan
• Signed documentation
• Authorization
• Facility acceptance
• Medical clearance
• Testing
• Medication plan
• Anesthesia
• Equipment
• Implant
• Staffing
• Patient instructions
• Transportation
• Financial requirements
• Follow-up

The case should then receive a formal status such as:

• Ready
• Ready with approved exception
• Not ready
• Escalated
• Cancelled
• Deferred

Day-of-Service Coordination

On the procedure day, the team should reconfirm:

• Patient identity
• Procedure
• Site
• Laterality
• Consent
• Medication compliance
• Fasting
• Recent illness
• Transportation
• Equipment
• Implant
• Authorization when required
• Unexpected discrepancies should be resolved before treatment.

Cancellation Management

When a case is cancelled, the organization should document:

• Reason
• Time identified
• Preventability
• Patient communication
• Clinical follow-up
• Rescheduling plan
• Resource impact
• Corrective action

Cancellation analysis should distinguish:

• Patient decision
• Clinical change
• Medical risk
• Authorization
• Facility issue
• Equipment or implant failure
• Transportation
• Financial issue
• Communication failure

Capacity Protection

Procedure readiness protects valuable clinical capacity.

An unused procedure room or operating room affects:

• Patient access
• Provider productivity
• Facility revenue
• Staff utilization
• Vendor coordination
• Scheduling efficiency

A readiness model allows leaders to identify high-risk cases early and replace cancelled capacity when appropriate.

Facility and Logistics Metrics

Relevant measures may include:

• Facility acceptance turnaround time
• Equipment-related delay rate
• Implant-related cancellation rate
• Anesthesia-related cancellation rate
• Transportation failure rate
• Day-of-service cancellation rate
• Unused room time
• Vendor readiness issues
• Patient instruction completion
• Financially unresolved cases
• Rescheduling interval
• Metrics should drive improvement across clinical, operational, facility, and vendor workflows.

GoHealthcare Insights

Operational readiness failures are often invisible until the final days before a procedure.

At that point, teams may work intensely to preserve the case, giving the appearance of strong performance.

In reality, repeated last-minute intervention indicates weak upstream coordination.

The GoHealthcare model moves facility, equipment, implant, anesthesia, and patient logistics planning closer to the original treatment decision.

Leadership Perspective

Leaders should recognize that procedure capacity is a strategic asset.

Protecting that capacity requires more than filling the calendar. It requires ensuring that scheduled cases are clinically appropriate, authorized, prepared, and operationally executable.

A full schedule with frequent cancellations is not efficient capacity management.

Key Takeaways

• Facility readiness includes credentialing, room capacity, staffing, equipment, recovery, and emergency capability.
• Implant procedures require clinical, authorization, vendor, inventory, financial, and tracking coordination.
• Anesthesia readiness should be completed before the day of service whenever possible.
• Patient transportation, caregiver support, financial communication, and postoperative logistics are part of readiness.
• One final reconciliation should confirm that every critical component is complete.
• Procedure readiness protects patient safety, access, facility capacity, provider productivity, and financial performance.

Back to top ↑

31

Establishing the Quality and Care Coordination Operating Model

Quality and care coordination connect every domain of the GoHealthcare Clinical & Utilization Excellence Framework™.

Medical necessity determines whether care is appropriate. Evidence-based pathways guide treatment selection. Utilization management supports access and appropriate resource use. Clinical documentation communicates the rationale. Procedure readiness prepares the patient and organization. Quality and care coordination determine whether these activities operate as one reliable system and produce meaningful patient outcomes.

In musculoskeletal specialty care, patients frequently move among physicians, advanced practice providers, therapists, imaging centers, hospitals, ambulatory surgery centers, anesthesia teams, device representatives, primary care clinicians, rehabilitation facilities, home health services, and payer utilization reviewers.

Each participant may perform an individual responsibility correctly while the patient still experiences fragmented care.

The GoHealthcare quality and care coordination operating model establishes shared accountability across the entire episode, from initial evaluation through treatment, recovery, outcome assessment, and the next clinical decision.

The Purpose of Quality and Care Coordination

The operating model should ensure that:

• Care is clinically appropriate and safely delivered
• The patient’s treatment plan is understood across teams
• Information follows the patient through every transition
• Clinical and operational risks are identified early
• Patient responsibilities and expectations are clearly communicated
• Follow-up occurs at the correct interval
• Treatment response is measured
• Complications and adverse events are escalated
• Unresolved cases remain visible
• Lessons from individual cases improve the larger system

Quality should not be treated as a retrospective reporting exercise. It should be built into the daily clinical workflow.

Quality Across the Care Continuum

Quality begins when the patient enters the organization.

At intake, quality includes accurate identification, history collection, medication reconciliation, insurance verification, outside record acquisition, and recognition of urgent clinical concerns.

During the clinical encounter, quality includes diagnostic reasoning, patient selection, evidence-informed treatment, documentation, shared decision-making, and appropriate escalation.

Before a procedure, quality includes authorization alignment, risk assessment, medication planning, facility readiness, equipment confirmation, patient preparation, and communication.

During treatment, quality includes correct-patient and correct-procedure verification, adherence to clinical standards, infection prevention, monitoring, technical execution, and response to unexpected events.

After treatment, quality includes recovery monitoring, discharge instructions, follow-up, complication surveillance, outcome measurement, and revision of the care plan.

The organization should therefore manage quality as a continuous process rather than as a separate department that reviews completed cases.

Defining the Episode of Care

Care coordination becomes more effective when the organization defines the episode being managed.

An episode may begin with:

• Initial consultation
• New diagnosis
• Procedure recommendation
• Surgical decision
• Neuromodulation evaluation
• Hospital discharge
• Referral from another provider

The episode may end when:

• The treatment goal is achieved
• The procedure is completed and the outcome is documented
• The patient transitions to another level of care
• The treatment is declined
• The service is denied and an alternative plan is established
• The patient is referred elsewhere
• The case is formally closed after unsuccessful outreach
• Every episode should have a beginning, an owner, milestones, and an appropriate conclusion.

Care Coordination Roles

The care coordination structure may include:

• Treating physicians
• Advanced practice providers
• Nurses
• Medical assistants
• Patient navigators
• Utilization specialists
• Procedure coordinators
• Surgical coordinators
• Scheduling teams
• Facility personnel
• Rehabilitation teams
• Quality leaders

The organization should define who coordinates each type of episode.

A patient undergoing a routine office procedure may need limited coordination. A patient undergoing spinal cord stimulator implantation, spine surgery, or joint replacement may need a dedicated coordinator who follows the patient across multiple clinical and operational stages.

The Care Plan as the Central Organizing Tool

The patient’s care plan should identify:

• Current diagnosis
• Clinical goals
• Treatment selected
• Required diagnostic or conservative steps
• Authorization status
• Readiness requirements
• Patient responsibilities
• Clinical risks
• Planned procedure or intervention
• Expected follow-up
• Outcome measures
• Escalation requirements
• The care plan should remain current and visible to authorized members of the team.

When clinical notes, authorization trackers, scheduling systems, facility records, and patient instructions reflect different plans, coordination failure becomes likely.

Shared Accountability

Care coordination does not mean that one employee performs every task.

It means that each task has:

• An assigned owner
• A completion expectation
• A due date
• A visible status
• An escalation pathway

Shared accountability requires that departments remain responsible for the patient’s progression rather than only for completion of their individual transaction.

For example, authorization staff may complete the approval process, but the case remains unresolved when the facility, medication plan, or patient readiness is incomplete.

Coordination Across Organizational Boundaries

Many aspects of MSK care occur outside the organization.

Coordination may be required with:

• Primary care physicians
• Cardiologists
• Pulmonologists
• Behavioral health professionals
• Physical therapists
• Imaging centers
• Hospitals
• Ambulatory surgery centers
• Rehabilitation facilities
• Home health agencies
• Pharmacies
• Implant or device vendors
• Payers
• External providers may use different systems, timelines, and communication methods.

The organization should establish processes for requesting, receiving, reviewing, documenting, and acting upon outside information.

Patient Navigation

Patients should understand where they are in the care pathway.

Navigation should help patients understand:

• What has been recommended
• Why it has been recommended
• What must happen next
• What records or testing are required
• Whether authorization is pending
• Whether the procedure date is tentative or confirmed
• What preparation is required
• What recovery may involve
• When follow-up will occur
• Whom to contact
• Patients should not be expected to coordinate complex clinical and payer processes without support.

High-Risk Patient Coordination

Selected patients may require enhanced coordination because of:

• Medical complexity
• Multiple comorbidities
• Anticoagulation
• Previous surgical complications
• Implant history
• Cognitive limitations
• Language barriers
• Transportation limitations
• Limited caregiver support
• Repeated missed appointments
• High emergency department utilization
• Behavioral health concerns
• Risk stratification should determine the appropriate level of navigation and follow-up.

Quality Standards

The organization should define quality standards for major episodes and procedures.

These may include:

• Required clinical documentation
• Maximum time between pathway stages
• Authorization follow-up standards
• Readiness completion requirements
• Patient communication intervals
• Follow-up timing
• Outcome-measure completion
• Complication escalation
• Care-transition communication
• Case-closure requirements
• Standards should be clinically meaningful and operationally achievable.

Coordination Technology

Technology may support care coordination through:

• Shared work queues
• Care pathway statuses
• Automated task assignment
• Deadline alerts
• Patient messaging
• Readiness checklists
• Referral tracking
• Outcome collection
• Transition summaries
• Escalation alerts
• Technology should support one coordinated plan rather than create additional disconnected systems.

Quality Metrics

Relevant measures may include:

• Time from treatment decision to treatment
• Percentage of cases with an identified coordinator
• Completion of required pathway milestones
• Patient communication timeliness
• Missed handoffs
• Procedure cancellation rate
• Follow-up completion
• Outcome-measure completion
• Unplanned emergency utilization
• Readmission
• Complication escalation time
• Patient complaints involving coordination
• Case-closure completeness

Metrics should show where the care pathway is failing, not merely whether individual tasks were completed.

GoHealthcare Insights

Many organizations believe they have care coordination because staff members communicate frequently.

Communication volume is not the same as coordination.

Coordination exists when the organization maintains one current plan, one visible case status, clear ownership, reliable handoffs, and documented completion of the next action.

The patient should not become the primary messenger among departments and external providers.

Leadership Perspective

Quality and care coordination should be treated as core operating capabilities.

Leaders should evaluate whether the organization can follow a patient’s episode from decision through outcome without relying on individual memory, informal relationships, or last-minute intervention.

The strongest system makes unresolved care visible and difficult to ignore.

Key Takeaways

• Quality and care coordination integrate all six domains of the framework.
• Quality should be built into each stage of the patient journey rather than reviewed only after treatment.
• Every episode requires an owner, milestones, visible status, and appropriate closure.
• The care plan should be the authoritative source for clinical and operational coordination.
• Patients require clear navigation through clinical, payer, facility, and recovery processes.
• Technology should support shared accountability rather than create additional fragmentation.

Back to top ↑

32

Patient Safety and Clinical Risk Management

Patient safety is the prevention of avoidable harm associated with healthcare delivery.

Clinical risk management is the structured identification, assessment, mitigation, escalation, and monitoring of conditions that may harm patients, providers, employees, or the organization.

Within MSK specialty care, risks may arise during diagnosis, medication management, authorization, procedure selection, preoperative preparation, interventional treatment, surgery, anesthesia, implantation, discharge, rehabilitation, or follow-up.

The GoHealthcare Clinical & Utilization Excellence Framework™ integrates patient safety into clinical operations rather than treating it as a separate compliance function.

Safety Begins Before the Procedure

Many safety events originate before the patient enters the procedure room.

Examples include:

• Incorrect patient identification
• Incomplete medication reconciliation
• Unrecognized anticoagulation
• Active infection
• Missing allergy information
• Incorrect procedure order
• Wrong laterality or level
• Unreviewed abnormal testing
• Incomplete medical clearance
• Failure to identify pregnancy risk
• Unavailable implant or equipment
• Conflicting patient instructions

These risks should be identified through prospective clinical review and procedure-readiness controls.

Safety Risk Categories

Organizations should assess risks involving:

• Patient identification
• Diagnosis
• Clinical decision-making
• Medication
• Allergy
• Infection
• Bleeding
• Anesthesia
• Procedure site
• Laterality
• Spinal level
• Equipment
• Implants
• Radiation
• Falls
• Transportation
• Discharge
• Communication
• Technology
• Data integrity
• The risk profile varies by procedure, patient, facility, and care setting.

Patient Identification

Reliable patient identification should occur at every critical point.

Identifiers should be verified during:

• Registration
• Clinical encounter
• Order entry
• Authorization
• Scheduling
• Facility check-in
• Medication administration
• Procedure verification
• Specimen handling
• Discharge

The organization should prevent duplicate records, wrong-patient documentation, and incorrect record merging.

Correct Procedure, Site, and Laterality

The clinical note, procedure order, authorization, schedule, consent, facility record, and procedure documentation should agree.

Verification should include:

• Procedure
• Anatomical region
• Laterality
• Spinal level
• Number of levels
• Implant or device
• Proceduralist
• Facility
• Discrepancies should trigger a stop and formal resolution.
• The operating culture must support any team member who raises a safety concern.

Medication Safety

Medication safety includes:

• Accurate reconciliation
• Allergy verification
• Anticoagulation management
• Diabetes medication planning
• Fasting instructions
• Sedation and opioid risk
• Antibiotic selection
• Postoperative prescribing
• Restart instructions
• Coordination among multiple prescribers

Conflicting medication instructions should be treated as a safety event, even when no patient harm occurs.

Infection Prevention

Infection controls should reflect the procedure and care setting.

Relevant controls may include:

• Active infection screening
• Hand hygiene
• Skin preparation
• Sterile technique
• Environmental cleaning
• Instrument sterilization
• Antibiotic prophylaxis
• Implant handling
• Glucose management
• Wound instructions
• Post-procedure surveillance

Implant and surgical infections require particular attention because they may result in revision, hospitalization, prolonged treatment, and substantial patient harm.

Fall Prevention

Patients with pain, weakness, gait impairment, sedation, neurologic deficits, or recent surgery may have increased fall risk.

Safety planning may include:

• Mobility assessment
• Assistive devices
• Staff assistance
• Transportation requirements
• Post-sedation precautions
• Home safety instructions
• Caregiver support
• Fall risk should be reassessed when the patient’s clinical status changes.

Anesthesia and Sedation Safety

The organization should assess:

• Airway risk
• Sleep apnea
• Cardiopulmonary status
• Fasting
• Medication interaction
• Previous anesthesia complications
• Level of sedation
• Monitoring requirements
• Recovery readiness
• Transportation
• Discharge supervision
• The proceduralist, anesthesia team, and facility should maintain aligned expectations.

Implant and Device Safety

Implant safety may include:

• Patient selection
• Device compatibility
• Correct component selection
• Sterility
• Lot and serial number capture
• Manufacturer instructions
• Imaging compatibility
• Programming
• Patient education
• Recall tracking
• Revision planning
• Cybersecurity for connected devices when relevant

The organization should maintain a process for responding to safety alerts and recalls.

Radiation Safety

Procedures using fluoroscopy or other radiation should follow appropriate safety practices involving:

• Patient exposure
• Staff exposure
• Protective equipment
• Dose awareness
• Pregnancy considerations
• Equipment maintenance
• Training
• Documentation
• Radiation use should be clinically justified and minimized while maintaining procedural effectiveness.

Emergency Preparedness

Office procedure suites, ASCs, and hospitals should maintain emergency capabilities appropriate to the services provided.

Preparedness may include:

• Emergency equipment
• Medication availability
• Resuscitation capability
• Staff training
• Transfer protocols
• Communication procedures
• Emergency drills
• Documentation requirements
• The facility’s emergency capability should match the patient’s risk and the procedure’s complexity.

Safety Event Identification

The organization should encourage reporting of:

• Adverse events
• Near misses
• Medication discrepancies
• Wrong-site concerns
• Equipment failures
• Implant problems
• Patient falls
• Unplanned transfers
• Emergency department visits
• Unexpected hospitalization
• Communication failures
• Technology errors
• A near miss should receive attention because it reveals a vulnerability before harm occurs.

Immediate Event Response

When an event occurs, the first priorities are:

• Protecting the patient
• Providing necessary clinical care
• Escalating to appropriate clinical leadership
• Preserving accurate information
• Communicating with the patient and family as appropriate
• Documenting the clinical event
• Reporting through required channels

The organization should avoid allowing concerns about liability or blame to delay appropriate patient care.

Root-Cause Analysis

Serious or recurring events should undergo structured analysis.

The review should examine:

• What happened
• When it happened
• Who was involved
• What information was available
• Which controls failed
• Whether policies were followed
• Whether the policy was adequate
• How technology contributed
• How workload or staffing contributed
• Why the event was not detected earlier

The objective is to identify system vulnerabilities, not merely the last individual involved.

Corrective and Preventive Action

Corrective action may include:

• Immediate patient-specific intervention
• Process redesign
• Policy revision
• Training
• Technology modification
• Equipment replacement
• Staffing changes
• Credentialing review
• Vendor intervention
• Additional monitoring
• Preventive action should reduce the likelihood of recurrence.
• Every action should have an owner, deadline, and effectiveness measure.

Just Culture

A credible safety program distinguishes among:

• Human error
• At-risk behavior
• Reckless behavior
• Intentional misconduct
• Human error generally requires system improvement, support, and education.
• At-risk behavior may require coaching and removal of incentives that encourage unsafe shortcuts.
• Reckless or intentional behavior may require disciplinary action.

Treating every error as misconduct discourages reporting. Treating every violation as a system issue undermines accountability.

Safety Metrics

Relevant measures may include:

• Adverse-event rate
• Near-miss reporting
• Wrong-site discrepancies identified before treatment
• Medication-related events
• Falls
• Infections
• Unplanned transfers
• Emergency department visits after procedures
• Readmissions
• Device-related events
• Corrective-action completion
• Recurrence of similar events

An increase in near-miss reporting may initially indicate improved safety culture rather than declining performance.

GoHealthcare Insights

A low number of reported safety events does not automatically indicate a safe organization.

It may indicate that events are not recognized, staff do not know how to report them, or employees fear consequences.

The more mature measure is whether risks are identified early, reported honestly, analyzed credibly, and corrected systematically.

Leadership Perspective

Leaders create the conditions for safety.

Staff should know that stopping an unsafe process is expected, reporting a near miss is valued, and corrective action will address the system as well as individual accountability.

Patient safety must remain more important than maintaining the schedule, avoiding inconvenience, or protecting short-term revenue.

Key Takeaways

• Patient safety begins before treatment and extends through recovery and follow-up.
• Medication, infection, identification, procedure verification, anesthesia, equipment, implants, and communication require formal safety controls.
• Near misses provide valuable information and should be reviewed.
• Immediate event response must prioritize the patient.
• Root-cause analysis should evaluate system design rather than focus only on individual blame.
• Corrective action must have ownership, deadlines, and measurable effectiveness.

Back to top ↑

33

Multidisciplinary Care Coordination and Closed-Loop Communication

Complex MSK patients often require care from several professionals and organizations.

A patient may simultaneously receive care from a pain physician, orthopedic surgeon, neurosurgeon, primary care physician, therapist, behavioral health professional, cardiologist, imaging center, ASC, hospital, rehabilitation facility, and device team.

Without disciplined coordination, these professionals may work from incomplete, outdated, or conflicting information.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes multidisciplinary coordination and closed-loop communication as essential components of clinical excellence.

Multidisciplinary Care

Multidisciplinary care brings different professional perspectives together around the patient’s needs.

Relevant participants may include:

• Physicians from multiple specialties
• Advanced practice providers
• Nurses
• Physical and occupational therapists
• Behavioral health professionals
• Pharmacists
• Anesthesia clinicians
• Case managers
• Patient navigators
• Utilization reviewers
• Coding and documentation professionals
• Facility staff
• Multidisciplinary care does not require every participant to attend every meeting.

It requires that clinically material information is shared, roles are clear, and the treatment plan remains coordinated.

When Multidisciplinary Review Is Most Valuable

Formal multidisciplinary review may be appropriate for:

• Complex spine cases
• Revision surgery
• Neuromodulation
• Implant complications
• Persistent pain after surgery
• Multiple treatment failures
• High-risk medical comorbidities
• Conflicting diagnoses
• Significant psychosocial barriers
• Repeated utilization without improvement
• Complex anticoagulation or medication issues
• Cases involving multiple care settings

Routine cases should move efficiently through established pathways. Complex or unresolved cases should receive focused multidisciplinary attention.

Defining the Clinical Lead

Every complex episode should have a clearly identified clinical lead.

The clinical lead is responsible for the overall treatment direction.

Other clinicians may provide consultation or perform components of care, but the patient should not receive contradictory treatment plans without resolution.

The lead role may change as the patient moves through the pathway.

For example, the pain physician may lead conservative and interventional management, while the surgeon assumes leadership after a surgical decision.

The transition should be explicit.

Communication Standards

Clinical communication should identify:

• The patient
• The clinical issue
• Relevant background
• Current assessment
• Recommended action
• Urgency
• Responsible recipient
• Expected response

Unstructured messages such as “please advise” or “patient needs clearance” may create delay because the recipient cannot identify the specific question.

Closed-Loop Communication

Closed-loop communication requires confirmation that:

• The message was received
• The intended recipient understood it
• The required action was accepted or clarified
• The action was completed
• The result was communicated back
• The case status was updated
• Sending a fax, portal message, email, or task does not complete the communication cycle.

High-Risk Communications

Closed-loop confirmation is particularly important for:

• Abnormal test results
• Critical imaging findings
• Medication interruption
• Anticoagulation decisions
• Medical clearance
• Infection concerns
• Authorization deadlines
• Procedure cancellations
• Implant changes
• Postoperative complications
• Neurologic deterioration
• Emergency referral
• The urgency and required response time should be explicit.

Referral Coordination

A referral should communicate:

• Reason for referral
• Clinical question
• Diagnosis
• Relevant history
• Prior treatment
• Imaging
• Urgency
• Requested service
• Referring clinician

The organization should track whether:

• The referral was received
• The patient was scheduled
• The consultation occurred
• The report was returned
• The recommendation was integrated into the care plan
• A referral is not complete when the order is sent.

External Record Management

Outside records may include:

• Imaging reports
• Imaging files
• Therapy documentation
• Operative reports
• Procedure reports
• Discharge summaries
• Consultations
• Medication records

The organization should ensure that relevant records are:

• Requested
• Received
• Associated with the correct patient
• Reviewed by an appropriate clinician
• Available for authorization and treatment planning
• Incorporated into the current care plan
• Uploading a document without clinical review does not complete the process.

Coordination With Primary Care

Primary care clinicians may support:

• Medical risk assessment
• Chronic disease management
• Medication reconciliation
• Preoperative evaluation
• Post-discharge follow-up

Coordination should identify the specific clinical question and avoid transferring procedural responsibility without clarity.

Coordination With Behavioral Health

Behavioral health involvement may support patients with:

• Chronic pain
• Implant evaluation
• Anxiety
• Depression
• Trauma history
• Substance use risk
• Treatment adherence concerns

Behavioral health assessment should not be treated solely as a payer requirement. Its purpose should be connected to patient selection, preparation, coping, expectations, and long-term outcomes.

Coordination With Therapy and Rehabilitation

Therapists may provide information regarding:

• Baseline function
• Movement limitations
• Treatment participation
• Progress
• Barriers
• Home exercise
• Postoperative recovery
• Readiness to transition
• The clinical plan should explain how therapy contributes to the broader treatment pathway.

Coordination With Facilities

Physician offices and facilities should maintain consistent information regarding:

• Procedure
• Site
• Laterality
• Level
• Authorization
• Medical clearance
• Medication plan
• Anesthesia
• Implant
• Patient instructions
• Discharge plan
• Conflicting instructions should be reconciled before the patient arrives.

Coordination With Payers and Utilization Vendors

Payer communication should be documented and connected to the care plan.

The organization should record:

• Submission
• Requests for information
• Determinations
• Peer-to-peer outcomes
• Appeal status
• Conditions of approval
• Site-of-care requirements
• The clinical team should receive material information that affects the treatment plan.

Team Conferences

Structured conferences may be useful for complex cases.

A case conference should identify:

• Clinical question
• Relevant facts
• Participants
• Recommendations
• Disagreement
• Final decision
• Assigned actions
• Follow-up date
• The conference should produce a documented care plan rather than only discussion.

Managing Disagreement

Multidisciplinary teams may disagree regarding diagnosis, timing, procedure, site of care, risk, or treatment sequence.

Disagreement should be resolved through:

• Clinical evidence
• Patient-specific facts
• Clarification of roles
• Clinical leadership
• Second opinion
• Formal governance review
• The patient should receive a coherent explanation after the team reaches a decision.

Patient and Family Participation

Patients and authorized family members may contribute important information regarding:

• Goals
• Function
• Preferences
• Home support
• Medication use
• Barriers
• Understanding
• Patient participation should be encouraged while preserving confidentiality and clinical responsibility.

Communication Technology

Technology may support:

• Secure messaging
• Shared care plans
• Referral tracking
• Task assignment
• Alerts
• Document exchange
• Patient portals
• Virtual case conferences
• Technology should not fragment communication across multiple unmonitored channels.

The organization should define which system contains the authoritative communication and case status.

Communication Metrics

Relevant measures may include:

• Referral completion rate
• Consultation report return time
• Unreviewed external records
• Unacknowledged critical messages
• Medical-clearance response time
• Closed-loop completion rate
• Patient complaints involving conflicting instructions
• Cases delayed because of external communication
• Repeated fax or portal requests
• Metrics should identify both internal and external coordination barriers.

GoHealthcare Insights

Most communication failures are not caused by a lack of messages.

They are caused by unclear ownership, vague requests, multiple communication channels, and failure to confirm completion.

A well-designed system reduces the number of messages by making the required action, owner, deadline, and status visible.

Leadership Perspective

Leaders should establish communication standards that match clinical risk.

Not every message requires urgent confirmation. Critical findings, medication decisions, readiness barriers, and patient-safety concerns do.

The organization should direct human attention toward the communications that can materially affect care.

Key Takeaways

• Multidisciplinary coordination is essential for complex MSK episodes.
• Every episode should have a clearly identified clinical lead.
• Communication should state the clinical issue, required action, urgency, and responsible recipient.
• Referrals and record requests are not complete until information is received, reviewed, and incorporated.
• Closed-loop communication is required for high-risk clinical and operational information.
• Technology should create one authoritative communication pathway rather than multiple disconnected channels.

Back to top ↑

34

Care Transitions, Discharge Planning, and Follow-Up Reliability

A care transition occurs when responsibility for the patient moves between clinicians, departments, facilities, levels of care, or phases of treatment.

Transitions are high-risk points because information, accountability, medication plans, pending results, follow-up requirements, and patient expectations may be lost.

Within MSK specialty care, common transitions include:

• Office to procedure suite
• Office to ASC
• Office to hospital
• Hospital to rehabilitation
• Hospital to home
• Surgery to postoperative care
• Procedure to referring physician
• Neuromodulation trial to permanent implantation
• Acute treatment to long-term management

The GoHealthcare Clinical & Utilization Excellence Framework™ requires transitions to be planned, documented, communicated, and confirmed.

Transition Planning Begins Early

Transition planning should begin when the care pathway is established.

For surgery or complex intervention, the organization should identify in advance:

• Expected recovery
• Probable discharge destination
• Transportation
• Caregiver support
• Mobility needs
• Equipment
• Medication access
• Wound care
• Therapy
• Follow-up
• Potential barriers

Waiting until the procedure is completed to address these needs may delay discharge or create an unsafe transition.

Transition Summary

A transition summary should communicate:

• Diagnosis
• Procedure or treatment performed
• Relevant findings
• Complications
• Medication plan
• Activity restrictions
• Wound or device instructions
• Pending tests
• Warning signs
• Follow-up appointments
• Responsible clinicians
• Contact information
• The summary should be available to the patient and the receiving care team.

Medication Reconciliation During Transitions

Medication discrepancies commonly occur during transitions.

The process should clarify:

• Medications continued
• Medications stopped
• Temporary medications
• Dose changes
• Anticoagulation restart
• Pain medication responsibility
• Antibiotics
• Diabetes management
• Duplicate prescriptions
• The patient should understand which list is current.

Discharge Readiness

Discharge readiness should consider:

• Clinical stability
• Pain control
• Neurologic status
• Mobility
• Oral intake when applicable
• Urination when relevant
• Wound status
• Medication understanding
• Transportation
• Home support
• Equipment
• Follow-up
• A completed discharge form does not establish readiness when these elements remain unresolved.

Post-Procedure Instructions

Instructions should be specific to the procedure.

They may include:

• Expected symptoms
• Activity limitations
• Driving restrictions
• Bathing
• Wound care
• Device care
• Medication use
• Diet
• Fever or infection signs
• Bleeding
• Neurologic warning signs
• Emergency contact
• Follow-up timing
• Instructions should distinguish normal recovery from symptoms requiring urgent evaluation.

Teach-Back

The patient or caregiver should demonstrate understanding of critical instructions.

Teach-back may confirm:

• Medication plan
• Warning signs
• Activity restrictions
• Transportation
• Wound care
• Device management
• Follow-up

This is particularly important when the patient has received sedation, has limited health literacy, or must manage a device or complex recovery plan.

Postoperative and Post-Procedure Follow-Up

The organization should define follow-up intervals by procedure.

Follow-up may evaluate:

• Pain
• Function
• Neurologic status
• Wound
• Infection
• Medication
• Adverse effects
• Device use
• Trial response
• Patient goals
• Readiness for rehabilitation
• Next treatment decision
• High-risk patients may require earlier contact.

Follow-Up Scheduling Before Discharge

Whenever practical, the follow-up appointment should be scheduled before the patient leaves the facility or procedure pathway.

The patient should know:

• Date
• Time
• Location
• Type of visit
• Records or imaging required
• Whom to contact for changes

Unscheduled follow-up creates a risk that the patient will not return or that important outcomes will not be captured.

Early Post-Procedure Outreach

Selected procedures may benefit from early outreach by phone, portal, or nursing review.

The outreach may assess:

• Pain control
• Medication access
• Bleeding
• Infection
• Neurologic symptoms
• Wound concerns
• Device issues
• Patient understanding
• Early outreach should not replace required clinical follow-up.

Transition to Rehabilitation

When rehabilitation is part of the plan, the transition should specify:

• Start date
• Restrictions
• Goals
• Precautions
• Weight-bearing status
• Range-of-motion limitations
• Device considerations
• Communication expectations
• Therapists should receive enough information to provide safe, coordinated care.

Transition to Primary or Referring Care

The referring or primary clinician may need information regarding:

• Treatment performed
• Outcome
• Medication changes
• Ongoing monitoring
• Rehabilitation
• Complications
• Further specialist involvement

Communication should reflect the clinical importance of the transition rather than automatically sending every available record.

Pending Results

The transition process should identify any pending:

• Laboratory result
• Pathology
• Imaging interpretation
• Culture
• Consultation
• Payer determination
• A specific clinician should own review and patient communication.
• Pending results should never become ownerless because the patient has left the care setting.

Missed Follow-Up

The organization should establish a process for patients who do not attend follow-up.

The process may include:

• Outreach
• Risk assessment
• Rescheduling
• Clinical escalation
• Notification of referring provider
• Certified communication for selected high-risk situations
• Formal case closure
• The intensity of outreach should reflect the clinical risk.

Emergency and After-Hours Escalation

Patients should know:

• What symptoms require emergency care
• Which number to call
• When the office is available
• How after-hours concerns are handled
• Which facility to use when instructed
• Instructions should not direct patients with emergency symptoms to wait for a routine office response.

Readmission and Unplanned Utilization

The organization should monitor:

• Emergency department visits
• Hospital admissions
• Readmissions
• Urgent postoperative calls
• Unplanned imaging
• Unplanned procedures

These events may reveal problems involving patient selection, discharge readiness, medication, communication, complications, or access to follow-up.

Transition Metrics

Relevant measures may include:

• Follow-up scheduled before discharge
• Follow-up completion rate
• Post-procedure outreach completion
• Medication-reconciliation completion
• Emergency department visits
• Readmissions
• Unplanned transfers
• Patient complaints regarding instructions
• Missed pending results
• Transition-summary completion
• Time to communicate with the referring provider
• Metrics should identify which transitions are most vulnerable.

GoHealthcare Insights

The procedure may be clinically successful while the episode fails because follow-up was not coordinated.

A patient who receives unclear medication instructions, cannot access rehabilitation, misses device follow-up, or does not understand warning signs remains at risk.

The treatment episode is not complete when the patient leaves the procedure room. It is complete when the organization confirms a safe transition and evaluates the result.

Leadership Perspective

Leaders should treat follow-up reliability as a core quality measure.

Clinical outcomes cannot be understood when patients disappear after treatment.

The organization must create workflows that make follow-up expected, scheduled, visible, and escalated when missed.

Key Takeaways

• Care transitions are high-risk points requiring planned transfer of information and accountability.
• Discharge planning should begin before the procedure.
• Medication reconciliation, warning signs, activity restrictions, and follow-up must be clearly communicated.
• Pending results require an assigned owner after the patient leaves the facility.
• Follow-up should be scheduled and tracked rather than left entirely to patient initiative.
• Unplanned emergency utilization and readmissions should inform quality improvement.

Back to top ↑

35

Outcomes Measurement and Patient-Reported Outcome Integration

Clinical and utilization excellence cannot be evaluated solely through authorization approvals, procedure volume, claim payment, or patient satisfaction.

The organization must determine whether treatment produced meaningful clinical benefit.

Outcomes measurement connects patient selection, medical necessity, treatment performance, utilization, quality, and future decision-making.

Within MSK specialty care, the result of treatment may include changes in pain, function, mobility, medication use, work capacity, sleep, quality of life, complications, and achievement of patient-defined goals.

The GoHealthcare Clinical & Utilization Excellence Framework™ requires outcomes to be integrated into routine clinical operations.

The Purpose of Outcomes Measurement

Outcomes measurement should help determine:

• Whether the patient improved
• How much improvement occurred
• How long the benefit lasted
• Whether function changed
• Whether medication use changed
• Whether complications occurred
• Whether treatment goals were achieved
• Whether repeat treatment is justified
• Whether the clinical pathway is effective
• Whether provider or facility variation exists
• Whether a new procedure or technology is producing value
• Outcomes should inform the next clinical decision rather than exist only for reporting.

Outcomes Versus Process Measures

Process measures indicate whether an activity occurred.

Examples include:

• Authorization submitted
• Checklist completed
• Follow-up scheduled
• Outcome form collected
• Outcome measures indicate what happened to the patient.

Examples include:

• Pain improved
• Walking tolerance increased
• Medication use decreased
• The patient returned to work
• A complication occurred
• Both types of measures are necessary.

A process may be completed correctly while the treatment produces limited benefit. A clinically effective treatment may be undermined by poor access or follow-up processes.

Patient-Reported Outcomes

Patient-reported outcomes capture the patient’s perception of symptoms, function, health status, and quality of life.

Relevant domains may include:

• Pain intensity
• Pain interference
• Physical function
• Mobility
• Sleep
• Daily activity
• Mental well-being
• Treatment satisfaction
• Ability to work

Patient-reported outcomes should supplement rather than replace clinical examination and professional judgment.

Functional Outcomes

Functional improvement is often more meaningful than pain reduction alone.

Relevant measures may include:

• Walking distance
• Standing tolerance
• Sitting tolerance
• Ability to lift
• Ability to sleep
• Ability to work
• Ability to perform personal care
• Ability to exercise
• Ability to participate in family activities
• Functional goals should be established before treatment and reassessed afterward.

Procedure-Specific Outcomes

Outcome measures should reflect the purpose of the intervention.

For diagnostic blocks, outcomes may include:

• Immediate pain relief
• Percentage of relief
• Functional activity during the assessment period
• Duration of response

For radiofrequency ablation, outcomes may include:

• Pain reduction
• Functional improvement
• Medication change
• Duration of benefit

For neuromodulation trials, outcomes may include:

• Pain relief
• Function
• Sleep
• Medication use
• Patient ability to operate the device
• Achievement of predefined trial goals

For orthopedic or spine surgery, outcomes may include:

• Pain
• Function
• Mobility
• Neurologic status
• Complications
• Return to work
• Reoperation
• Readmission

The organization should not use one generic outcome measure for every procedure.

Baseline Measurement

Outcome measurement requires a baseline.

The baseline should be collected:

• Before treatment
• Using the same or comparable instrument
• At a clinically relevant point
• Before the patient’s recollection is influenced by the result

Without a reliable baseline, improvement may be difficult to assess accurately.

Follow-Up Intervals

Outcome timing should reflect the procedure and expected recovery.

Possible intervals may include:

• Immediate post-procedure
• Several days
• Several weeks
• Several months
• One year or longer for selected implants and surgeries

The organization should define which intervals are required for clinical decision-making and which are used for longer-term quality evaluation.

Treatment Success Criteria

Success should be defined before treatment when possible.

Criteria may include:

• Clinically meaningful pain reduction
• Functional improvement
• Reduced medication use
• Improved sleep
• Return to work
• Avoidance of surgery
• Ability to participate in rehabilitation
• Achievement of patient-defined goals
• Success should not be reduced to one universal percentage.

The appropriate threshold depends on the intervention, clinical purpose, patient condition, and applicable coverage requirements.

Outcomes and Repeat Procedures

Repeat treatment should be informed by the documented result of the previous intervention.

The clinical record should address:

• Magnitude of benefit
• Duration
• Functional change
• Medication change
• Adverse effects
• Reason for repetition
• Alternative options
• Outcome data strengthens medical necessity and helps prevent ineffective repetitive care.

Complications and Negative Outcomes

Outcomes measurement must include negative results.

These may include:

• No improvement
• Temporary worsening
• Infection
• Bleeding
• Neurologic change
• Device malfunction
• Revision
• Emergency department visit
• Hospitalization
• Readmission
• Patient dissatisfaction
• Failure to collect negative outcomes creates a misleading performance picture.

Patient Experience Versus Clinical Outcome

Patient experience reflects how care was delivered.

Clinical outcome reflects what happened to the patient’s health or function.

A patient may report an excellent experience despite limited clinical improvement. Another patient may improve clinically but report poor communication or access.

Both dimensions should be measured separately.

Outcome Collection Workflow

Outcome data may be collected through:

• Clinical interviews
• Patient portals
• Digital questionnaires
• Telephone follow-up
• Text-based tools
• Paper forms
• Remote monitoring

The workflow should identify:

• Who sends the assessment
• When it is sent
• Who reviews the result
• How abnormal findings are escalated
• How the result enters the clinical record
• What happens when the patient does not respond
• Collection without clinical review creates data rather than actionable information.

Standardized Instruments

Validated instruments may support reliable comparison when appropriate.

The organization should select tools based on:

• Clinical relevance
• Patient burden
• Ease of administration
• Licensing requirements
• Interpretability
• Integration capability
• Applicability to the procedure
• Using too many instruments may reduce patient participation and provider adoption.

Risk Adjustment

Outcome comparison should consider differences in:

• Diagnosis
• Severity
• Age
• Comorbidities
• Previous surgery
• Baseline function
• Social barriers
• Procedure complexity
• Patient population

Raw outcome comparison may create misleading conclusions when providers treat substantially different populations.

Outcome Dashboards

Leadership dashboards may display:

• Baseline and follow-up completion
• Pain improvement
• Functional improvement
• Medication change
• Treatment durability
• Complications
• Readmissions
• Revision
• Patient experience
• Provider variation
• Procedure variation
• Facility variation
• Outcome data should be interpreted with sufficient case volume and clinical context.

Real-World Evidence

Aggregated organizational outcomes may provide valuable real-world evidence.

The organization may use this information to:

• Improve pathways
• Refine patient selection
• Evaluate emerging technology
• Support payer discussions
• Identify training needs
• Improve patient education
• Guide strategic service development

Internal outcomes should not be represented as formal clinical research unless appropriate research methods, governance, and regulatory requirements have been satisfied.

Data Integrity

Outcome data must be:

• Associated with the correct patient
• Linked to the correct procedure
• Collected at the correct interval
• Complete enough for interpretation
• Protected for privacy and security
• Available to the treating clinician
• Outcome definitions should remain consistent over time.

Patient Nonresponse

Nonresponse may create bias because patients with poor results may be less likely to complete surveys, or highly dissatisfied patients may be more likely to respond.

The organization should track:

• Response rate
• Follow-up attempts
• Patient characteristics
• Procedure type
• Timing
• Results should be interpreted in light of missing data.

Outcomes and Clinical Governance

The Clinical and Utilization Excellence Committee should review outcome trends.

Governance should examine:

• Procedures with consistently poor outcomes
• Provider variation
• Facility variation
• Unexpected complications
• Outcome deterioration over time
• New technology performance
• Repeat treatment without benefit
• Low follow-up completion
• Findings should inform pathways, credentialing, education, patient selection, and service strategy.

GoHealthcare Insights

Many organizations collect outcome forms but do not use the information.

The measure becomes another document in the record rather than part of clinical decision-making.

The GoHealthcare model requires the result to return to the physician and influence whether the treatment should be repeated, modified, escalated, or discontinued.

Leadership Perspective

Leaders should be cautious about building a large outcomes program before establishing reliable follow-up.

A small set of meaningful, consistently collected measures is more valuable than a large registry with incomplete data.

The organization should begin with high-volume, high-risk, high-cost, and strategically important procedures.

Key Takeaways

• Outcomes measurement determines whether treatment produced meaningful patient benefit.
• Pain, function, medication use, complications, durability, and patient goals should be considered.
• Every procedure requires an appropriate baseline and follow-up interval.
• Outcome measures should reflect the purpose of the intervention.
• Negative outcomes and complications must be captured.
• Outcome data should influence repeat treatment, clinical pathways, patient selection, provider education, and governance decisions.

Back to top ↑

36

Adverse Events, Complications, Near Misses, and Organizational Learning

Clinical excellence requires an organization to recognize when care does not proceed as expected, respond appropriately, learn from the event, and reduce the likelihood of recurrence.

Adverse events, complications, near misses, and operational failures are not interchangeable. Each requires an appropriate response.

A complication may be a recognized risk of a procedure even when the care was properly delivered. An adverse event involves harm associated with care. A near miss is a failure that could have caused harm but was identified before the patient was affected. An operational failure may delay or disrupt treatment without causing immediate clinical injury.

The GoHealthcare Clinical & Utilization Excellence Framework™ requires all four categories to be identified, documented, escalated, analyzed, and incorporated into organizational improvement.

Differentiating Event Types

The organization should establish consistent definitions.

A complication may include:

• Post-procedure infection
• Bleeding
• Neurologic change
• Wound disruption
• Medication reaction
• Implant migration
• Device malfunction
• Unexpected pain escalation
• Unplanned reoperation
• An adverse event may involve preventable or nonpreventable patient harm associated with clinical care.

A near miss may include:

• Incorrect laterality detected before treatment
• Unrecognized anticoagulant use identified during final verification
• Incorrect implant discovered before opening
• Authorization issued for the wrong facility and corrected before surgery
• Abnormal testing identified before anesthesia
• A medication allergy detected before administration

An operational failure may include:

• Missed authorization deadline
• Delayed referral
• Lost outside records
• Incorrect procedure scheduling
• Incomplete patient instructions
• Failure to arrange transportation
• Every category provides information about the reliability of the care system.

Immediate Clinical Response

When an event occurs, the first responsibility is to protect the patient.

The immediate response should address:

• Clinical assessment
• Patient stabilization
• Emergency intervention when required
• Notification of the treating physician
• Notification of facility leadership
• Transfer to a higher level of care when necessary
• Accurate documentation
• Communication with the patient and authorized family members
• Preservation of relevant equipment, medications, records, or devices
• Internal reporting should not delay necessary clinical care.

Event Reporting

The organization should maintain a clear reporting pathway for:

• Adverse events
• Complications
• Near misses
• Medication discrepancies
• Wrong-site or wrong-level concerns
• Equipment failures
• Device issues
• Patient falls
• Unexpected transfers
• Emergency department visits
• Readmissions
• Procedure cancellations involving safety concerns
• Technology or data failures

Employees should understand what must be reported, where it should be reported, and how quickly reporting should occur.

Nonpunitive Reporting

Staff are more likely to report concerns when they believe the organization will respond fairly.

A punitive reporting culture creates concealment, delayed escalation, and incomplete information.

The organization should distinguish among:

• Unintentional human error
• At-risk behavior
• Reckless behavior
• Intentional misconduct
• Human error often requires process redesign, training, stronger controls, or technology improvement.
• Reckless or intentional conduct may require formal corrective action.
• A credible learning system requires both fairness and accountability.

Event Triage

Not every event requires the same level of review.

Events may be categorized by:

• Severity
• Actual patient harm
• Potential patient harm
• Likelihood of recurrence
• Clinical complexity
• Compliance exposure
• Regulatory reporting requirement
• Reputational risk
• Financial impact
• Lower-risk events may be addressed through local review.

Serious events, recurring events, implant-related failures, unexpected hospitalization, wrong-site concerns, or events involving significant harm should receive formal leadership and governance review.

Complication Review

A complication should be assessed according to:

• Whether it was an expected risk
• Whether appropriate preventive measures were taken
• Whether the complication was recognized promptly
• Whether the response was clinically appropriate
• Whether communication was timely
• Whether the patient received adequate follow-up
• Whether the complication reveals a pathway or patient-selection problem
• The existence of a known risk does not eliminate the need for review.

The organization should determine whether the frequency or severity of complications exceeds expected performance.

Near-Miss Review

Near misses are especially valuable because they reveal weaknesses before harm occurs.

Examples may include:

• A staff member catches an incorrect procedure order
• A nurse identifies that the patient did not stop a medication
• A facility detects an authorization mismatch
• A vendor identifies an incorrect implant component
• A scheduler discovers that medical clearance expired

The organization should not treat these events as evidence that the system worked perfectly.

The near miss often demonstrates that the process depended on individual vigilance rather than reliable controls.

Root-Cause Analysis

Root-cause analysis should examine why the event became possible.

The review may explore:

• Workflow design
• Policy clarity
• Training
• Staffing
• Workload
• Communication
• Handoffs
• Technology
• Data accuracy
• Environmental factors
• Leadership decisions
• Vendor performance
• Patient instructions
• The analysis should move beyond asking who made the final error.
• It should examine why the system did not prevent, detect, or correct the problem earlier.

Contributing Factors

Events rarely have only one cause.

Contributing factors may include:

• Incomplete documentation
• Unclear accountability
• Multiple communication channels
• Poorly designed templates
• Inadequate training
• Outdated payer information
• Insufficient staffing
• Fatigue
• Scheduling pressure
• Equipment failure
• Inconsistent facility rules
• Patient misunderstanding
• Vendor dependency
• Artificial intelligence or automation error

The corrective plan should address the significant contributing factors rather than only the most visible failure.

Corrective and Preventive Action

Corrective action addresses the immediate problem.

Preventive action reduces the likelihood of recurrence.

Actions may include:

• Revising a policy
• Redesigning a workflow
• Changing a checklist
• Adding a technology validation
• Improving staff training
• Clarifying decision rights
• Strengthening medication review
• Improving patient communication
• Changing vendor requirements
• Increasing clinical review
• Revising credentialing standards

Each action should have:

• An accountable owner
• A completion deadline
• A measure of effectiveness
• A follow-up review date
• Corrective action is incomplete until the organization verifies that the change worked.

Patient Communication

Patients should receive honest, clinically appropriate communication when an unexpected event occurs.

Communication should address:

• What is known
• What is being done
• What the patient should expect
• What follow-up is required
• Whom to contact
• What warning signs require urgent attention

Communication should be coordinated among clinical leadership, risk management, and other appropriate organizational representatives.

Regulatory and Contractual Reporting

Some events may require reporting to:

• Government agencies
• State licensing bodies
• Accrediting organizations
• Payers
• Manufacturers
• Device registries
• Professional liability carriers

The organization should maintain policies defining:

• Which events require reporting
• Who makes the determination
• Who submits the report
• Applicable deadlines
• Required documentation
• Regulatory reporting should be managed through authorized leadership and compliance processes.

Device and Implant Events

Implant and device events require specialized review.

The organization may need to assess:

• Device identification
• Manufacturer
• Model
• Serial or lot number
• Implant date
• Procedure
• Patient symptoms
• Programming or function
• Imaging findings
• Manufacturer communication
• Recall status
• Need for revision or removal
• Other affected patients
• Accurate implant tracking is essential for effective response.

Trend Analysis

Events should be reviewed collectively.

Trend analysis may identify:

• Repeated medication discrepancies
• Procedure-specific complications
• Provider variation
• Facility variation
• Recurring device failures
• Common cancellation causes
• Technology errors
• Patient communication failures
• Infection patterns
• Readmission patterns

A single event may appear isolated. Multiple similar events may reveal a systemic risk.

Learning Dissemination

Lessons should be communicated to the roles that can prevent recurrence.

Education may include:

• Case review
• Safety briefing
• Updated checklist
• Procedure-specific training
• Policy revision
• Technology alert
• Provider education
• Vendor communication
• Patient instruction changes
• Information should be shared without unnecessary disclosure of confidential patient or employee details.

Measuring the Learning System

Relevant measures may include:

• Event reporting rate
• Near-miss reporting rate
• Time from event to escalation
• Time from event to review
• Corrective-action completion
• Recurrence of similar events
• Complication rate
• Readmission rate
• Unplanned transfer rate
• Staff participation in safety reporting

A mature learning system is measured by the quality of response and prevention, not merely by a low number of reports.

GoHealthcare Insights

Organizations often celebrate staff members who repeatedly rescue cases at the last minute.

Those individuals are valuable, but repeated rescue is not evidence of operational excellence.

Each rescue should trigger the question: Why did the process require individual heroics?

The strongest organizations convert near misses and last-minute saves into redesigned workflows that prevent recurrence.

Leadership Perspective

Leaders determine whether adverse-event review becomes a compliance exercise or a genuine learning system.

Employees must see that reporting produces meaningful improvement.

Leadership should protect transparency, insist on accountability, and ensure that patient safety remains more important than schedule preservation, departmental reputation, or short-term financial performance.

Key Takeaways

• Complications, adverse events, near misses, and operational failures require different but coordinated responses.
• Immediate patient protection is the first priority.
• Near misses should be reviewed because they reveal system vulnerabilities before harm occurs.
• Root-cause analysis must examine processes, technology, communication, staffing, and governance.
• Corrective action requires accountable ownership, deadlines, and effectiveness monitoring.
• A strong reporting culture balances learning, fairness, and individual accountability.

Back to top ↑

37

Clinical Quality Metrics, Utilization Analytics, and Performance Intelligence

Clinical and utilization excellence must be measurable.

Organizations cannot manage patient access, medical necessity, clinical documentation, procedure readiness, quality, or outcomes through anecdotal information alone.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes performance intelligence as the disciplined conversion of clinical and operational data into decisions, accountability, and improvement.

Performance intelligence is more than a dashboard. It is the ability to understand what is happening, why it is happening, where risk exists, and what leadership must do next.

The Purpose of Performance Intelligence

Performance intelligence should help leaders determine:

• Whether patients are receiving appropriate care
• Where access is delayed
• Why authorizations are denied
• Which documentation deficiencies are recurring
• Where procedures are cancelled
• Whether patients are fully prepared
• How treatments perform
• Where provider variation exists
• Which payers create the greatest friction
• Whether corrective actions are working
• Which processes require redesign

The objective is not to collect every available data point. It is to produce reliable information that supports action.

Balanced Measurement

A balanced framework should include:

• Clinical measures
• Utilization measures
• Patient-access measures
• Documentation measures
• Procedure-readiness measures
• Quality and safety measures
• Patient outcome measures
• Patient-experience measures
• Financial and operational measures
• No single category should dominate the organization’s assessment of performance.

A high authorization approval rate does not establish excellence when treatment is delayed, documentation is inaccurate, procedures are cancelled, or outcomes are poor.

Medical Necessity Measures

Medical necessity performance may include:

• Percentage of cases meeting internal criteria at first review
• Clinical clarification rate
• Procedure-specific deficiency rate
• Repeat procedure response completion
• Medical necessity denial rate
• Exception review volume
• Time to resolve medical necessity questions

These measures show whether the clinical record reliably supports the treatment decision.

Evidence-Based Care Measures

Relevant measures may include:

• Pathway adoption
• Pathway deviation rate
• Exception frequency
• Conservative-care documentation
• Use of defined outcome measures
• Repeat procedure appropriateness
• Provider variation
• New technology review compliance

A high deviation rate may indicate poor adherence, an unrealistic pathway, or a patient population that requires pathway revision.

Utilization Management Measures

Core utilization measures may include:

• Initial approval rate
• Overall approval rate
• Submission turnaround time
• Payer determination time
• Requests for additional information
• Peer-to-peer rate
• Appeal rate
• Appeal overturn rate
• Authorization aging
• Frequency denials
• Site-of-care denials
• Administrative denials
• Clinical denials
• Performance should be stratified by payer, procedure, provider, location, and denial reason.

Documentation Measures

Documentation performance may include:

• Note completion time
• Unsigned note volume
• Documentation completeness
• Clarification requests
• Addendum rate
• Internal inconsistency
• Coding queries
• Payer requests for additional information
• Documentation-related denials
• Outcome documentation completion
• Measurement should focus on clinically material deficiencies rather than minor formatting variation.

Procedure-Readiness Measures

Readiness measures may include:

• Percentage of cases fully ready before final scheduling
• Authorization reconciliation completion
• Medical-clearance completion
• Testing completion
• Medication-plan completion
• Facility acceptance
• Implant confirmation
• Patient instruction acknowledgment
• Transportation confirmation
• Day-of-procedure cancellation rate
• Last-minute intervention rate

A case saved through urgent intervention should still be counted as a readiness failure when the required element was not completed within the expected timeframe.

Quality and Safety Measures

Relevant measures may include:

• Complication rate
• Infection rate
• Medication-related event rate
• Near-miss reporting
• Unplanned transfer rate
• Emergency department utilization
• Readmission
• Falls
• Wrong-site discrepancies identified before treatment
• Device-related events
• Corrective-action completion

Measures should be risk-adjusted and interpreted according to procedure complexity and patient population.

Outcome Measures

Outcome performance may include:

• Pain improvement
• Functional improvement
• Medication reduction
• Duration of benefit
• Return to work
• Return to activity
• Patient-defined goal attainment
• Revision or reoperation
• Device continuation
• Outcome completion rate
• Outcomes should be procedure-specific and collected at clinically appropriate intervals.

Access Measures

Patient access measures may include:

• Time from referral to consultation
• Time from clinical decision to authorization submission
• Time from submission to approval
• Time from approval to readiness
• Time from readiness to treatment
• Time from treatment to follow-up
• Patients lost during the pathway
• Appointments or procedures delayed by payer requirements
• Access measurement should identify where the patient is waiting and who owns the next action.

Patient Experience Measures

Patient experience may include:

• Clarity of communication
• Understanding of the treatment plan
• Understanding of authorization status
• Procedure preparation experience
• Ease of contacting the organization
• Coordination across providers
• Discharge instruction quality
• Follow-up reliability
• Patient experience should be interpreted separately from clinical outcome.

Financial and Capacity Measures

Clinical and operational performance may affect:

• Procedure capacity utilization
• Cancellation-related revenue loss
• Staff rework
• Physician time spent on peer-to-peer review
• Appeal cost
• Implant financial exposure
• Unused facility time
• Claim denials

Metrics should be used to understand operational consequences, not to allow financial performance to override clinical appropriateness.

Metric Definitions

Every measure should have a controlled definition.

The definition should identify:

• What is being measured
• Numerator
• Denominator
• Included cases
• Excluded cases
• Data source
• Reporting frequency
• Accountable owner
• Performance target

Without standard definitions, departments may report different results for the same measure.

Data Validation

Performance intelligence depends on reliable data.

Validation should address:

• Duplicate records
• Missing data
• Incorrect statuses
• Inconsistent timestamps
• Procedure-code mapping
• Provider attribution
• Payer mapping
• Outcome linkage
• Cancelled-case categorization
• Manual data entry
• Data defects should be corrected before leadership relies on the results.

Stratification

Aggregate performance may hide important differences.

Measures should be stratified when useful by:

• Provider
• Procedure
• Specialty
• Payer
• Utilization vendor
• Facility
• Location
• Patient population
• Denial reason
• Clinical risk
• Case complexity
• Stratification supports targeted intervention.

Leading and Lagging Indicators

Lagging indicators show what has already happened.

Examples include:

• Denial rate
• Cancellation rate
• Complication rate
• Readmission
• Leading indicators identify emerging risk.

Examples include:

• Unsigned notes
• Cases approaching payer deadlines
• Incomplete clearance
• Unconfirmed implants
• Unreviewed abnormal results
• Unacknowledged patient instructions

A mature performance system emphasizes leading indicators so the organization can intervene before failure.

Dashboard Design

Dashboards should be designed for the decisions each audience must make.

Executive dashboards should show enterprise performance, strategic risk, and major trends.

Clinical leadership dashboards should show outcomes, variation, complications, and pathway performance.

Utilization dashboards should show aging, payer status, denials, peer-to-peer activity, and appeals.

Procedure-readiness dashboards should show unresolved requirements and cases at risk.

Staff dashboards should show the work requiring immediate action.

One dashboard should not attempt to serve every audience.

Thresholds and Alerts

The organization should establish thresholds for escalation.

Examples may include:

• Authorization pending beyond the expected timeframe
• Documentation incomplete after a defined interval
• Medical clearance overdue
• Appeal deadline approaching
• Procedure scheduled without final readiness
• Outcome follow-up overdue
• Increase in procedure-specific complications
• Repeated provider variation
• Alerts should be meaningful.
• Excessive alerts may create fatigue and reduce attention to truly significant risk.

Performance Review Cadence

A structured review cadence may include:

• Daily operational review of urgent cases
• Weekly review of aging and procedure readiness
• Monthly review of denials, documentation, access, and cancellations
• Quarterly review of outcomes, variation, quality, and strategic improvement
• Annual evaluation of framework maturity and performance priorities

Each review should result in decisions, owners, deadlines, and follow-up.

Benchmarking

Benchmarking may compare:

• Performance over time
• Providers within the organization
• Locations
• Facilities
• Payers
• Procedures
• External benchmarks when valid and comparable
• External comparisons should be used carefully.

Differences in patient population, coding, procedure mix, organizational structure, and data definitions may limit comparability.

Performance Improvement Prioritization

Not every performance gap should receive equal attention.

Priorities may be based on:

• Patient safety
• Clinical impact
• Access impact
• Frequency
• Financial exposure
• Compliance risk
• Strategic importance
• Feasibility of improvement

The organization should focus resources on the gaps that create the greatest total impact.

GoHealthcare Insights

A dashboard does not create accountability.

Performance intelligence becomes valuable only when leaders use the information to ask better questions, identify root causes, assign action, and verify improvement.

The organization should avoid creating large volumes of reporting that do not change decisions.

Leadership Perspective

Leaders should insist on data that is accurate enough to guide action but should not wait for perfect information before addressing obvious risk.

The central leadership question is not merely, “What is our rate?”

It is, “Why is this happening, which patients are affected, who owns the correction, and how will we know that performance improved?”

Key Takeaways

• Performance intelligence converts clinical and operational data into accountable action.
• Measures should balance appropriateness, access, documentation, utilization, readiness, safety, outcomes, experience, and operational performance.
• Every metric requires a controlled definition and validated data source.
• Leading indicators allow intervention before denial, cancellation, or harm occurs.
• Dashboards should be role-specific and connected to decisions.
• Performance review must result in assigned corrective action and verified improvement.

Back to top ↑

38

Technology, Data, Automation, and Artificial Intelligence in Clinical Operations

Technology can strengthen clinical and utilization excellence by improving visibility, standardization, communication, decision support, and performance measurement.

Technology can also amplify poor workflows, create inaccurate documentation, introduce automation bias, fragment information, and obscure accountability.

The GoHealthcare Clinical & Utilization Excellence Framework™ treats technology as an enabling layer across all six domains. Technology supports the clinical operating model. It does not replace governance, clinical judgment, accountability, or human oversight.

Technology as an Enabler

Technology may support:

• Clinical pathways
• Documentation prompts
• Payer-policy access
• Medical necessity review
• Authorization submission
• Case tracking
• Procedure readiness
• Patient communication
• Outcome collection
• Safety alerts
• Referral management
• Performance dashboards

The organization should first define the desired workflow and then select technology that supports it.

Automating an unclear or fragmented process usually creates faster fragmentation.

The Clinical Technology Ecosystem

The organization may use:

• Electronic health records
• Practice management systems
• Authorization platforms
• Payer portals
• Clinical decision-support tools
• Patient portals
• Digital intake tools
• Scheduling systems
• ASC or hospital systems
• Remote monitoring
• Outcome platforms
• Analytics tools
• Artificial intelligence applications

These systems should exchange reliable information whenever practical.

Multiple disconnected systems increase duplicate entry, inconsistent statuses, and communication risk.

Single Source of Truth

The organization should identify the authoritative source for:

• Clinical documentation
• Treatment order
• Authorization status
• Procedure date
• Facility
• Medication plan
• Readiness status
• Outcome

Different systems may support different functions, but the organization must define which source governs each critical data element.

When two systems conflict, staff should know which information controls the decision and how discrepancies are corrected.

Data Standards

Reliable technology requires standardized data.

Important elements may include:

• Patient identity
• Provider
• Payer
• Plan
• Procedure
• Procedure code
• Diagnosis
• Anatomical site
• Laterality
• Spinal level
• Facility
• Authorization status
• Readiness status
• Outcome status
• Consistent naming and structured fields improve reporting, automation, and interoperability.

Workflow Automation

Automation may support:

• Task creation
• Status updates
• Deadline reminders
• Authorization follow-up
• Record requests
• Patient instructions
• Readiness alerts
• Outcome questionnaires
• Escalation
• Automation should be designed around defined rules and clear ownership.

The organization should know what happens when the automated process fails, the data are incomplete, or the patient does not respond.

Clinical Decision Support

Clinical decision support may help clinicians identify:

• Relevant pathway requirements
• Potential contraindications
• Medication risk
• Diagnostic considerations
• Procedure-specific documentation elements
• Payer requirements
• Follow-up needs
• Decision support should provide relevant information at the correct point in workflow.
• Excessive prompts can create alert fatigue and reduce adoption.

Artificial Intelligence Use Cases

Artificial intelligence may support:

• Record summarization
• Clinical documentation drafting
• Payer-policy extraction
• Identification of missing documentation
• Authorization preparation
• Denial categorization
• Appeal drafting
• Outcome analysis
• Case prioritization
• Contradiction detection
• Patient communication drafting

These tools should assist qualified professionals rather than independently determine diagnosis, medical necessity, treatment selection, or payer submission.

Human Oversight

Human review should be required when artificial intelligence influences:

• Clinical documentation
• Patient-specific recommendations
• Medical necessity analysis
• Authorization submission
• Appeal content
• Medication instructions
• Risk assessment
• Patient communication
• Outcome interpretation
• The responsible clinician or staff member must verify accuracy before the information is used.
• Automation should not create the false impression that responsibility has transferred to the technology.

Artificial Intelligence Governance

The organization should establish governance addressing:

• Approved use cases
• Prohibited uses
• Clinical oversight
• Validation
• Accuracy
• Bias
• Privacy
• Security
• Data retention
• Vendor access
• Auditability
• Error reporting
• Change management
• User education

Clinical and operational leaders should understand how the tool produces its output and what limitations may affect performance.

Automation Bias

Automation bias occurs when users accept a system’s recommendation without sufficient independent review.

This may occur when:

• A documentation tool inserts an unsupported diagnosis
• An authorization application identifies the wrong payer criteria
• A decision-support tool overlooks an exception
• A summarization tool omits a critical clinical finding
• An AI model misinterprets laterality or procedure history

Training should reinforce that technology output is a draft, alert, or recommendation requiring verification.

Data Privacy and Security

Technology use should protect:

• Protected health information
• Patient identity
• Clinical records
• Authorization data
• Financial information
• Device data
• Employee credentials

The organization should evaluate:

• Access controls
• Encryption
• Vendor security
• Data storage
• Data sharing
• Audit logs
• Incident response
• User permissions

Security should be designed into the technology lifecycle rather than addressed only after implementation.

Vendor Governance

Technology vendors should be evaluated for:

• Product capability
• Clinical relevance
• Data security
• Privacy practices
• Interoperability
• Reliability
• Support
• Implementation resources
• Financial stability
• Use of organizational data
• Artificial intelligence model practices
• Contractual responsibility

The organization should know whether vendor data may be used to train external models or shared with third parties.

Testing Before Implementation

New technology should be tested before broad deployment.

Testing should evaluate:

• Workflow accuracy
• Clinical safety
• Data mapping
• Integration
• User experience
• Alert logic
• Downtime procedures
• Reporting
• Security
• Unexpected consequences
• High-risk tools should be piloted with controlled users and limited scope.

Technology Change Control

System updates may affect:

• Templates
• Clinical prompts
• Order sets
• Authorization rules
• Patient instructions
• Dashboards
• Coding
• Data interfaces
• Artificial intelligence behavior
• Material changes should be reviewed, tested, communicated, and monitored.

The organization should not assume that vendor updates are operationally neutral.

Downtime and Business Continuity

Organizations should maintain contingency processes for:

• Electronic health record downtime
• Payer portal failure
• Internet disruption
• Authorization-platform outage
• Scheduling-system failure
• Device-platform failure
• Cybersecurity incident

The downtime process should preserve patient safety, procedure readiness, documentation, and case visibility.

Data Quality Monitoring

Technology does not guarantee accurate data.

The organization should monitor:

• Duplicate patients
• Missing fields
• Incorrect mappings
• Stale statuses
• Interface failures
• Wrong provider attribution
• Incorrect payer identification
• Outcome linkage errors
• Manual overrides
• Data quality issues should be assigned to accountable owners.

Measuring Technology Value

Technology should be evaluated according to whether it improves:

• Patient access
• Documentation completeness
• Authorization performance
• Readiness
• Provider efficiency
• Staff workload
• Clinical safety
• Outcome collection
• Data accuracy
• Cost

A system that adds administrative effort without measurable benefit should be redesigned, replaced, or discontinued.

GoHealthcare Insights

Healthcare organizations frequently purchase technology before redesigning the workflow.

The result is an expensive digital layer placed over the same fragmented process.

The GoHealthcare model reverses that sequence.

The organization first defines the operating standard, ownership, data requirements, and escalation. Technology is then selected or configured to support that model.

Leadership Perspective

Technology decisions are clinical and operational governance decisions.

Executives should not delegate responsibility solely to information technology or vendors.

Clinical leaders, operations, compliance, quality, data, and frontline users must participate in selection, implementation, validation, and monitoring.

Key Takeaways

• Technology supports clinical and utilization excellence but does not replace clinical judgment or accountability.
• The organization should define the workflow before automating it.
• Critical data require standardized definitions and authoritative sources.
• Artificial intelligence outputs must be verified by qualified humans.
• AI governance should address approved use, accuracy, privacy, security, bias, auditability, and vendor practices.
• Technology value should be measured through clinical, access, operational, and workforce outcomes.

Back to top ↑

39

Continuous Improvement, Workforce Competency, and Change Management

Clinical and utilization excellence is not achieved through a one-time framework launch.

It requires continuous improvement, workforce competency, leadership reinforcement, and disciplined change management.

Policies, payer requirements, evidence, procedures, technology, staffing, and patient needs continue to evolve. An operating model that is not maintained will gradually become inconsistent, outdated, or disconnected from daily work.

The GoHealthcare Clinical & Utilization Excellence Framework™ establishes continuous improvement as the mechanism for sustaining and advancing performance.

Continuous Improvement as an Operating Discipline

Continuous improvement should help the organization:

• Identify performance gaps
• Understand root causes
• Design corrective action
• Test changes
• Measure results
• Standardize effective solutions
• Monitor sustainability
• Improvement should occur through a controlled process rather than through repeated informal workarounds.

Improvement Sources

Opportunities may arise from:

• Denial trends
• Patient complaints
• Procedure cancellations
• Provider feedback
• Staff suggestions
• Audit findings
• Near misses
• Adverse events
• Outcome data
• Payer changes
• Technology changes
• New evidence
• Variation analysis
• Improvement systems should make it easy for frontline teams to identify recurring barriers.

Root-Cause Identification

Before changing a process, the organization should determine why the problem occurs.

Potential causes may involve:

• Policy
• Workflow
• Role ambiguity
• Training
• Technology
• Staffing
• Workload
• Communication
• Payer behavior
• Facility requirements
• Patient barriers
• Vendor performance
• A weak analysis often produces more reminders or training when the actual problem is poor process design.

Improvement Prioritization

Organizations should prioritize improvement according to:

• Patient safety
• Clinical impact
• Access impact
• Frequency
• Severity
• Compliance risk
• Financial exposure
• Strategic importance
• Feasibility
• Not every problem requires an enterprise project.

Some issues can be corrected through local workflow improvement. Others require governance, technology, policy, or leadership intervention.

Structured Improvement Cycle

A structured improvement cycle may include:

• Define the problem
• Establish baseline performance
• Identify root causes
• Design the intervention
• Assign accountability
• Pilot the change
• Measure the result
• Refine the process
• Standardize the solution
• Monitor sustainability

Changes should be tested before broad deployment when patient safety or major operational consequences are possible.

Workforce Competency

Competency means that individuals can perform their assigned responsibilities accurately, safely, and consistently.

Competency should be defined for:

• Physicians
• Advanced practice providers
• Nurses
• Medical assistants
• Utilization specialists
• Authorization teams
• Procedure coordinators
• Schedulers
• Clinical documentation staff
• Quality and compliance personnel
• Data and technology teams
• Competency is more than completion of orientation or training.
• It requires demonstration of knowledge and performance.

Role-Specific Competency

Competency standards may address:

• Clinical pathways
• Medical necessity
• Payer criteria
• Documentation
• Procedure readiness
• Medication management
• Patient communication
• Technology use
• Safety reporting
• Outcome collection
• Escalation
• The standard should reflect the role’s authority and responsibility.

Nonclinical staff should understand the boundaries of their role and when clinical escalation is required.

Initial Training

New employees and providers should receive structured orientation to:

• The framework
• Organizational standards
• Clinical pathways
• Documentation expectations
• Authorization workflow
• Readiness requirements
• Communication standards
• Patient safety
• Technology systems
• Escalation
• Training should be completed before the individual independently manages high-risk responsibilities.

Ongoing Education

Ongoing education should address:

• Payer-policy changes
• New procedures
• New technology
• Updated clinical guidance
• Documentation trends
• Denial patterns
• Safety events
• Outcome performance
• Workflow changes
• Education should be concise, role-specific, and connected to actual operational needs.

Competency Validation

Competency may be validated through:

• Observation
• Case review
• Knowledge assessment
• Documentation audit
• Simulation
• Peer review
• Demonstration
• Performance data
• Completion of training alone does not confirm competent execution.

Cross-Training

Cross-training can support continuity and workload flexibility.

It may help organizations manage:

• Employee absence
• Volume changes
• Payer-specific complexity
• New service lines
• Location coverage

However, cross-training should not result in staff performing clinical functions beyond their qualifications or scope.

Change Management

Every significant change should include:

• Clear rationale
• Leadership sponsor
• Affected roles
• Workflow impact
• Training
• Technology configuration
• Communication
• Implementation date
• Support plan
• Performance measures
• Feedback pathway

The organization should explain not only what is changing but why it matters.

Stakeholder Involvement

Frontline users should participate in process design.

They can identify:

• Workflow barriers
• Unnecessary steps
• Technology limitations
• Patient communication problems
• Operational risks
• A change created without frontline input may be clinically sound but operationally impractical.

Resistance to Change

Resistance may reflect:

• Lack of understanding
• Loss of autonomy
• Increased workload
• Previous failed initiatives
• Poor technology
• Inadequate resources
• Disagreement with the standard

Leaders should distinguish legitimate concerns from simple preference for the status quo.

Credible feedback should be used to improve the implementation.

Implementation Support

Implementation may require:

• Super users
• Office hours
• Job aids
• Real-time assistance
• Workflow coaching
• Data review
• Rapid problem resolution
• Temporary staffing support

Organizations should not announce a major change and then expect adoption without support.

Adoption Monitoring

The organization should measure:

• Use of the new process
• Completion of required steps
• Provider and staff participation
• Workarounds
• Error rate
• Patient impact
• Time requirements
• Performance improvement
• A new policy may be technically active while staff continue using the previous process.

Sustainment

Improvement must be maintained.

Sustainment may require:

• Ongoing measurement
• Leadership review
• Refresher education
• Audits
• Technology controls
• Updated onboarding
• Recognition
• Accountability
• Processes often regress when attention shifts to another priority.

Workforce Capacity

Performance problems may reflect inadequate capacity rather than poor competency.

Leadership should assess:

• Case volume
• Complexity
• Staffing levels
• Provider responsiveness
• Technology burden
• Payer demands
• Appeal volume
• Procedure growth
• Capacity planning should account for work complexity, not merely the number of cases.

Employee Well-Being

High administrative burden, repeated payer conflict, urgent procedure rescue, and unclear accountability can contribute to burnout.

The framework should reduce unnecessary rework and cognitive burden.

Workforce sustainability supports:

• Accuracy
• Patient communication
• Retention
• Safety
• Continuous improvement

Recognition and Accountability

Leaders should recognize:

• Process improvement
• Strong documentation
• Reliable coordination
• Safety reporting
• High-quality patient communication
• Sustained performance improvement

Persistent failure to follow established standards should also be addressed through appropriate accountability.

Recognition and accountability should operate together.

GoHealthcare Insights

Organizations frequently respond to performance problems by repeating training.

Training cannot correct:

Unclear ownership

Poor technology

Incomplete data

Excessive workload

Contradictory policies

Inadequate staffing

The GoHealthcare model treats education as one intervention within a broader operating system.

Leadership Perspective

Leaders should manage change as an operational responsibility, not a communication event.

The announcement of a new framework, policy, checklist, or technology does not constitute implementation.

Implementation is complete only when the new behavior is visible, measurable, reliable, and sustained.

Key Takeaways

• Clinical and utilization excellence requires continuous improvement rather than one-time implementation.
• Improvement should begin with root-cause analysis and measurable baseline performance.
• Competency must be demonstrated, not assumed from training attendance.
• Change management requires leadership sponsorship, frontline involvement, education, support, measurement, and sustainment.
• Repeated performance problems may reflect process, capacity, technology, or governance failure rather than lack of employee effort.
• The organization should build improvement into its normal operating rhythm.

Back to top ↑

40

Framework Implementation, Maturity, and Enterprise Accountability

The GoHealthcare Clinical & Utilization Excellence Framework™ is intended to function as an enterprise operating model.

It should not remain a conceptual document, website statement, committee presentation, or collection of policies.

Implementation requires the organization to convert the framework’s six domains into defined governance, workflows, responsibilities, technology, data, education, and measurable performance.

The six domains are:

• Medical Necessity
• Evidence-Based Care
• Utilization Management
• Clinical Documentation
• Procedure Readiness
• Quality and Care Coordination
• Technology, data, automation, and performance intelligence support all six domains.

The Implementation Objective

The objective is to create a clinical operating system in which:

• Appropriate care is clearly identified
• Clinical decisions are supported by evidence
• Documentation communicates medical necessity
• Payer requirements are anticipated
• Authorization is managed reliably
• Procedures are fully prepared
• Patients receive coordinated communication
• Outcomes are measured
• Risks are escalated
• Leadership can see and improve performance

Implementation should make appropriate care easier to deliver and administrative failure more difficult to overlook.

Executive Sponsorship

The framework requires an executive sponsor with authority to:

• Establish organizational priority
• Allocate resources
• Resolve cross-functional barriers
• Support physician leadership
• Hold departments accountable
• Approve technology and staffing investments
• Review performance
• Executive sponsorship should remain active beyond the launch phase.

Clinical Leadership

A designated physician or clinical leadership group should oversee:

• Clinical pathways
• Medical necessity standards
• Procedure-specific criteria
• Clinical exceptions
• Provider variation
• Safety
• Outcome review
• Evidence updates
• Clinical leadership ensures that operational standardization remains clinically credible.

Governance Structure

The organization should establish a Clinical and Utilization Excellence Committee or equivalent body.

The committee should include appropriate representation from:

• Physician leadership
• Advanced practice providers
• Clinical operations
• Utilization management
• Patient access
• Prior authorization
• Clinical documentation
• Procedure scheduling
• Facility operations
• Quality and safety
• Compliance
• Revenue cycle
• Technology
• Data analytics
• Executive leadership

The governance body should have a written charter, decision authority, meeting cadence, and reporting responsibility.

Implementation Phases

Implementation should occur in structured phases.

Foundation Phase

The organization should establish:

• Executive sponsorship
• Governance charter
• Framework ownership
• Current-state assessment
• Baseline metrics
• Priority procedures
• Role definitions
• Initial data standards
• The foundation phase creates the structure required for coordinated implementation.

Standardization Phase

The organization should develop:

• Medical necessity standards
• Clinical pathways
• Procedure-specific documentation requirements
• Authorization workflows
• Readiness checklists
• Escalation pathways
• Patient communication standards
• Outcome measures

Standardization should begin with high-volume, high-risk, high-denial, or strategically important services.

Integration Phase

The organization should connect:

• Clinical documentation
• Utilization review
• Authorization
• Scheduling
• Facility readiness
• Patient communication
• Follow-up
• Outcome measurement
• The goal is one visible episode rather than multiple departmental processes.

Technology Enablement Phase

Technology should then support:

• Structured work queues
• Case status
• Task ownership
• Payer intelligence
• Documentation prompts
• Readiness alerts
• Patient communication
• Outcome collection
• Dashboards
• Technology should reinforce the standardized operating model.

Performance Optimization Phase

The organization should use data to improve:

• Access
• Initial approval rate
• Documentation completeness
• Procedure readiness
• Cancellation prevention
• Patient safety
• Treatment outcomes
• Provider variation
• Workforce efficiency

This phase establishes continuous improvement as the normal operating model.

Current-State Assessment

The organization should evaluate its present capabilities across all six domains.

The assessment may examine:

• Governance
• Clinical pathways
• Medical necessity review
• Payer intelligence
• Documentation
• Authorization
• Procedure readiness
• Patient communication
• Quality
• Outcomes
• Technology
• Data
• Workforce competency
• The assessment should identify both formal processes and actual frontline behavior.

Framework Maturity Levels

Organizations may evaluate progress through a maturity model.

Initial Maturity

At the initial level:

• Processes depend on individual experience.
• Work is managed through email, memory, and disconnected spreadsheets.
• Policies are inconsistent.
• Case status is unclear.
• Problems are discovered late.
• Performance data are limited.
• Success depends on individual heroics.

Developing Maturity

At the developing level:

• Core workflows are documented.
• Priority procedures have standards.
• Authorization tracking is more consistent.
• Some readiness controls exist.
• Basic performance measures are available.
• Variation remains significant.
• Departments continue to operate partially in silos.

Defined Maturity

At the defined level:

• Governance is established.
• Clinical pathways and documentation standards are controlled.
• Roles and escalation processes are clear.
• Payer intelligence is centralized.
• Procedure readiness is standardized.
• Patient communication follows defined expectations.
• Performance is reviewed consistently.

Integrated Maturity

At the integrated level:

• Clinical, utilization, documentation, scheduling, facility, and outcome workflows operate as one coordinated pathway.
• Technology supports shared status and accountability.
• Leading indicators identify risk before failure.
• Outcome data inform treatment decisions.
• Cross-functional governance resolves system problems.

Optimized Maturity

At the optimized level:

• Performance intelligence drives continuous improvement.
• Clinical and operational variation is actively managed.
• Automation reduces administrative burden.
• Artificial intelligence operates under formal governance.
• Patient outcomes influence strategy and payer discussions.

The organization continuously updates pathways, workforce competencies, and technology.

Performance remains reliable despite growth, staffing changes, and increasing complexity.

Enterprise Accountability

Every executive and clinical leader should understand how their function affects the framework.

Physician leadership owns clinical appropriateness and standards.

Clinical operations own reliable care delivery and documentation support.

Utilization management owns payer review, case progression, and escalation.

Scheduling owns readiness-based coordination.

Facility leadership owns safe operational execution.

Quality owns event analysis, outcomes, and improvement.

Compliance owns integrity and regulatory alignment.

Technology owns reliable system enablement.

Data leadership owns accurate performance intelligence.

Executive leadership owns enterprise alignment.

No department can achieve framework excellence independently.

Prioritizing the Initial Scope

Organizations should not attempt to redesign every service simultaneously.

Initial priorities may include:

• High-volume procedures
• High-denial procedures
• Implant-based services
• Procedures with frequent cancellations
• Services with significant provider variation
• Procedures with incomplete outcome data
• Strategic service lines

The organization should select a manageable scope and demonstrate measurable improvement before expanding.

The First Ninety Days

A practical first ninety-day implementation may include:

• Establishing governance
• Completing the current-state assessment
• Selecting initial procedures
• Defining baseline measures
• Mapping the current workflow
• Identifying major failure points
• Assigning episode ownership
• Developing medical necessity and documentation standards
• Creating readiness controls
• Implementing an operational review cadence
• The initial phase should produce visible operational change, not only planning documents.

The First Year

Within the first year, the organization should work toward:

• Standardized priority pathways
• Centralized payer intelligence
• Defined documentation standards
• Integrated utilization workflows
• Procedure-readiness dashboards
• Outcome collection
• Provider education
• Quality and safety reporting
• Technology integration
• Quarterly framework performance review

The organization should expand based on demonstrated readiness and results.

Resource Requirements

Implementation may require investment in:

• Clinical leadership time
• Utilization expertise
• Documentation integrity
• Procedure coordination
• Quality improvement
• Data analytics
• Technology
• Training
• Change management

The organization should avoid assuming that existing staff can absorb major framework implementation without workload adjustment.

Implementation Risks

Common risks include:

• Insufficient physician engagement
• Lack of executive sponsorship
• Too many priorities
• Unclear accountability
• Technology implemented before process design
• Excessive documentation burden
• Inadequate data
• Failure to address staffing capacity
• Policies without workflow integration
• Failure to sustain changes
• Governance should monitor these risks throughout implementation.

Measuring Framework Success

Framework success should be demonstrated through improvements in:

• Appropriate patient access
• Initial authorization approval
• Authorization turnaround
• Documentation completeness
• Procedure readiness
• Cancellation prevention
• Patient communication
• Safety
• Clinical outcomes
• Provider efficiency
• Staff workload
• Performance sustainability
• No single measure should define success.

Scaling the Framework

As the organization grows, the framework should support:

• New providers
• New locations
• New facilities
• New procedures
• New payer contracts
• New technologies
• Acquisitions
• Partnerships
• Centralized services

Scalability depends on standardized processes, controlled knowledge, reliable data, role clarity, and governance.

Growth without standardization magnifies inconsistency.

Protecting Clinical Autonomy

The framework should support physician judgment rather than replace it.

Standardization should focus on:

• Reliable information
• Safe processes
• Clear documentation
• Consistent readiness
• Evidence-informed care
• Outcome measurement

The physician retains authority to make patient-specific decisions and document clinically justified exceptions.

The GoHealthcare Standard

The GoHealthcare standard is not defined by the number of authorizations completed, procedures performed, or policies written.

It is defined by the organization’s ability to reliably answer:

• Why is this care appropriate?
• Does the record clearly support it?
• Does the patient meet applicable clinical and coverage requirements?
• Is the procedure fully prepared?
• Is the patient safe and informed?
• Did the treatment produce meaningful benefit?
• What did the organization learn?
• What will leadership improve next?

GoHealthcare Insights

Clinical excellence is often discussed as an individual professional attribute.

The GoHealthcare model recognizes that individual clinical expertise requires a reliable operating environment.

Even an excellent physician can be undermined by incomplete documentation, outdated payer information, unclear medication instructions, poor readiness, fragmented communication, or absent follow-up.

The framework builds the infrastructure that allows clinical expertise to produce consistent patient access, quality, and outcomes.

Leadership Perspective

The framework should become part of how the organization is led.

It should influence:

Strategic planning

Leadership meetings

Clinical governance

Provider onboarding

Staff education

Technology investment

Payer strategy

Facility relationships

Quality improvement

Performance evaluation

When the framework becomes embedded in leadership decisions and daily operations, clinical and utilization excellence becomes an enterprise capability rather than a temporary initiative.

Key Takeaways

• The GoHealthcare Clinical & Utilization Excellence Framework™ must be implemented as an operating model, not maintained as a conceptual document.
• Executive sponsorship and physician leadership are essential.
• Implementation should proceed through foundation, standardization, integration, technology enablement, and performance optimization.
• Maturity progresses from individual-dependent work to integrated, data-driven, continuously improving clinical operations.
• Every department has defined accountability within the framework.
• Success requires measurable improvement in appropriateness, access, documentation, authorization, readiness, safety, outcomes, and workforce performance.
• The framework is complete when its standards are visible in daily behavior, supported by technology and data, and sustained through governance and leadership accountability.

Back to top ↑

↗

References and Related Reading

Medicare Coverage, Prior Authorization, and Appeals

CMS Medicare Coverage Database

Use this database to locate current National Coverage Determinations, Local Coverage Determinations, and Medicare billing and coding articles.

Visit resource →

CMS Medicare Coverage Center

Visit resource →

CMS Local Coverage Determination Process and Resources

Visit resource →

CMS Medicare Program Integrity Manual

The complete manual page provides access to the current chapters and revisions.

Visit resource →

CMS Medicare Program Integrity Manual, Chapter 3: Verifying Potential Errors and Taking Corrective Actions

Visit resource →

CMS Prior Authorization and Pre-Claim Review Initiatives

Visit resource →

CMS Electronic Prior Authorization

Visit resource →

CMS Interoperability and Prior Authorization Final Rule, CMS-0057-F

Visit resource →

CMS Medicare Part C Utilization Management Annual Data Submission

Visit resource →

CMS Medicare Advantage Program Audits

Visit resource →

CMS Appealing Health Plan Decisions

Visit resource →

Quality, Patient Safety, and Care Coordination

Agency for Healthcare Research and Quality: Patient Safety

Visit resource →

AHRQ Care Coordination

Visit resource →

AHRQ Care Coordination Measurement Framework

Visit resource →

AHRQ Care Coordination Measures Atlas

Visit resource →

ONC SAFER Guides for Electronic Health Record Safety

The updated SAFER Guides support clinical communication, system management, contingency planning, order entry, patient identification, and test-result follow-up.

Visit resource →

Joint Commission National Performance Goal: Right Patient, Right Care

Visit resource →

Joint Commission Sentinel Event Policy and Procedures

Visit resource →

Joint Commission Speak Up for Safe Surgery

Visit resource →

MSK Specialty Guidelines and Evidence Resources

American Academy of Orthopaedic Surgeons Clinical Practice Guidelines

Visit resource →

AAOS Guideline and Evidence Methodology

Visit resource →

North American Spine Society Clinical Guidelines

Visit resource →

North American Spine Society Coverage Recommendations

Some detailed recommendations require member, purchaser, or payer access.

Visit resource →

American Society of Interventional Pain Physicians Guidelines

Visit resource →

ClinicalTrials.gov

This resource may be used when reviewing emerging procedures, devices, implants, and developing evidence.

Visit resource →

Compliance, Documentation Integrity, Technology, and AI Governance

HHS Office of Inspector General General Compliance Program Guidance

Visit resource →

HHS-OIG General Compliance Program Guidance PDF

Visit resource →

OIG Compliance Programs for Physicians

Visit resource →

HHS HIPAA for Professionals

Visit resource →

HHS Summary of the HIPAA Privacy Rule

Visit resource →

HHS Summary of the HIPAA Security Rule

Visit resource →

HHS Guidance on HIPAA Security Risk Analysis

Visit resource →

NIST Artificial Intelligence Risk Management Framework

NIST states that AI RMF 1.0 is being revised, so GoHealthcare should monitor this page for the current version and implementation resources.

Visit resource →

ONC HTI-1 Final Rule

Visit resource →

FDA Clinical Decision Support Software Guidance

Visit resource →

FDA Clinical Decision Support Software Frequently Asked Questions

Visit resource →

FDA Digital Health Guidance Resources

Visit resource →

Back to top ↑

↗

GoHealthcare Related Reading

Core GoHealthcare Operational Excellence Frameworks

These pages establish the broader internal-linking architecture surrounding the Clinical & Utilization Excellence Framework™. The URLs are live on the GoHealthcare website.

GoHealthcare Clinical & Utilization Excellence Framework™

Visit resource →

GoHealthcare Patient Access Excellence Framework™

Visit resource →

GoHealthcare Regulatory, Risk & Compliance Excellence Framework™

Visit resource →

GoHealthcare Technology, Data & AI Excellence Framework™

Visit resource →

GoHealthcare Performance Intelligence Excellence Framework™

Visit resource →

GoHealthcare Leadership, Governance & Organizational Excellence Framework™

Visit resource →

Prior Authorization, Utilization Management, and Medical Necessity

Prior Authorization Overview for Pain Management, Spine, Orthopedic Surgery, Neurosurgery, Neuromodulation, and ASCs

Visit resource →

Our Prior Authorization Process

This is the strongest related internal link for the Utilization Management domain because it contains the complete 40-section GoHealthcare operating process.

Visit resource →

Prior Authorization Services

Visit resource →

Medical Necessity

Visit resource →

Pain Management Prior Authorization

Visit resource →

Prior Authorization in Interventional Pain Management: A Strategic Framework for Clinical, Financial, and Compliance Alignment

Visit resource →

Why Medical Necessity Matters Under CMS Guidance in 2026 for Pain and Orthopedic Procedures

Visit resource →

Mastering Prior Authorization for Advanced Interventional Pain Procedures

Visit resource →

Sample Letter of Medical Necessity for Interventional Pain Management

This should be identified as a sample requiring patient-specific clinical review and customization.

Visit resource →

CMS WISeR Prior Authorization for Pain Management in 2026

Visit resource →

How Prior Authorization Affects Reimbursement for Pain Management and Orthopedic Services

Visit resource →

MSK Specialty and Procedure Resources

Radiofrequency Ablation Procedure Knowledge Center

Visit resource →

Radiofrequency Ablation Documentation Guidance

Visit resource →

Neuromodulation

Visit resource →

Spinal Surgery

Visit resource →

Neurosurgery

Visit resource →

Orthopedics

Visit resource →

Sample Letter of Medical Necessity for Minimally Invasive SI Joint Fusion

Visit resource →

Sample Letter of Medical Necessity for Orthopedic Knee Surgery

Visit resource →

Revenue Cycle, Documentation, Compliance, and Performance

Our Revenue Cycle Management Process

Visit resource →

GoHealthcare RCM Framework™

Visit resource →

Revenue Cycle Management Overview

Visit resource →

Technology and AI in Revenue Cycle Management

Visit resource →

RCM Key Performance Indicators for MSK Specialty Care

Visit resource →

MSK Compliance and Audit Readiness

Visit resource →

Frequently Asked RCM Questions for MSK Specialty Care

Visit resource →

Why CMS Audits Are Increasing in 2026 for Pain and Orthopedic Practices

Visit resource →

Technology and AI Related Reading

AI in Revenue Cycle Management: What Every Medical Practice Should Know Now

Visit resource →

AI in Specialty Coding: The 2026 Leadership Blueprint for Accuracy, Compliance, and Revenue Integrity

Visit resource →

Why Healthcare Leaders Must Trust AI in 2026

Visit resource →

Case Study and Knowledge Center

Case Study: Prior Authorization and Clinical Operations Support

Visit resource →

GoHealthcare Blog and Knowledge Articles

Visit resource →

Back to top ↑

Disclaimer: This framework is provided for educational and operational guidance only. It does not constitute medical, legal, coding, reimbursement, or compliance advice and does not replace clinical judgment or current payer, regulatory, contractual, accreditation, or facility requirements. Organizations should verify applicable requirements with current authoritative sources and qualified advisors.